Gene info: ID 5468

Gene: PPARG

GENE ID: 5468

Description: peroxisome proliferator activated receptor gamma

Gene type: protein-coding

Location: 3p25.2

dbXrefs: Ensembl:ENSG00000132170 MIM:601487 Vega:OTTHUMG00000129764 UniprotKB:P37231

RefSeq: NG_011749.1

Retrived from: PubMed|SNP Mapped

SNPs: 1 ANCO-SNPs

Phenotype: ND|AD

# Publications: 20

Sherlock p-value : NA (AD) NA (ND) (Frontal_Cortex)

Pascal p-value : 8.014e-1 (AD) 5.125e-2 (ND)

ANCO-SNPs

SNP ID	Position	Alleles	Trait	Variation Type
rs4135275	chr3:12402345 (GRCh38.p7)	A>G	alcohol dependence	SNV(Single Nucleotide Variation)

DNA Methylation

There is no related methylation information for this gene.

Gene Expression in Different Tissues

Temporal and Spatial Expressions (BrainSpan)

Footnote:
SC: sub-cortical regions; SM: sensory-motor regions; FC: frontal cortex; and TP: temporal-parietal cortex
ST1: fetal (13 - 26 postconception weeks), ST2: early infancy to late childhood (4 months to 11 years), and ST3: adolescence to adulthood (13 - 23 years)
The bar shown representes average value of the expressions.

Top Co-expressed Genes in Brain-Frontal Cortex (BA9) (GTEx v7)

Top 10 positively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
RAB11FIP1	0.782
CDC42EP3	0.741
ATF7IP2	0.74
SLC37A1	0.717
CDC6	0.712
CD276	0.71
PLEKHA2	0.708
BAHD1	0.707
SRXN1	0.707
MAN1C1	0.705

Top 10 negatively co-expressed genes

Gene Symbol	Pearson Correlation Coefficient
CTNNA3	-0.457
PAIP2B	-0.421
MOBP	-0.416
SLCO1A2	-0.404
C5orf64	-0.393
FXYD4	-0.374
ZFP57	-0.365
TRPV5	-0.365
SNX22	-0.364
LPAR1	-0.361

ID	Drug Name	Drug Type	CAS Num	Status	Role
DB00132	Alpha-Linolenic Acid	Small Molecule	463-40-1	Approved\|Nutraceutical	Target
DB00159	Icosapent	Small Molecule	10417-94-4	Approved\|Nutraceutical	Target
DB00197	Troglitazone	Small Molecule	97322-87-7	Investigational\|Withdrawn	Target
DB00244	Mesalazine	Small Molecule	89-57-6	Approved	Target
DB00313	Valproic Acid	Small Molecule	99-66-1	Approved\|Investigational	Target
DB00328	Indomethacin	Small Molecule	53-86-1	Approved\|Investigational	Target
DB00412	Rosiglitazone	Small Molecule	122320-73-4	Approved\|Investigational	Target
DB00573	Fenoprofen	Small Molecule	29679-58-1	Approved	Target
DB00731	Nateglinide	Small Molecule	105816-04-4	Approved\|Investigational	Target
DB00795	Sulfasalazine	Small Molecule	599-79-1	Approved	Target
DB00912	Repaglinide	Small Molecule	135062-02-1	Approved\|Investigational	Target
DB00966	Telmisartan	Small Molecule	144701-48-4	Approved\|Investigational	Target
DB01014	Balsalazide	Small Molecule	80573-04-2	Approved\|Investigational	Target
DB01039	Fenofibrate	Small Molecule	49562-28-9	Approved	Target
DB01050	Ibuprofen	Small Molecule	15687-27-1	Approved	Target
DB01067	Glipizide	Small Molecule	29094-61-9	Approved\|Investigational	Target
DB01118	Amiodarone	Small Molecule	1951-25-3	Approved\|Investigational	Target
DB01132	Pioglitazone	Small Molecule	111025-46-8	Approved\|Investigational	Target
DB01252	Mitiglinide	Small Molecule	145375-43-5	Approved\|Investigational	Target
DB01393	Bezafibrate	Small Molecule	41859-67-0	Approved\|Investigational	Target
DB02266	Flufenamic Acid	Small Molecule	530-78-9	Experimental	Target
DB02709	Resveratrol	Small Molecule	501-36-0	Approved\|Experimental\|Investigational	Target
DB02746	Phthalic Acid	Small Molecule	88-99-3	Experimental	Target
DB03600	Capric acid	Small Molecule	334-48-5	Experimental	Target
DB03756	Doconexent	Small Molecule	6217-54-5	Approved\|Investigational	Target
DB04224	Oleic Acid	Small Molecule	112-80-1	Approved\|Investigational	Target
DB04270	(S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid	Small Molecule		Experimental	Target
DB04689	2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	Small Molecule		Experimental	Target
DB04971	Reglixane	Small Molecule	-	Investigational	Target
DB05187	Elafibranor	Small Molecule	923978-27-2	Investigational	Target
DB05490	T131	Small Molecule	-	Investigational	Target
DB05854	CLX-0921	Small Molecule	-	Investigational	Target
DB06510	Muraglitazar	Small Molecule	331741-94-7	Investigational	Target
DB06521	Ertiprotafib	Small Molecule	251303-04-5	Investigational	Target
DB06533	Ragaglitazar	Small Molecule	222834-30-2	Investigational	Target
DB06536	Tesaglitazar	Small Molecule	251565-85-2	Investigational	Target
DB06908	(2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID	Small Molecule		Experimental	Target
DB06926	(9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid	Small Molecule		Experimental	Target
DB07053	2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID	Small Molecule		Experimental	Target
DB07111	(4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid	Small Molecule		Experimental	Target
DB07172	(5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid	Small Molecule		Experimental	Target
DB07208	(8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid	Small Molecule		Experimental	Target
DB07209	(8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid	Small Molecule		Experimental	Target
DB07302	(9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid	Small Molecule		Experimental	Target
DB07509	difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron	Small Molecule		Experimental	Target
DB07675	(2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID	Small Molecule		Experimental	Target
DB07723	3-(5-methoxy-1H-indol-3-yl)propanoic acid	Small Molecule		Experimental	Target
DB07724	Indeglitazar	Small Molecule	835619-41-5	Experimental	Target
DB07842	(2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid	Small Molecule		Experimental	Target
DB07863	2-chloro-5-nitro-N-phenylbenzamide	Small Molecule		Experimental	Target
DB08121	(2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid	Small Molecule		Experimental	Target
DB08302	3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid	Small Molecule		Experimental	Target
DB08402	2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID	Small Molecule		Experimental	Target
DB08435	(5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid	Small Molecule		Experimental	Target
DB08560	3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE	Small Molecule		Experimental	Target
DB08604	Triclosan	Small Molecule	3380-34-5	Approved\|Investigational	Target
DB08760	(2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid	Small Molecule		Experimental	Target
DB08915	Aleglitazar	Small Molecule	475479-34-6	Investigational	Target
DB09006	Clinofibrate	Small Molecule	30299-08-2	Approved	Target
DB09061	Cannabidiol	Small Molecule	13956-29-1	Approved\|Investigational	Target
DB09198	Lobeglitazone	Small Molecule	607723-33-1	Approved\|Investigational	Target
DB09201	Ciglitazone	Small Molecule	74772-77-3	Experimental	Target
DB09213	Dexibuprofen	Small Molecule	51146-56-6	Approved\|Investigational	Target
DB11133	Omega-3 fatty acids	Small Molecule	329042-31-1	Approved\|Nutraceutical	Target
DB11672	Curcumin	Small Molecule	458-37-7	Approved\|Investigational	Target
DB11811	Arhalofenate	Small Molecule	24136-23-0	Investigational	Target
DB12662	Naveglitazar	Small Molecule	476436-68-7	Investigational	Target
DB13873	Fenofibric acid	Small Molecule	42017-89-0	Approved	Target

ID	Drug Name	Action	PubMed
C492909	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	"1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased activity of PPARG protein"	15345676
C492909	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	"2-chloro-5-nitrobenzanilide inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased activity of PPARG protein]"	15345676
C492909	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide]"	18041089
C492909	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	"1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein"	18041089
C492909	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with IFNG protein co-treated with TNF protein] results in increased expression of BAX protein]"	18041089
C492909	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] promotes the reaction [NCOR2 protein binds to NOS2 enhancer]]"	18041089
C492909	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] promotes the reaction [RELA protein binds to NOS2 promoter]]"	18041089
C492909	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]"	18041089
C492909	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein]"	18041089
C492909	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [manganese chloride promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]]"	18041089
C492909	1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] results in decreased susceptibility to [manganese chloride co-treated with IFNG protein co-treated with TNF protein]"	18041089
C576882	1-(2-trifluoromethoxyphenyl)-2-nitroethanone	1-(2-trifluoromethoxyphenyl)-2-nitroethanone affects the activity of PPARG protein	25596134
C038649	13-hydroperoxy-9,11-octadecadienoic acid	"13-hydroperoxy-9,11-octadecadienoic acid results in increased expression of PPARG protein"	22135674
C038806	1,4-dihydropyridine	"1,4-dihydropyridine results in increased activity of PPARG protein"	25257666
C046760	15-acetyldeoxynivalenol	15-acetyldeoxynivalenol results in decreased activity of PPARG protein	27481073
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 affects the expression of PPARG"	15254749
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 affects the localization of and results in increased expression of PPARG protein"	23943857
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in decreased activity of PPARG protein"	12839938
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in increased activity of PPARG protein"	12065695\|1260436
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in increased localization of and results in increased activity of PPARG protein"	11030710
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [deoxynivalenol results in increased expression of PPARG protein]"	18485432
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of PPARG mRNA]"	14625208
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]"	12604364
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of PPARG protein"	17341418
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein"	15707588\|2617226
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of PPARG mRNA"	11278336
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein]"	15707588
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"MG 262 promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein]"	15707588
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"PPARG protein affects the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in decreased expression of TBXA2R mRNA alternative form]"	16499875
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"PPARG protein mutant form results in decreased susceptibility to 15-deoxy-delta(12,14)-prostaglandin J2"	19922793
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in increased activity of PPARG protein"	12847270
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]"	12847270
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein"	15322177
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"MED1 protein promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein]"	16324150
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [AGT protein results in decreased expression of PPARG protein]"	18278065
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]"	15994020
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of PPARG mRNA"	10662598\|1599402
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 results in increased expression of PPARG protein"	10662598\|1521294
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 binds to and affects the activity of PPARG protein"	16303604
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in increased activity of PPARG protein"	11687581\|1297009
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"[15-deoxy-delta(12,14)-prostaglandin J2 binds to and results in increased activity of PPARG protein] which results in decreased secretion of LEP protein"	16037295
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 binds to PPARG protein"	10813377\|1107870
C097240	15-deoxy-delta(12,14)-prostaglandin J2	"15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein"	16712844
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 affects the localization of PPARG protein	23220503
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]	15531761
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 results in increased activity of PPARG protein	10866999\|1251797
C477819	15-deoxyprostaglandin J2	[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein	23964924
C477819	15-deoxyprostaglandin J2	[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species	23964924
C477819	15-deoxyprostaglandin J2	[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to docetaxel	23964924
C477819	15-deoxyprostaglandin J2	[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to Doxorubicin	23964924
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 results in increased expression of PPARG mRNA	21354099\|2151191
C477819	15-deoxyprostaglandin J2	2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxyprostaglandin J2 results in increased activity of PPARG protein]	22992727
C477819	15-deoxyprostaglandin J2	2-chloro-5-nitrobenzanilide inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species]	23964924
C477819	15-deoxyprostaglandin J2	Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species]	23964924
C477819	15-deoxyprostaglandin J2	Fluticasone promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]]	15531761
C477819	15-deoxyprostaglandin J2	Salmeterol Xinafoate promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]]	15531761
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein	17891158
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 affects the localization of and results in increased activity of PPARG protein	16912651
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein	15876570
C477819	15-deoxyprostaglandin J2	[15-deoxyprostaglandin J2 co-treated with AGT protein] results in increased expression of PPARG protein	25874449
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 inhibits the reaction [AGT protein results in decreased activity of PPARG protein]	25874449
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 promotes the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide binds to and results in increased activity of PPARG protein]	15876570
C477819	15-deoxyprostaglandin J2	4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide promotes the reaction [15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein]	15876570
C477819	15-deoxyprostaglandin J2	PPARG mutant form inhibits the reaction [15-deoxyprostaglandin J2 inhibits the reaction [AGT protein results in increased expression of KLF5 protein]]	25874449
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein	16034372\|2402578
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 binds to PPARG protein	10600944\|1742560
C477819	15-deoxyprostaglandin J2	15-deoxyprostaglandin J2 results in increased activity of [RXRA protein binds to PPARG protein]	11752099
C477819	15-deoxyprostaglandin J2	2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein]	24025786
C062894	17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid	"17-hydroxy-4,7,10,13,15,19-docosahexaenoic acid binds to and affects the activity of PPARG protein"	17056761
C119129	18alpha-glycyrrhetinic acid	18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA]	28414158
C119129	18alpha-glycyrrhetinic acid	18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein]	28414158
C078632	1-acyl-2-(12-((7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl)phosphatidylcholine	"[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased uptake of 1-acyl-2-(12-((7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl)phosphatidylcholine]"	21123845
C513115	1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester	PPARG mRNA affects the susceptibility to 1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester	17535976
C513115	1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester	1-(methylimino-N-oxy)-6-(2-morpholinoethoxy)-3-phenyl-1H-indene-2-carboxylic acid ethyl ester binds to and results in increased activity of PPARG protein	17535976
C548651	2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester	2-(1'H-indolo-3'-carbonyl)thiazole-4-carboxylic acid methyl ester results in decreased expression of PPARG mRNA	19933214
C541131	2,2',3,3',4,4',5-heptachlorobiphenyl	"2,2',3,3',4,4',5-heptachlorobiphenyl results in increased activity of PPARG protein"	27602593
C477694	2,2',4,4',5-brominated diphenyl ether	"2,2',4,4',5-brominated diphenyl ether metabolite binds to PPARG protein"	25314719
C477694	2,2',4,4',5-brominated diphenyl ether	"2,2',4,4',5-brominated diphenyl ether results in increased activity of PPARG protein"	27602593
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether results in increased activity of PPARG protein"	24559133
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether analog results in increased activity of PPARG protein"	28282128
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether binds to and results in increased activity of PPARG protein"	23398518
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether binds to PPARG protein"	25314719
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether metabolite binds to PPARG protein"	25314719
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether metabolite results in increased activity of PPARG protein"	26172262
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether results in increased activity of PPARG protein"	26172262
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PPARG mRNA"	23146750
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether results in decreased methylation of PPARG promoter"	24559133
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PPARG mRNA"	24559133\|2911273
C511295	2,2',4,4'-tetrabromodiphenyl ether	"ESR1 gene mutant form inhibits the reaction [2,2',4,4'-tetrabromodiphenyl ether results in increased expression of PPARG mRNA]"	29112739
C511295	2,2',4,4'-tetrabromodiphenyl ether	"2,2',4,4'-tetrabromodiphenyl ether results in increased activity of PPARG protein"	27602593
C483845	2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid	2-(2-(4-phenoxy-2-propylphenoxy)ethyl)indole-5-acetic acid binds to and results in increased activity of PPARG protein	17259670
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein]	17030193
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]	17030193
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]	16945329
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased phosphorylation of PPARG protein	22593575
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide results in decreased expression of and results in decreased activity of PPARG protein]	22137902
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]	12758056\|1505041
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of PPARG mRNA	21352814
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of PPARG protein	21352814
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of PPARG mRNA	17372590
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in increased expression of PPARG protein	17372590
C093973	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [LEP protein inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]]	21352814
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in decreased activity of PPARG protein"	12927354\|1499830
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in increased localization of and results in increased activity of PPARG protein"	11030710
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Capsaicin results in increased activity of PPARG protein]"	15383218
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Docosahexaenoic Acids results in increased activity of PPARG protein]"	15698426
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eicosapentaenoic Acid results in increased activity of PPARG protein]"	15698426
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Indomethacin results in increased activity of PPARG protein]"	12485869
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]"	12927354
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein results in increased susceptibility to troglitazone]"	12824901
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein"	21543282
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in decreased activity of PPARG protein"	15187150\|1827218
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in increased activity of PPARG protein"	11991651
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [butylparaben results in increased expression of PPARG mRNA]"	22956630
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of PPARG mRNA]"	23264188
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eugenol analog binds to and results in increased activity of PPARG protein]"	20064974
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [magnolol binds to and results in increased activity of PPARG protein]"	20064974
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane results in increased expression of PPARG mRNA"	11991651
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in decreased activity of PPARG protein"	24011919\|2418820
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA]"	22989705
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Genistein results in increased activity of PPARG protein]"	19903033
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG mRNA]]"	24612634
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG protein]]"	24612634
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [TRIB3 protein affects the expression of PPARG protein]"	21190014
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]]"	27274199
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein"	27363640
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane results in decreased expression of PPARG protein"	22726273
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in decreased activity of PPARG protein"	14519784
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [troglitazone results in increased activity of PPARG protein]"	14506076
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]"	27602593
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane binds to and affects the activity of PPARG protein"	16303604
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane binds to and results in decreased activity of PPARG protein"	10636887\|1189074
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]"	10636887
C019273	2,2-bis(4-glycidyloxyphenyl)propane	"2,2-bis(4-glycidyloxyphenyl)propane results in decreased activity of PPARG protein"	16567512\|1698204
C116893	2,2-dichloro-12-(p-chlorophenyl)-dodecanoic acid	"2,2-dichloro-12-(p-chlorophenyl)-dodecanoic acid results in increased activity of PPARG protein"	15273253
C558395	2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone	"2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of PPARG mRNA]"	21315688
C014024	2,4,5,2',4',5'-hexachlorobiphenyl	"2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]"	27602593
C004554	2,4,6-tribromophenol	"2,4,6-tribromophenol binds to PPARG protein"	25314719
C024564	2,4,6-trichlorophenol	"2,4,6-trichlorophenol binds to PPARG protein"	25314719
C066859	2,4,6-triiodophenol	"2,4,6-triiodophenol binds to PPARG protein"	25314719
C526470	2,4,6-trimethylbenzaldehyde	"2,4,6-trimethylbenzaldehyde binds to and results in increased activity of PPARG protein"	27633901
C548544	2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid	"2-(4-chloro-6-(2,3-dimethylphenylamino)pyrimidin-2-ylthio)octanoic acid binds to and results in increased activity of PPARG protein"	19934399
C016403	2,4-dinitrotoluene	"2,4-dinitrotoluene results in increased activity of PPARG protein"	24893713
C016403	2,4-dinitrotoluene	"2,4-dinitrotoluene results in increased expression of PPARG mRNA"	24893713
C016403	2,4-dinitrotoluene	"2,4-dinitrotoluene results in decreased expression of PPARG mRNA"	16917068
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG mRNA	17372590
C085911	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one	2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of PPARG protein	17372590
C089946	2,4-thiazolidinedione	"2,4-thiazolidinedione binds to and results in increased activity of PPARG protein"	15521013
C089946	2,4-thiazolidinedione	"2,4-thiazolidinedione binds to PPARG protein"	15916743
C089946	2,4-thiazolidinedione	"2,4-thiazolidinedione results in increased expression of PPARG mRNA"	20724125
C089946	2,4-thiazolidinedione	"2,4-thiazolidinedione binds to and results in increased activity of PPARG protein"	14519784
C089946	2,4-thiazolidinedione	"2,4-thiazolidinedione binds to and affects the activity of PPARG protein"	15867269
C007997	25-hydroxycholesterol	[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA]	12595494
C007997	25-hydroxycholesterol	[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol]	12595494
C018520	2,6-diisopropylnaphthalene	"2,6-diisopropylnaphthalene binds to and results in increased activity of PPARG protein"	27633901
C023514	2,6-dinitrotoluene	"2,6-dinitrotoluene results in decreased expression of PPARG mRNA"	20406850
C076996	27-hydroxycholesterol	27-hydroxycholesterol results in increased expression of PPARG mRNA	28167099
C076996	27-hydroxycholesterol	27-hydroxycholesterol results in increased expression of PPARG protein	28167099
C584787	2-acetylphenothiazine	2-acetylphenothiazine inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA]	25617244
C022776	2-bromopalmitate	2-bromopalmitate results in increased expression of PPARG protein	10650946
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide affects the reaction [rosiglitazone affects the localization of PPARG protein]	22321707
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein	12927354\|1525474
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]]	21734263
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in decreased abundance of Cholesterol]	20372816
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in increased expression of AGER protein]	20372816
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 mRNA]	15781755
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 protein]	15781755
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [TNF protein results in decreased susceptibility to FSHB protein]	21734263
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [troglitazone affects the localization of CYCS protein]	22108328
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [troglitazone results in increased abundance of Reactive Oxygen Species]	22108328
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [troglitazone results in increased expression of PRODH]	22108328
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to perfluorooctanoic acid	23978332
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to resveratrol	20372816
C457499	2-chloro-5-nitrobenzanilide	"2-chloro-5-nitrobenzanilide inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane results in increased activity of PPARG protein]"	15345676
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxyprostaglandin J2 results in increased activity of PPARG protein]	22992727
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species]	23964924
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [3-methylquercetin results in increased activity of PPARG protein]	22992727
C457499	2-chloro-5-nitrobenzanilide	"2-chloro-5-nitrobenzanilide inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of PPARG protein]"	28834734
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [Celecoxib affects the localization of PPARG protein]	23943857
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [cilostazol results in increased activity of PPARG protein]	21660147
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein]	26863638
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide promotes the reaction [PPARG binds to PPARG promoter]]	15705899
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]	12927354
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of PPARG mRNA]	23041272
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]]	21333731
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	21660147\|2396492
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]	18949406\|2135409
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of PPARG protein]	22321707\|2479381
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in increased activity of PPARG protein]	15345676\|2396492
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein	15345676\|2154328
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [9-deoxy-delta-9-prostaglandin D2 results in increased expression of GDF15 protein]	14662774
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of FADS2 mRNA]	21123845
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of SCD mRNA]	21123845
C457499	2-chloro-5-nitrobenzanilide	"[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased uptake of 1-acyl-2-(12-((7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl)phosphatidylcholine]"	21123845
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of troglitazone]	16945329
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide results in decreased expression of PPARG mRNA	23041272
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide results in decreased expression of PPARG protein	21376716
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein	19797938
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [butylparaben results in increased expression of PPARG mRNA]	22956630
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of PPARG protein]	22710028
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide results in increased expression of PPARG mRNA]	15705899
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [notoginsenoside R1 results in increased expression of PPARG]	25714973
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide promotes the reaction [PPARG protein results in increased susceptibility to Methamphetamine]	17019405
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of FABP4 mRNA	20863820
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of NAMPT mRNA	20863820
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of NAMPT protein	20863820
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of RETN mRNA	20863820
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of RETN protein	20863820
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased expression of SCD1 mRNA	20863820
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased susceptibility to rosiglitazone	17394460
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein	28973641
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to rosiglitazone	19732122
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased expression of PPARG mRNA]	17531121
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased expression of PPARG protein]	17531121
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [Genistein results in increased activity of PPARG protein]	19903033
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone affects the expression of PPARG mRNA]	28744220
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone affects the expression of PPARG protein]	28744220
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]]	16617452
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]]	16617452
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [rosmarinic acid affects the expression of PPARG mRNA]	28744220
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [rosmarinic acid affects the expression of PPARG protein]	28744220
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]	21153920
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]	21153920
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] which results in increased expression of SFTPA1 mRNA]	21153920
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein]	24192212
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]	24954035
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in decreased expression of PPARG protein]	24192212
C457499	2-chloro-5-nitrobenzanilide	Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]]	24954035
C457499	2-chloro-5-nitrobenzanilide	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein]]	24192212
C457499	2-chloro-5-nitrobenzanilide	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in decreased expression of PPARG protein]]	24192212
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein	12897060\|1575107
C457499	2-chloro-5-nitrobenzanilide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] promotes the reaction [manganese chloride promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]]	18041089
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide binds to and results in increased activity of PPARG protein	21067863
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein]	24025786
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [dodecylbenzenesulfonic acid binds to and results in increased activity of PPARG protein]	24025786
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]	24025786
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone promotes the reaction [PPARG protein results in increased activity of INSIG1 promoter]]	15073165
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide inhibits the reaction [Sodium Dodecyl Sulfate binds to and results in increased activity of PPARG protein]	24025786
C457499	2-chloro-5-nitrobenzanilide	2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein	14662774\|1630375
C034047	2-cresol	2-cresol results in increased expression of PPARG mRNA	21705299
C034047	2-cresol	Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA]	21705299
C040668	2-ethylhexanoic acid	2-ethylhexanoic acid results in increased expression of PPARG mRNA	15647598
C040668	2-ethylhexanoic acid	2-ethylhexanoic acid results in increased expression of PPARG protein	15647598
C576261	2-ethylhexyl 2,3,4,5-tetrabromobenzoate	"2-ethylhexyl 2,3,4,5-tetrabromobenzoate metabolite binds to PPARG protein"	25314719
C576261	2-ethylhexyl 2,3,4,5-tetrabromobenzoate	"2-ethylhexyl 2,3,4,5-tetrabromobenzoate results in increased activity of PPARG protein"	27506419
C036758	2-ethylhexyl acrylate	2-ethylhexyl acrylate binds to and results in increased activity of PPARG protein	27633901
C018535	2-ethylhexyldiphenylphosphate	2-ethylhexyldiphenylphosphate results in increased activity of PPARG protein	28282128
C018535	2-ethylhexyldiphenylphosphate	PPARG protein affects the reaction [2-ethylhexyldiphenylphosphate results in increased expression of HSD3B1 mRNA]	28282128
C000590793	2-isopropyl-5-methylcyclohexanone	2-isopropyl-5-methylcyclohexanone binds to and results in decreased activity of PPARG protein	27633901
C511621	2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide	"2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PPARG mRNA]"	25304490
C487401	2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid	"2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid results in increased activity of PPARG protein"	14982965
C487401	2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid	"2-methyl-c-5-(4-(5-methyl-2-(4-methylphenyl)-4-oxazolyl)butyl)-1,3-dioxane-r-2-carboxylic acid results in increased activity of PPARG protein"	14982965
C098340	2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose	"PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]"	23954466
C098340	2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose	"PPARG mutant form inhibits the reaction [rosiglitazone inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]"	23954466
C041525	3,3',4,5'-tetrahydroxystilbene	"3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]"	22298784
C041525	3,3',4,5'-tetrahydroxystilbene	"3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]"	22298784
C438457	3,3,5-trimethylcyclohexanone	"3,3,5-trimethylcyclohexanone binds to and results in decreased activity of PPARG protein"	27633901
C023035	3,4,5,3',4'-pentachlorobiphenyl	"2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PPARG mRNA]"	25304490
C023035	3,4,5,3',4'-pentachlorobiphenyl	"3,4,5,3',4'-pentachlorobiphenyl results in decreased expression of PPARG mRNA"	25304490
C023035	3,4,5,3',4'-pentachlorobiphenyl	"3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PPARG mRNA]"	28973532
C005975	3,4-dihydroxyphenylethanol	"3,4-dihydroxyphenylethanol results in decreased expression of PPARG mRNA"	21569430
C578987	3,4'-dihydroxystilbene	"3,4'-dihydroxystilbene results in decreased expression of PPARG mRNA"	23748787
C476925	3,4-dimethylbenzaldehyde	"3,4-dimethylbenzaldehyde binds to and results in decreased activity of PPARG protein"	27633901
C561058	3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-ethyl-5-isobutyl-7-methyl-3H-imidazo(4,5-b)pyridine	"3-(5-(2-(1H-tetrazol-5-yl)phenyl)-2,3-dihydro-1H-inden-1-yl)-2-ethyl-5-isobutyl-7-methyl-3H-imidazo(4,5-b)pyridine binds to and results in increased activity of PPARG protein"	21557540
C513957	3,5-di-tert-butyl-4-hydroxybenzaldehyde	"3,5-di-tert-butyl-4-hydroxybenzaldehyde binds to and results in decreased activity of PPARG protein"	27633901
C026423	3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one	"3,8-dihydroxy-6H-dibenzo(b,d)pyran-6-one results in increased expression of PPARG protein"	23811531
C043247	3-acetyldeoxynivalenol	3-acetyldeoxynivalenol results in decreased activity of PPARG protein	27481073
C484543	3-hydroxystilbene	3-hydroxystilbene results in decreased expression of PPARG mRNA	23748787
C091768	3'-methoxy-4'-nitroflavone	3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]	15050417
C047368	3-methylquercetin	2-chloro-5-nitrobenzanilide inhibits the reaction [3-methylquercetin results in increased activity of PPARG protein]	22992727
C047368	3-methylquercetin	3-methylquercetin binds to and results in increased activity of PPARG protein	22992727
C047368	3-methylquercetin	3-methylquercetin results in increased expression of PPARG protein	22992727
C581004	3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile	"2-chloro-5-nitrobenzanilide inhibits the reaction [3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of PPARG protein]"	28834734
C581004	3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile	"3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of PPARG protein"	28834734
C581004	3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile	"3-oxo-29-noroleana-1,9(11),12-trien-2,20-dicarbonitrile results in increased expression of PPARG protein"	28834734
C031285	3-xylene	3-xylene results in decreased expression of PPARG mRNA	12815608
C038864	4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid	"4-(2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthalenyl)-1-propenyl)benzoic acid results in decreased expression of PPARG mRNA"	15583048
C520164	4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid	4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid binds to PPARG protein	11779144
C520164	4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid	4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid results in increased activity of PPARG protein	15273253
C572961	4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid	4-(4-(3-(4-trifluoromethoxy-phenyl)ureido)cyclohexyloxy)benzoic acid results in increased activity of PPARG protein	25377915
C119130	4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide	15-deoxyprostaglandin J2 promotes the reaction [4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide binds to and results in increased activity of PPARG protein]	15876570
C119130	4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide	4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide binds to and results in increased activity of PPARG protein	15876570
C119130	4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide	4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	15876570
C119130	4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide	4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide promotes the reaction [15-deoxyprostaglandin J2 binds to and results in increased activity of PPARG protein]	15876570
C119130	4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide	4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide results in increased expression of PPARG mRNA	15876570
C459179	4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide	"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPARG mRNA"	27188386
C116322	4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine	4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [Niacin results in increased activity of PPARG protein]	16386710
C547957	4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide	4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide inhibits the reaction [GW 1929 results in increased expression of PPARG mRNA]	20516370
C547957	4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide	4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide results in increased expression of PPARG mRNA	20516370
C429623	4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide	"4-chloro-N-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1H-pyrazole-5-carboxamide results in increased activity of PPARG protein"	20143881
C027576	4-hydroxy-2-nonenal	4-hydroxy-2-nonenal results in decreased expression of PPARG protein	27417252
C064297	4-hydroxystilbene	4-hydroxystilbene results in decreased expression of PPARG mRNA	23748787
C097470	4'-methoxychalcone	4'-methoxychalcone analog inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA]	28528971
C097470	4'-methoxychalcone	4'-methoxychalcone analog results in increased expression of and results in increased activity of PPARG protein	28528971
C097470	4'-methoxychalcone	4'-methoxychalcone analog results in increased expression of PPARG mRNA	28528971
C020627	4-methylbenzaldehyde	4-methylbenzaldehyde binds to and results in decreased activity of PPARG protein	27633901
C406734	4-methylene-2-octyl-5-oxofuran-3-carboxylic acid	4-methylene-2-octyl-5-oxofuran-3-carboxylic acid results in decreased expression of PPARG mRNA	15707987
C041594	4-nonylphenol	4-nonylphenol results in increased expression of PPARG mRNA	24388992
C029728	4-phenylenediamine	4-phenylenediamine results in increased expression of PPARG mRNA	16314067
C105260	4-tert-octylphenol	4-tert-octylphenol results in increased expression of PPARG mRNA	26382854
C105260	4-tert-octylphenol	[nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of PPARG mRNA	28208108
C116017	5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide	"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide binds to and results in increased activity of PPARG protein"	11139385\|9836514
C116017	5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide	"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide results in increased activity of PPARG protein"	15273253
C116017	5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide	"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide binds to and results in decreased activity of PPARG protein"	12676649
C116017	5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide	"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide binds to and results in increased activity of PPARG protein"	11712408\|1280888
C116017	5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide	"5-((2,4-dioxo-5-thiazolidinyl)methyl)-2-methoxy-N-((4-(trifluoromethyl)phenyl)methyl)benzamide results in increased activity of PPARG protein"	10799317
C570539	5-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedione	5-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedione analog binds to PPARG protein	22070604
C570539	5-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedione	5-(3-((3-(5-methoxybenzisoxazol-3-yl)benzimidazol-1-yl)methyl)phenyl)-5-methyloxazolidinedione analog results in increased activity of PPARG protein	22070604
C112100	5-((4-(2-(1-indolyl)ethoxy)-phenyl)methyl)thiazolidine-2,4-dione	"5-((4-(2-(1-indolyl)ethoxy)-phenyl)methyl)thiazolidine-2,4-dione results in increased activity of PPARG protein alternative form"	23563205
C471831	5-(4-(2-(2-ethyl-4-methyl-6-oxo-1,6-dihydro-1-pyrimidinyl)ethoxy)phenylmethyl)thiazolidine-2,4-dione	"5-(4-(2-(2-ethyl-4-methyl-6-oxo-1,6-dihydro-1-pyrimidinyl)ethoxy)phenylmethyl)thiazolidine-2,4-dione results in increased activity of PPARG protein alternative form"	23563205
C558243	5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid	5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid binds to and results in decreased activity of PPARG protein	21296151
C558243	5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid	5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid inhibits the reaction [rosiglitazone promotes the reaction [PPARG protein binds to CREBBP protein]]	21296151
C573233	5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one	"5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one affects the expression of PPARG mRNA"	24646949
C573233	5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one	"5,7-dihydroxy-2-methyl-8-(4-(3-hydroxy-1-methyl)-piperidinyl)-4H-1-benzopyran-4-one affects the expression of PPARG protein"	24646949
C516138	(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine	"(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in decreased expression of PPARG mRNA]"	24584901
C516138	(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine	"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPARG mRNA"	27188386
C055656	8-((4-chlorophenyl)thio)cyclic-3',5'-GMP	"8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased expression of PPARG protein"	20471953
C055656	8-((4-chlorophenyl)thio)cyclic-3',5'-GMP	"8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased expression of PPARG protein]"	20471953
C090860	8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate	"8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP results in increased expression of PPARG protein]"	20471953
C090860	8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate	"8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of PPARG protein]"	20471953
C047628	8-hydroxyeicosatetraenoic acid	8-hydroxyeicosatetraenoic acid results in increased expression of PPARG protein	15964169
C120038	9,10-dihydroxy-12-octadecenoic acid	"9,10-dihydroxy-12-octadecenoic acid binds to PPARG protein"	12021203
C051208	9,10-epoxy-12-octadecenoic acid	"9,10-epoxy-12-octadecenoic acid binds to PPARG protein"	12021203
C046938	9,11-linoleic acid	"9,11-linoleic acid binds to PPARG protein"	23843199
C046938	9,11-linoleic acid	"9,11-linoleic acid results in increased activity of PPARG protein"	18155510
C046938	9,11-linoleic acid	"9,11-linoleic acid results in increased expression of PPARG mRNA"	15778275
C037112	9-deoxy-delta-9-prostaglandin D2	9-deoxy-delta-9-prostaglandin D2 results in increased expression of PPARG protein	15964169
C037112	9-deoxy-delta-9-prostaglandin D2	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [9-deoxy-delta-9-prostaglandin D2 results in increased expression of GDF15 protein]	14662774
C037112	9-deoxy-delta-9-prostaglandin D2	9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein	11343236\|1549141
C037112	9-deoxy-delta-9-prostaglandin D2	[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased expression of ABCA1 mRNA]	12595494
C037112	9-deoxy-delta-9-prostaglandin D2	[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol]	12595494
C037112	9-deoxy-delta-9-prostaglandin D2	[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]	12595494
C037112	9-deoxy-delta-9-prostaglandin D2	[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] which results in increased expression of ABCA1 mRNA	12595494
C037112	9-deoxy-delta-9-prostaglandin D2	[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] which results in increased expression of NR1H3 mRNA	12595494
C037112	9-deoxy-delta-9-prostaglandin D2	9-deoxy-delta-9-prostaglandin D2 results in increased activity of PPARG protein	17030193
C037112	9-deoxy-delta-9-prostaglandin D2	9-deoxy-delta-9-prostaglandin D2 results in increased expression of PPARG mRNA	12595494\|1451278
C037112	9-deoxy-delta-9-prostaglandin D2	Ethanol inhibits the reaction [9-deoxy-delta-9-prostaglandin D2 results in increased activity of PPARG protein]	17030193
C037112	9-deoxy-delta-9-prostaglandin D2	[9-deoxy-delta-9-prostaglandin D2 co-treated with alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter]	15150131
C037112	9-deoxy-delta-9-prostaglandin D2	9-deoxy-delta-9-prostaglandin D2 promotes the reaction [PPARG protein alternative form results in decreased activity of SLC2A4 promoter]	12777391
C037112	9-deoxy-delta-9-prostaglandin D2	9-deoxy-delta-9-prostaglandin D2 binds to and affects the activity of PPARG protein	11409902
C037112	9-deoxy-delta-9-prostaglandin D2	9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein	12065618\|1259549
C037112	9-deoxy-delta-9-prostaglandin D2	[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] inhibits the reaction [IL1B protein results in decreased expression of ABCA1 mRNA]	12595494
C037112	9-deoxy-delta-9-prostaglandin D2	9-deoxy-delta-9-prostaglandin D2 binds to PPARG protein	11401521
C024347	9-hydroxy-10,12-octadecadienoic acid	"9-hydroxy-10,12-octadecadienoic acid results in increased expression of PPARG"	16647253
C099958	acanthoic acid	acanthoic acid inhibits the reaction [Ethanol results in increased expression of PPARG protein]	28964808
D000079	Acetaldehyde	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
D000079	Acetaldehyde	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]	17030193
D000079	Acetaldehyde	ABL1 protein promotes the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]	17030193
D000079	Acetaldehyde	Acetaldehyde inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	17030193
D000079	Acetaldehyde	Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein	17030193
D000079	Acetaldehyde	[Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein	17030193
D000079	Acetaldehyde	Imatinib Mesylate inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]	17030193
D000079	Acetaldehyde	PPARG protein promotes the reaction [Acetaldehyde results in increased expression of COL1A1 mRNA]	17030193
D000079	Acetaldehyde	PPARG protein promotes the reaction [Acetaldehyde results in increased expression of COL1A1 protein]	17030193
D000079	Acetaldehyde	U 0126 inhibits the reaction [Acetaldehyde inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
D000079	Acetaldehyde	U 0126 inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]	17030193
D000082	Acetaminophen	Acetaminophen results in decreased expression of PPARG mRNA	26690555
D000082	Acetaminophen	Acetaminophen results in increased expression of PPARG mRNA	29067470
D000082	Acetaminophen	Acetaminophen affects the expression of PPARG mRNA	17562736
D000082	Acetaminophen	Acetaminophen affects the expression of PPARG mRNA	16701773
C038699	acetophenone	acetophenone binds to and results in decreased activity of PPARG protein	27633901
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species]	23964924
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]	16945329
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein]	22046279
D000111	Acetylcysteine	Acetylcysteine inhibits the reaction [INS1 protein results in increased expression of PPARG protein]	27117918
D000111	Acetylcysteine	Acetylcysteine results in increased expression of PPARG mRNA	17602960
D000111	Acetylcysteine	Acetylcysteine results in increased expression of PPARG protein	17602960
D000111	Acetylcysteine	Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA]	17602960
D000111	Acetylcysteine	Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG protein]	17602960
C033116	acetyl methyl tetramethyl tetralin	acetyl methyl tetramethyl tetralin binds to and results in increased activity of PPARG protein	24155963
C036804	acifran	acifran results in increased activity of PPARG protein	16386710
C036804	acifran	HCAR2 protein promotes the reaction [acifran results in increased activity of PPARG protein]	16386710
C036804	acifran	HCAR3 protein promotes the reaction [acifran results in increased activity of PPARG protein]	16386710
C106812	adefovir dipivoxil	adefovir dipivoxil affects the activity of PPARG protein	25596134
D000255	Adenosine Triphosphate	FASN protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]]	26670611
D000255	Adenosine Triphosphate	PPARG protein mutant form results in decreased abundance of Adenosine Triphosphate	26670611
D000255	Adenosine Triphosphate	PPARG protein results in decreased abundance of Adenosine Triphosphate	26670611
D000255	Adenosine Triphosphate	rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]	26670611
D000255	Adenosine Triphosphate	UCP1 protein promotes the reaction [PPARG protein mutant form results in decreased abundance of Adenosine Triphosphate]	26670611
D000255	Adenosine Triphosphate	UCP1 protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]]	26670611
D016604	Aflatoxin B1	Aflatoxin B1 results in decreased methylation of PPARG gene	27153756
D016604	Aflatoxin B1	Aflatoxin B1 results in increased expression of PPARG mRNA	19770486
C412373	AG 1879	AG 1879 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
C031143	AICA ribonucleotide	AICA ribonucleotide inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein]	27688165
C031143	AICA ribonucleotide	AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]	25108154
C048980	ajoene	ajoene analog promotes the reaction [RELA protein binds to PPARG protein]	27449564
C048980	ajoene	ajoene analog results in increased expression of PPARG protein	27449564
C121227	AL 8810	AL 8810 results in increased expression of PPARG mRNA	21236357
D000450	Aldosterone	PPARG protein affects the abundance of Aldosterone	16007095
C103303	alitretinoin	alitretinoin results in increased activity of PPARG protein	15707588
C103303	alitretinoin	benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [alitretinoin results in increased activity of PPARG protein]	15707588
C103303	alitretinoin	MG 262 promotes the reaction [alitretinoin results in increased activity of PPARG protein]	15707588
C103303	alitretinoin	[pioglitazone co-treated with alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]	17019405
C103303	alitretinoin	PPARG protein promotes the reaction [alitretinoin results in increased expression of PPARGC1A mRNA]	16513826
C103303	alitretinoin	[9-deoxy-delta-9-prostaglandin D2 co-treated with alitretinoin] promotes the reaction [[PPARG protein binds to RXRA protein] which binds to GSTA2 promoter]	15150131
C103303	alitretinoin	alitretinoin binds to and results in increased activity of PPARG protein	18063688
C103303	alitretinoin	alitretinoin binds to [PPARG protein binds to RXRA protein]	10882139
D000487	Allethrin	Allethrin results in increased activity of PPARG protein	20143881
C518327	aloe emodin	aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA]	22645054
D013196	Dihydrotestosterone	Dihydrotestosterone results in decreased expression of PPARG mRNA	18801408
D013196	Dihydrotestosterone	Dihydrotestosterone results in decreased expression of PPARG protein	18801408
D013196	Dihydrotestosterone	Dihydrotestosterone results in decreased expression of PPARG mRNA	12960001
D013196	Dihydrotestosterone	Dihydrotestosterone results in decreased expression of PPARG protein	12960001
D013196	Dihydrotestosterone	Dihydrotestosterone results in increased expression of PPARG mRNA	16990341
D017962	alpha-Linolenic Acid	alpha-Linolenic Acid binds to and results in increased activity of PPARG protein	16731579
D017962	alpha-Linolenic Acid	alpha-Linolenic Acid results in increased activity of PPARG protein	20696231
D017962	alpha-Linolenic Acid	alpha-Linolenic Acid binds to and results in increased activity of PPARG protein	16731579
D017962	alpha-Linolenic Acid	alpha-Linolenic Acid results in increased expression of PPARG mRNA	18154422
D017962	alpha-Linolenic Acid	alpha-Linolenic Acid binds to and results in increased activity of PPARG protein	16731579
D024502	alpha-Tocopherol	alpha-Tocopherol results in increased activity of PPARG protein	19083475
D024502	alpha-Tocopherol	alpha-Tocopherol results in increased expression of PPARG mRNA	14521714
D024502	alpha-Tocopherol	alpha-Tocopherol results in increased expression of PPARG protein	14521714\|2806235
D024502	alpha-Tocopherol	[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]	22389237
D024502	alpha-Tocopherol	[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]	22389237
D024502	alpha-Tocopherol	alpha-Tocopherol results in increased expression of PPARG protein	11752099
D019804	Mesalamine	[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with Mesalamine] results in increased expression of PPARG protein	27818126
D019804	Mesalamine	Mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin 3-O-glucoside] results in increased expression of PPARG protein]	27818126
D000638	Amiodarone	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of FADS2 mRNA]	21123845
D000638	Amiodarone	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased expression of SCD mRNA]	21123845
D000638	Amiodarone	"[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Amiodarone results in increased uptake of 1-acyl-2-(12-((7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)dodecanoyl)phosphatidylcholine]"	21123845
D000638	Amiodarone	Amiodarone binds to and results in increased activity of PPARG protein	24489787
D000638	Amiodarone	Amiodarone results in increased expression of PPARG mRNA	21123845
D000643	Ammonium Chloride	Ammonium Chloride affects the expression of PPARG mRNA	16483693
C530884	anacetrapib	anacetrapib results in increased expression of PPARG mRNA	25617244
D000894	Anti-Inflammatory Agents, Non-Steroidal	"Anti-Inflammatory Agents, Non-Steroidal results in decreased activity of PPARG protein"	16061222
C030419	andrographolide	andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]	27475717
D047310	Apigenin	Apigenin binds to and results in increased activity of PPARG protein	11343698
D047310	Apigenin	Apigenin results in decreased expression of PPARG mRNA	18359623
D047310	Apigenin	PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]	11343698
D047310	Apigenin	PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]	11343698
D016718	Arachidonic Acid	Arachidonic Acid results in decreased expression of PPARG mRNA	11172467
D016718	Arachidonic Acid	Arachidonic Acid results in decreased expression of PPARG protein	11172467
D016718	Arachidonic Acid	Arachidonic Acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA]	19063610
D016718	Arachidonic Acid	Arachidonic Acid results in increased expression of PPARG protein	12604186
C081565	arachidonyltrifluoromethane	arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA]	19063610
D001149	Arsenates	[Atrazine co-treated with Arsenates] results in increased expression of PPARG mRNA	18585445
D001151	Arsenic	Arsenic affects the expression of PPARG mRNA	28793237
D001151	Arsenic	Arsenic inhibits the reaction [CEBPA protein binds to PPARG protein]	23108036
D001151	Arsenic	Arsenic inhibits the reaction [CEBPB protein binds to PPARG protein]	23108036
D001151	Arsenic	Arsenic results in decreased expression of PPARG mRNA	23108036
D001151	Arsenic	Arsenic results in decreased expression of PPARG protein	23108036
D001151	Arsenic	[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA	28793237
D001151	Arsenic	T 0070907 promotes the reaction [Arsenic results in decreased expression of PPARG protein]	23108036
D001151	Arsenic	troglitazone inhibits the reaction [Arsenic results in decreased expression of PPARG mRNA]	23108036
D001151	Arsenic	troglitazone inhibits the reaction [Arsenic results in decreased expression of PPARG protein]	23108036
C006632	arsenic trioxide	arsenic trioxide results in increased expression of PPARG mRNA	22684020
C006632	arsenic trioxide	arsenic trioxide results in increased expression of PPARG protein	22684020
C006632	arsenic trioxide	KEAP1 protein inhibits the reaction [arsenic trioxide results in increased expression of PPARG mRNA]	22684020
C006632	arsenic trioxide	KEAP1 protein inhibits the reaction [arsenic trioxide results in increased expression of PPARG protein]	22684020
C006632	arsenic trioxide	NFE2L2 protein promotes the reaction [arsenic trioxide results in increased expression of PPARG mRNA]	22684020
C006632	arsenic trioxide	PPARG protein results in decreased susceptibility to arsenic trioxide	20707922
C006632	arsenic trioxide	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to arsenic trioxide	22684020
C006632	arsenic trioxide	[troglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to arsenic trioxide	22684020
C006632	arsenic trioxide	arsenic trioxide inhibits the reaction [AKT1 protein binds to PPARG protein]	15916724
C006632	arsenic trioxide	arsenic trioxide inhibits the reaction [RXRA protein binds to PPARG protein]	15916724
C006632	arsenic trioxide	arsenic trioxide results in decreased expression of PPARG protein	15916724
C015001	arsenite	arsenite results in increased expression of PPARG mRNA	15868481
C078098	ar-turmerone	ar-turmerone binds to PPARG protein	15713005
D017638	Asbestos, Crocidolite	"Asbestos, Crocidolite results in increased expression of PPARG mRNA"	23634900
D017638	Asbestos, Crocidolite	"Asbestos, Crocidolite results in increased expression of PPARG protein"	23634900
D001205	Ascorbic Acid	Ascorbic Acid affects the expression of PPARG mRNA	21281732
D001205	Ascorbic Acid	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA	25932594
D001205	Ascorbic Acid	[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA	14505802
D001205	Ascorbic Acid	SRC protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]]	14505802
D001205	Ascorbic Acid	Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]	14505802
D001241	Aspirin	Aspirin inhibits the reaction [Niacin results in increased activity of PPARG protein]	16386710
D001241	Aspirin	Aspirin results in decreased activity of PPARG protein	15646027
D001241	Aspirin	Aspirin results in increased expression of PPARG	18971601
D001241	Aspirin	Aspirin results in increased expression of PPARG mRNA	19880272
D001241	Aspirin	Aspirin results in increased expression of PPARG protein	19880272
D001241	Aspirin	Aspirin results in increased expression of PPARG mRNA	19462226
D001241	Aspirin	Aspirin results in decreased expression of PPARG mRNA	18222077
D001280	Atrazine	[Atrazine co-treated with Arsenates] results in increased expression of PPARG mRNA	18585445
D001280	Atrazine	Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA]	24440342
D006051	Aurothioglucose	[Dietary Fats co-treated with Aurothioglucose] results in decreased expression of PPARG protein	21382165
D001374	Azacitidine	Azacitidine results in decreased methylation of PPARG promoter	19589179
D001374	Azacitidine	Azacitidine results in increased expression of PPARG mRNA	19589179
C010038	azelaic acid	azelaic acid results in increased activity of PPARG protein	20545756
C010038	azelaic acid	azelaic acid results in increased expression of PPARG mRNA	20545756
C547126	AZM551248	AZM551248 results in decreased expression of PPARG mRNA	22323515
C006680	baicalein	baicalein results in decreased expression of PPARG mRNA	24560969
C006680	baicalein	baicalein results in decreased expression of PPARG protein	24560969
C038044	baicalin	baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein]	24312512
D001507	Beclomethasone	Beclomethasone results in decreased expression of PPARG mRNA	23656298
D001549	Benzamides	Benzamides binds to PPARG protein	28242381
D001549	Benzamides	Benzamides results in increased expression of PPARG mRNA	28242381
D001553	Benzbromarone	Benzbromarone affects the expression of PPARG mRNA	19048458
D001553	Benzbromarone	Benzbromarone binds to PPARG protein	18274627
D001554	Benzene	Benzene results in increased expression of PPARG mRNA	19162166
D001572	Benzofurans	Benzofurans results in decreased expression of PPARG mRNA	20863820
D001572	Benzofurans	Benzofurans results in decreased expression of PPARG protein	20863820
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of PPARG mRNA	20064835
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of PPARG mRNA	15735009
D001564	Benzo(a)pyrene	[Soot co-treated with Benzo(a)pyrene] results in decreased activity of PPARG protein	24464499
D001564	Benzo(a)pyrene	Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]	27329536
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in decreased expression of PPARG mRNA	19770486
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased activity of PPARG protein	27329536
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of PPARG mRNA	22228805
D001564	Benzo(a)pyrene	Docosahexaenoic Acids promotes the reaction [Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]]	27329536
D001564	Benzo(a)pyrene	Docosahexaenoic Acids promotes the reaction [Benzo(a)pyrene results in increased activity of PPARG protein]	27329536
D001564	Benzo(a)pyrene	[Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA	20920559
D001564	Benzo(a)pyrene	[Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG protein	20920559
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of PPARG mRNA	20920559\|2237450
D001564	Benzo(a)pyrene	Benzo(a)pyrene results in increased expression of PPARG protein	20920559
D015123	7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide	"7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of PPARG mRNA"	19150397
C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	"benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein]"	15707588
C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	benzyloxycarbonylleucyl-leucyl-leucine aldehyde promotes the reaction [alitretinoin results in increased activity of PPARG protein]	15707588
C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased activity of PPARG protein	15707588
C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of PPARG protein]	18555852
C072553	benzyloxycarbonylleucyl-leucyl-leucine aldehyde	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein]	18555852
C057775	benzylparaben	benzylparaben results in increased activity of PPARG protein	28527915
C057775	benzylparaben	benzylparaben results in increased expression of PPARG mRNA	22956630\|2765973
D001599	Berberine	Berberine results in decreased expression of PPARG mRNA	26478571
D001599	Berberine	Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA]	20564506
D001599	Berberine	Berberine inhibits the reaction [Clozapine results in increased expression of PPARG protein]	20564506
D001599	Berberine	Berberine inhibits the reaction [Risperidone results in increased expression of PPARG mRNA]	20564506
D001599	Berberine	Berberine inhibits the reaction [Risperidone results in increased expression of PPARG protein]	20564506
D019207	beta Carotene	beta Carotene results in decreased expression of PPARG mRNA	21569430
D004958	Estradiol	Estradiol results in increased expression of PPARG protein	15964169
D004958	Estradiol	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]]	21734263
D004958	Estradiol	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA	19619570
D004958	Estradiol	Estradiol results in decreased expression of PPARG mRNA	21632903\|2859187
D004958	Estradiol	Estradiol results in increased expression of PPARG mRNA	19619570\|2118537
D004958	Estradiol	Estradiol results in increased expression of PPARG mRNA	18359623
D004958	Estradiol	[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]	22389237
D004958	Estradiol	[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]	22389237
D004958	Estradiol	Estradiol affects the expression of PPARG mRNA	22389237
D004958	Estradiol	Estradiol affects the expression of PPARG protein	22389237
C031463	beta-glycerophosphoric acid	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA	25932594
C031463	beta-glycerophosphoric acid	[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA	14505802
C031463	beta-glycerophosphoric acid	SRC protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]]	14505802
C031463	beta-glycerophosphoric acid	Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]	14505802
D024503	beta-Tocopherol	[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]	22389237
D024503	beta-Tocopherol	[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]	22389237
D001629	Bezafibrate	Bezafibrate affects the expression of PPARG mRNA	21703979
D001629	Bezafibrate	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Bezafibrate promotes the reaction [TNF protein inhibits the reaction [FSHB protein results in increased secretion of Estradiol]]]	21734263
D001629	Bezafibrate	Bezafibrate binds to PPARG protein	11779144\|2384319
D001629	Bezafibrate	Bezafibrate results in decreased expression of PPARG mRNA	15708366
D001629	Bezafibrate	Bezafibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein]	11779144
D001629	Bezafibrate	Bezafibrate results in increased expression of PPARG mRNA	19201410\|2475975
D001629	Bezafibrate	PPARG protein affects the reaction [Bezafibrate results in increased susceptibility to TNF protein]	21734263
D001629	Bezafibrate	[Bezafibrate co-treated with Dietary Fats] results in increased expression of PPARG mRNA	24759758
D001629	Bezafibrate	Bezafibrate results in increased activity of PPARG protein	12401884
D001629	Bezafibrate	Bezafibrate results in increased expression of PPARG mRNA	19201410\|2132491
D001629	Bezafibrate	PPARA protein affects the reaction [Bezafibrate results in increased expression of PPARG mRNA]	21324916
D001629	Bezafibrate	Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]	12967931
D001629	Bezafibrate	Bezafibrate results in decreased expression of PPARG mRNA	11473052
D001629	Bezafibrate	Bezafibrate binds to and results in increased activity of PPARG protein	17190905\|1866045
D001629	Bezafibrate	Bezafibrate binds to PPARG protein	24759758
D001629	Bezafibrate	Bezafibrate results in increased activity of PPARG protein	12759900\|1616805
C452139	BIRB 796	BIRB 796 results in increased expression of PPARG mRNA	21328587
C576262	bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate	"bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate metabolite binds to PPARG protein"	25314719
C576262	bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate	"bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate metabolite results in increased activity of PPARG protein"	27506419
C576262	bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate	"bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate results in increased activity of PPARG protein"	27506419
C576262	bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate	"PPARG mutant form inhibits the reaction [bis(2-ethylhexyl) 2,3,4,5-tetrabromophthalate metabolite results in increased expression of FABP4 mRNA]"	23014847
C034786	bis(4-hydroxycinnamoyl)methane	bis(4-hydroxycinnamoyl)methane binds to PPARG protein	15713005
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone binds to and results in decreased activity of PPARG protein	27633901
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone binds to and results in increased activity of PPARG protein	27633901
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone results in increased expression of PPARG mRNA	27003841
C543008	bis(4-hydroxyphenyl)sulfone	[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA	27273607
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27273607
C543008	bis(4-hydroxyphenyl)sulfone	bis(4-hydroxyphenyl)sulfone results in increased activity of PPARG protein	27273607
C543008	bis(4-hydroxyphenyl)sulfone	[Dietary Fats co-treated with bis(4-hydroxyphenyl)sulfone] affects the expression of PPARG mRNA	27241191
C070515	bisindolylmaleimide I	bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]	16945329
C006780	bisphenol A	bisphenol A analog binds to and results in increased activity of PPARG protein	21622942
C006780	bisphenol A	bisphenol A binds to and results in increased activity of PPARG protein	21622942\|2415596
C006780	bisphenol A	bisphenol A binds to PPARG protein	23843199
C006780	bisphenol A	bisphenol A results in decreased expression of PPARG mRNA	28711546
C006780	bisphenol A	bisphenol A results in increased expression of PPARG mRNA	20064783\|2309057
C006780	bisphenol A	bisphenol A results in increased localization of PPARG protein	20064783
C006780	bisphenol A	PPARG protein affects the reaction [bisphenol A results in increased secretion of APLN protein]	28111160
C006780	bisphenol A	SREBF1 protein affects the reaction [bisphenol A results in increased expression of PPARG mRNA]	28483554
C006780	bisphenol A	[1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of PPARG protein	26820058
C006780	bisphenol A	bisphenol A affects the methylation of PPARG promoter	27334623
C006780	bisphenol A	[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA	27273607
C006780	bisphenol A	bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]	22197818
C006780	bisphenol A	bisphenol A promotes the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]	26944108
C006780	bisphenol A	bisphenol A results in increased activity of PPARG protein	27273607
C006780	bisphenol A	bisphenol A results in increased expression of PPARG	26942597
C006780	bisphenol A	bisphenol A results in increased expression of PPARG mRNA	18359623\|2193240
C006780	bisphenol A	bisphenol A results in increased expression of PPARG protein	26996129\|2714500
C006780	bisphenol A	[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein	26944108
C006780	bisphenol A	MAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]]	26996129
C006780	bisphenol A	MAP2K3 protein inhibits the reaction [MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG protein]]	26996129
C006780	bisphenol A	Mifepristone inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]	27145005
C006780	bisphenol A	MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]	26996129
C006780	bisphenol A	MIR21A mRNA inhibits the reaction [bisphenol A results in increased expression of PPARG protein]	26996129
C006780	bisphenol A	T 0070907 inhibits the reaction [[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein]	26944108
C006780	bisphenol A	bisphenol A results in decreased expression of PPARG mRNA	28938450
C006780	bisphenol A	bisphenol A results in increased expression of PPARG mRNA	28938450
C006780	bisphenol A	bisphenol A results in decreased expression of PPARG mRNA	23399309\|2518105
C006780	bisphenol A	bisphenol A results in increased expression of PPARG mRNA	20019905
C006780	bisphenol A	bisphenol A results in increased methylation of PPARG gene	28505145
C006780	bisphenol A	[Dietary Fats co-treated with bisphenol A] results in increased expression of PPARG mRNA	25112833
C006780	bisphenol A	wortmannin inhibits the reaction [bisphenol A results in decreased expression of PPARG mRNA]	23399309
C006780	bisphenol A	bisphenol A results in increased expression of PPARG mRNA	26382854
C006780	bisphenol A	[nonylphenol co-treated with bisphenol A] results in increased expression of PPARG mRNA	28208108
C006780	bisphenol A	bisphenol A inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
C005961	bis(tri-n-butyltin)oxide	bis(tri-n-butyltin)oxide results in increased expression of PPARG mRNA	18958704
D001761	Bleomycin	Bleomycin results in decreased expression of PPARG mRNA	19147827
D001761	Bleomycin	rosiglitazone inhibits the reaction [Bleomycin results in decreased expression of PPARG mRNA]	19147827
D001786	Blood Glucose	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]]"	27274199
D001786	Blood Glucose	[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein	27274199
D001786	Blood Glucose	ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]	27274199
D001865	Bongkrekic Acid	Bongkrekic Acid analog results in increased activity of PPARG protein	25786526
D001865	Bongkrekic Acid	Bongkrekic Acid results in increased activity of PPARG protein	25786526
C032688	boric acid	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]	28285642
C032688	boric acid	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]	28285642
C032688	boric acid	CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]	28285642
D015124	8-Bromo Cyclic Adenosine Monophosphate	8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]	15994020
D015124	8-Bromo Cyclic Adenosine Monophosphate	8-Bromo Cyclic Adenosine Monophosphate results in decreased expression of PPARG mRNA	15994020
D019328	Buthionine Sulfoximine	Buthionine Sulfoximine results in increased expression of PPARG mRNA	21520053
D019328	Buthionine Sulfoximine	PPARG mRNA promotes the reaction [Tamoxifen inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]]	27358406
D019328	Buthionine Sulfoximine	S-ethyl glutathione inhibits the reaction [Buthionine Sulfoximine results in increased expression of PPARG mRNA]	21520053
D019328	Buthionine Sulfoximine	Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG mRNA]	17602960
D019328	Buthionine Sulfoximine	Buthionine Sulfoximine inhibits the reaction [Acetylcysteine results in increased expression of PPARG protein]	17602960
D019328	Buthionine Sulfoximine	Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of PPARG mRNA]	17602960
D019328	Buthionine Sulfoximine	Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of PPARG protein]	17602960
D002084	Butylated Hydroxytoluene	Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of PPARG mRNA]	17070507
D002084	Butylated Hydroxytoluene	Butylated Hydroxytoluene results in increased expression of PPARG mRNA	19925653
C027561	butylbenzyl phthalate	butylbenzyl phthalate binds to and results in increased activity of PPARG protein	24155963
C027561	butylbenzyl phthalate	butylbenzyl phthalate binds to PPARG protein	23843199
C027561	butylbenzyl phthalate	butylbenzyl phthalate results in increased activity of PPARG protein	26172262
C027561	butylbenzyl phthalate	[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG mRNA	26820058
C027561	butylbenzyl phthalate	[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG protein	26820058
C027561	butylbenzyl phthalate	butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	28595985
C027561	butylbenzyl phthalate	butylbenzyl phthalate results in increased expression of PPARG mRNA	27923775
C027561	butylbenzyl phthalate	Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]	28595985
C027561	butylbenzyl phthalate	PPARG protein promotes the reaction [butylbenzyl phthalate binds to and results in increased activity of PPARG protein]	24155963
C061482	butyl diglycol acetate	butyl diglycol acetate binds to and results in decreased activity of PPARG protein	27633901
D020122	tert-Butylhydroperoxide	tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]	20847119
D020122	tert-Butylhydroperoxide	tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]	20847119
D020122	tert-Butylhydroperoxide	tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]	20847119
D020122	tert-Butylhydroperoxide	tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]	20847119
D020122	tert-Butylhydroperoxide	tert-Butylhydroperoxide results in increased activity of PPARG protein	16417216
D020122	tert-Butylhydroperoxide	troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]	20847119
D020122	tert-Butylhydroperoxide	troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]	20847119
D020122	tert-Butylhydroperoxide	troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]	20847119
D020122	tert-Butylhydroperoxide	troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]]	20847119
C038091	butylparaben	butylparaben binds to and results in increased activity of PPARG protein	24155963
C038091	butylparaben	butylparaben results in increased expression of PPARG mRNA	22956630
C038091	butylparaben	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [butylparaben results in increased expression of PPARG mRNA]"	22956630
C038091	butylparaben	2-chloro-5-nitrobenzanilide inhibits the reaction [butylparaben results in increased expression of PPARG mRNA]	22956630
C038091	butylparaben	butylparaben promotes the reaction [Dexamethasone results in increased expression of PPARG mRNA]	22956630
C038091	butylparaben	butylparaben results in increased activity of PPARG protein	28527915
C038091	butylparaben	butylparaben results in increased expression of PPARG mRNA	22956630\|2765973
C038091	butylparaben	Mifepristone inhibits the reaction [butylparaben results in increased expression of PPARG mRNA]	22956630
C038091	butylparaben	PPARG mutant form inhibits the reaction [butylparaben results in increased expression of FABP4 mRNA]	22956630
C038091	butylparaben	PPARG mutant form inhibits the reaction [butylparaben results in increased expression of PLIN1 mRNA]	22956630
C038091	butylparaben	PPARG protein inhibits the reaction [butylparaben results in decreased expression of SPP1 mRNA]	28527915
C038091	butylparaben	PPARG protein promotes the reaction [butylparaben binds to and results in increased activity of PPARG protein]	24155963
C038091	butylparaben	PPARG protein promotes the reaction [butylparaben results in decreased expression of ALPL mRNA]	28527915
C038091	butylparaben	PPARG protein promotes the reaction [butylparaben results in increased expression of CEBPA mRNA]	28527915
C038091	butylparaben	PPARG protein promotes the reaction [butylparaben results in increased expression of FABP4 mRNA]	28527915
C038091	butylparaben	PPARG protein promotes the reaction [butylparaben results in increased expression of PLIN1 mRNA]	28527915
C038091	butylparaben	PPARG protein results in increased susceptibility to butylparaben	28527915
D002087	Butyrates	Butyrates results in increased expression of PPARG mRNA	16112107
D002087	Butyrates	PPARG protein affects the reaction [Butyrates results in increased expression of CDKN1B mRNA]	16112107
D020148	Butyric Acid	Butyric Acid results in increased expression of PPARG mRNA	10833422
D020148	Butyric Acid	Butyric Acid results in increased expression of PPARG protein	10833422
D002101	Cacodylic Acid	[Arsenic results in increased abundance of Cacodylic Acid] which affects the expression of PPARG mRNA	28793237
D002101	Cacodylic Acid	Cacodylic Acid results in decreased expression of PPARG mRNA	23221991
D002101	Cacodylic Acid	Cacodylic Acid results in decreased expression of PPARG mRNA	23221991
D002104	Cadmium	Cadmium results in decreased expression of PPARG protein	21848503
D002104	Cadmium	PPARG protein affects the reaction [Cadmium results in increased abundance of Reactive Oxygen Species]	16737744
D002104	Cadmium	Cadmium results in increased expression of PPARG mRNA	25388156
D002104	Cadmium	Cadmium results in decreased expression of PPARG mRNA	24095957
D019256	Cadmium Chloride	Cadmium Chloride affects the activity of PPARG protein	25596134
D019256	Cadmium Chloride	Cadmium Chloride results in decreased expression of PPARG mRNA	24794047
D019256	Cadmium Chloride	Cadmium Chloride results in decreased expression of PPARG mRNA	23921151
D019256	Cadmium Chloride	Cadmium Chloride results in increased expression of PPARG mRNA	26352046
D019256	Cadmium Chloride	[MT1 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of PPARG mRNA	23921151
D019256	Cadmium Chloride	[MT2 gene mutant form results in increased susceptibility to Cadmium Chloride] which results in decreased expression of PPARG mRNA	23921151
D019256	Cadmium Chloride	Cadmium Chloride results in decreased expression of PPARG mRNA	25993096
D019256	Cadmium Chloride	CR8 compound inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]	24481447
D019256	Cadmium Chloride	[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein]	24481447
D019256	Cadmium Chloride	[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [PPARG protein binds to GFAP promoter]	24481447
D019256	Cadmium Chloride	[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein	24481447
D019256	Cadmium Chloride	[[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein	24481447
D019256	Cadmium Chloride	T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of PPARG protein]	24481447
D019256	Cadmium Chloride	T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]	24481447
C037123	cadmium sulfate	cadmium sulfate affects the reaction [MTF1 affects the expression of PPARG mRNA]	16221973
C040048	caffeic acid	caffeic acid results in increased expression of PPARG mRNA	21870829
C055494	caffeic acid phenethyl ester	caffeic acid phenethyl ester results in decreased expression of PPARG mRNA	21467634
D002110	Caffeine	Caffeine results in decreased expression of PPARG mRNA	23727198
D002110	Caffeine	Caffeine results in decreased expression of PPARG mRNA	23727198
D061207	Calcium Ionophores	[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] affects the expression of PPARG mRNA	21511917
D002185	Cannabidiol	Cannabidiol results in increased expression of and affects the localization of PPARG protein	23220503
D002185	Cannabidiol	Cannabidiol results in increased expression of PPARG mRNA	23220503
D002185	Cannabidiol	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Cannabidiol affects the localization of PPARG protein]	23220503
D002185	Cannabidiol	Cannabidiol binds to PPARG protein	19285060
D002185	Cannabidiol	Cannabidiol results in increased expression of PPARG mRNA	19285060
D000074262	Canola Oil	Canola Oil affects the expression of PPARG mRNA	16177195
D002211	Capsaicin	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Capsaicin results in increased activity of PPARG protein]"	15383218
D002211	Capsaicin	Capsaicin results in decreased expression of PPARG mRNA	18769453
D002211	Capsaicin	Capsaicin results in increased activity of PPARG protein	15383218
D002211	Capsaicin	Capsaicin results in decreased expression of PPARG protein	17295509
D002211	Capsaicin	Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA]	20359164
D002220	Carbamazepine	Carbamazepine affects the expression of PPARG mRNA	24752500
D002248	Carbon Monoxide	Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein]	22046279
D002248	Carbon Monoxide	[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein	22046279
D002248	Carbon Monoxide	PPARG protein promotes the reaction [Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]	22046279
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in decreased expression of PPARG mRNA	28428136
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in decreased expression of PPARG protein	28428136
D002251	Carbon Tetrachloride	hesperetin analog inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	28428136
D002251	Carbon Tetrachloride	hesperetin analog inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein]	28428136
D002251	Carbon Tetrachloride	Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	28428136
D002251	Carbon Tetrachloride	Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein]	28428136
D002251	Carbon Tetrachloride	4-(5-(4-chlorophenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl)benzenesulfonamide inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	15876570
D002251	Carbon Tetrachloride	Carbon Tetrachloride affects the expression of PPARG protein	15959796
D002251	Carbon Tetrachloride	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA	28935427
D002251	Carbon Tetrachloride	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG protein	28935427
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in decreased activity of PPARG protein	25858767
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in decreased expression of PPARG mRNA	12055599\|1587657
D002251	Carbon Tetrachloride	Carbon Tetrachloride results in decreased expression of PPARG protein	23500774
D002251	Carbon Tetrachloride	Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	18006644
D002251	Carbon Tetrachloride	Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA]	28935427
D002251	Carbon Tetrachloride	Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG protein]	28935427
D002251	Carbon Tetrachloride	pioglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	12055599
D002251	Carbon Tetrachloride	puerarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein]	23500774
D002251	Carbon Tetrachloride	rosiglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	12055599
D002251	Carbon Tetrachloride	Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	24582681
D002338	Carotenoids	Carotenoids results in decreased expression of PPARG mRNA	11237167
C054133	casticin	casticin results in increased expression of PPARG mRNA	27862857
D002392	Catechin	Catechin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	23365609
C580959	CAY10415	CAY10415 results in increased activity of PPARG protein alternative form	23563205
C580960	CAY10506	CAY10506 results in increased activity of PPARG protein alternative form	23563205
D000068579	Celecoxib	2-chloro-5-nitrobenzanilide inhibits the reaction [Celecoxib affects the localization of PPARG protein]	23943857
D000068579	Celecoxib	Celecoxib affects the localization of PPARG protein	23943857
D000068579	Celecoxib	[Celecoxib results in decreased activity of and results in decreased expression of PTGS2 protein] which results in increased expression of PPARG	19522023
D000068579	Celecoxib	Celecoxib results in increased expression of PPARG mRNA	23943857
D000068579	Celecoxib	Celecoxib results in increased expression of PPARG protein	23943857
D000068579	Celecoxib	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Celecoxib affects the localization of PPARG protein]	23943857
D000068579	Celecoxib	[Celecoxib co-treated with docetaxel] results in increased expression of PPARG protein	16052515
D000068579	Celecoxib	Celecoxib inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA]	19247274
D002569	Cerulenin	Cerulenin results in decreased expression of PPARG mRNA	15707987
D002108	Ceruletide	PPARG affects the reaction [Ceruletide results in increased expression of CCL2 mRNA]	17463185
D002108	Ceruletide	PPARG affects the reaction [Ceruletide results in increased expression of CXCL1 mRNA]	17463185
D002599	Chalcone	Chalcone analog results in increased expression of PPARG mRNA	28528971
D002635	Chenodeoxycholic Acid	Chenodeoxycholic Acid results in increased expression of PPARG mRNA	27174168
D002635	Chenodeoxycholic Acid	Chenodeoxycholic Acid results in increased expression of PPARG mRNA	15980055
C515629	chiglitazar	chiglitazar results in increased activity of PPARG protein	23150725
C515629	chiglitazar	chiglitazar binds to and results in increased activity of PPARG protein	16751799
C004656	chloroacetaldehyde	chloroacetaldehyde affects the activity of PPARG protein	25596134
D020111	Chlorodiphenyl (54% Chlorine)	Chlorodiphenyl (54% Chlorine) results in increased expression of PPARG mRNA	16934159
D020111	Chlorodiphenyl (54% Chlorine)	[Diethylhexyl Phthalate co-treated with Chlorodiphenyl (54% Chlorine)] results in increased expression of PPARG mRNA	23804495
D002726	Chlorogenic Acid	Chlorogenic Acid results in decreased expression of PPARG mRNA	20706672
D002726	Chlorogenic Acid	Chlorogenic Acid results in increased expression of PPARG mRNA	21870829
D002746	Chlorpromazine	Chlorpromazine affects the activity of PPARG protein	25596134
D004390	Chlorpyrifos	Chlorpyrifos results in decreased expression of PPARG protein	24793810
D004390	Chlorpyrifos	rosiglitazone inhibits the reaction [Chlorpyrifos results in decreased expression of PPARG protein]	24793810
D002784	Cholesterol	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in decreased abundance of Cholesterol]	20372816
D002784	Cholesterol	[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [[25-hydroxycholesterol binds to and results in increased activity of NR1H3 protein] which results in increased transport of Cholesterol]	12595494
D002784	Cholesterol	[9-deoxy-delta-9-prostaglandin D2 binds to and results in increased activity of PPARG protein] promotes the reaction [APOA1 protein results in increased transport of Cholesterol]	12595494
D002784	Cholesterol	Pravastatin inhibits the reaction [[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol]	12044893
D002784	Cholesterol	[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased abundance of Cholesterol	16946405
D002784	Cholesterol	[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased abundance of Cholesterol	16946405
D002784	Cholesterol	[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol	12044893
D002784	Cholesterol	Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA]	24440342
D002784	Cholesterol	[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA	18302760
D002784	Cholesterol	[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA	24440342
D002784	Cholesterol	Losartan inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA]	18302760
D002784	Cholesterol	PPARG protein promotes the reaction [Niacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]]	19797938
D002784	Cholesterol	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA]	18302760
D002784	Cholesterol	Cholesterol results in decreased expression of PPARG mRNA	18402819
D002784	Cholesterol	Niacin inhibits the reaction [Cholesterol results in decreased expression of PPARG mRNA]	18402819
D002784	Cholesterol	[Niacin results in increased expression of PPARG mRNA] which results in increased export of Cholesterol	17395297\|1796363
D002791	Cholesterol, Dietary	"[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG mRNA"	20835264
D002791	Cholesterol, Dietary	"[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG protein"	20835264
D002791	Cholesterol, Dietary	"Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG mRNA]"	20835264
D002791	Cholesterol, Dietary	"Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG protein]"	20835264
D002791	Cholesterol, Dietary	"Cholesterol, Dietary results in increased expression of PPARG protein"	27019295
D002791	Cholesterol, Dietary	"oleuropein inhibits the reaction [Cholesterol, Dietary results in increased expression of PPARG protein]"	27019295
D002794	Choline	"3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PPARG mRNA]"	28973532
D002794	Choline	[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA	18991162
D002794	Choline	[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein	18991162
D002794	Choline	[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PPARG mRNA	28973532
D002794	Choline	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA]	18991162
D002794	Choline	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein]	18991162
C043561	chrysin	chrysin binds to and results in increased activity of PPARG protein	11343698
C043561	chrysin	PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]	11343698
C043561	chrysin	PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]	11343698
C059262	cidofovir	cidofovir affects the activity of PPARG protein	25596134
C039671	ciglitazone	ciglitazone binds to and results in decreased activity of PPARG protein	12391285
C039671	ciglitazone	ciglitazone binds to and results in increased activity of PPARG protein	11030710\|1134323
C039671	ciglitazone	ciglitazone binds to PPARG protein	12839938\|2151191
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ABHD3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACAA2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACADM mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACADVL mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ACSM3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of AKAP2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of AKR1C1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of AKR1C2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ANG mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ANGPTL4 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of APOL1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of APOM mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of AQP3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ARHGEF2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ATF7IP2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of BCL6 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of BDH1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of BHMT mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of BLVRB mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CAT mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CCL14 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CCL15 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CCL20 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CDH1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CIDEC mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of COBLL1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of COPA mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CSTB mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CTSC mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CYB5R3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of CYP1A2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of DKK1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of DLC1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of DOK4 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of EFNA1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ELF5 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of FABP1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of FAM102A mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of FAM13A mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of FLNB mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GALNT2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GCN1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GK3P mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GK mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GPX3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of GRAMD2B mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of HADHA mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of HAMP mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of HMGCS2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of HMOX1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of HPN mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ITIH3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of LIPC mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of LMCD1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of LOX mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of LPCAT1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MAGED4B mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MAGED4 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MAP4K3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MAPK14 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MKI67 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of MTMR4 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of NDRG2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of NR1H3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of NREP mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of OAS1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of OPTN mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PALM2-AKAP2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PALM2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PCK1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PDZK1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PHLPP1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PIM1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLA2G2A mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLAC8 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLCXD1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLIN2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PLSCR4 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PMM1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of POR mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PRKCD mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of PSD4 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of RETSAT mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of RNASE4 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of RNF128 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of RPS6KC1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of S100P mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SEC23A mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SEMA3G mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SEPT10 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SERPINE1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SLC30A10 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SLC50A1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SNRK mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SORL1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SOWAHC mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of STBD1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of SUN2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of TCAF1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of TIMP3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of TMEM53 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of TNS1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of TRAF3IP2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of UGT1A6 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of UGT1A9 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of VEGFA mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of VNN1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein alternative form] which results in increased expression of ZNF185 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of ABHD3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of ACAA1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of ACADM mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of ACSL1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of AKR1C1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of AKR1C2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of ANGPTL4 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of AQP3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of CCL14 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of CCL15 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of CCL20 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of CDH1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of CEBPD mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of CHMP5 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of CITED2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of CYP1A2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of DOK4 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of ELF5 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of EPAS1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of FABP1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of FAM13A mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of FOXO1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of GALNT2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of GPX3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of HADHA mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of HCAR3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of HMGCS2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of HMOX1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of IL1R1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of IL6ST mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of ITGB5 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of JAG1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of LGALS3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of LIPC mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of LPCAT3 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of MPC1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of MPZL2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of NPC1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of OAS1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of OPTN mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of OSMR mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of PCK1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of PDZK1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of PHKA2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of PIM1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of PLIN2 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of PNRC1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of POR mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of RBMS1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of RNF10 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of S100P mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of SERPINE1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of SLC30A10 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of SLC4A7 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of SORL1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of SOWAHC mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of SQSTM1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of STBD1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of STX7 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of TBC1D4 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of TCAF1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of TGIF1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of TMBIM1 mRNA	16197558
C039671	ciglitazone	[ciglitazone binds to PPARG protein] which results in increased expression of VEGFA mRNA	16197558
C039671	ciglitazone	ciglitazone inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]	12604364
C039671	ciglitazone	ciglitazone promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]	11840453
C039671	ciglitazone	ciglitazone results in increased activity of PPARG protein	12517972\|1638671
C039671	ciglitazone	ciglitazone results in increased expression of PPARG mRNA	11278336\|1184045
C039671	ciglitazone	ciglitazone results in increased expression of PPARG protein	21067863
C039671	ciglitazone	ciglitazone results in increased localization of PPARG protein	12517972
C039671	ciglitazone	monobutyl phthalate inhibits the reaction [ciglitazone binds to and results in increased activity of PPARG protein]	16326050
C039671	ciglitazone	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [ciglitazone results in increased expression of PPARG mRNA]	11840453
C039671	ciglitazone	nimesulide inhibits the reaction [ciglitazone promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]]	11840453
C039671	ciglitazone	nimesulide inhibits the reaction [ciglitazone results in increased expression of PPARG mRNA]	11840453
C039671	ciglitazone	norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein]	18393431
C039671	ciglitazone	PPARG promotes the reaction [ciglitazone results in increased expression of PTGS2 mRNA]	11840453
C039671	ciglitazone	PPARG promotes the reaction [ciglitazone results in increased expression of PTGS2 protein]	11840453
C039671	ciglitazone	PPARG protein mutant form results in decreased susceptibility to ciglitazone	19922793
C039671	ciglitazone	PPARG protein promotes the reaction [ciglitazone promotes the reaction [SR 11237 results in increased expression of RARB protein]]	12839938
C039671	ciglitazone	PPARG protein promotes the reaction [ciglitazone results in increased activity of DIO2 protein]	19036883
C039671	ciglitazone	Quercetin inhibits the reaction [ciglitazone results in increased activity of PPARG protein]	18393431
C039671	ciglitazone	ciglitazone binds to and results in increased activity of PPARG protein	12847270\|1518715
C039671	ciglitazone	[ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA	19698295
C039671	ciglitazone	[ciglitazone co-treated with Bucladesine] results in increased expression of PPARG protein	19698295
C039671	ciglitazone	ciglitazone inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]	12847270
C039671	ciglitazone	ciglitazone inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]	17019405
C039671	ciglitazone	ciglitazone results in increased activity of PPARG protein	11683414\|1602342
C039671	ciglitazone	ciglitazone results in increased expression of PPARG protein	19698295
C039671	ciglitazone	PPARG protein promotes the reaction [ciglitazone results in increased expression of PPARGC1A mRNA]	16513826
C039671	ciglitazone	ciglitazone affects the localization of PPARG protein	20578043
C039671	ciglitazone	ciglitazone binds to and results in increased activity of PPARG protein	18063688
C039671	ciglitazone	[ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose	18063688
C039671	ciglitazone	ciglitazone inhibits the reaction [Glycerol results in decreased expression of PPARG protein]	16820301
C039671	ciglitazone	ciglitazone binds to and affects the activity of PPARG protein	11409902\|1630360
C039671	ciglitazone	ciglitazone binds to and results in increased activity of PPARG protein	12065618\|1568404
C039671	ciglitazone	ciglitazone binds to PPARG protein	17499714\|2152578
C065927	cilnidipine	cilnidipine results in decreased activity of PPARG protein	25257666
C045645	cilostazol	2-chloro-5-nitrobenzanilide inhibits the reaction [cilostazol results in increased activity of PPARG protein]	21660147
C045645	cilostazol	cilostazol results in increased activity of PPARG protein	21660147
C045645	cilostazol	HMOX1 protein promotes the reaction [cilostazol results in increased activity of PPARG protein]	21660147
C045645	cilostazol	zinc protoporphyrin inhibits the reaction [cilostazol results in increased activity of PPARG protein]	21660147
C029010	cinnamic acid	cinnamic acid results in increased expression of PPARG mRNA	21870829
C012843	cinnamic aldehyde	cinnamic aldehyde results in decreased expression of PPARG mRNA	21401097
D002953	Citrinin	Citrinin results in decreased activity of PPARG protein	27481073
C006231	clinofibrate	clinofibrate binds to PPARG protein	11779144
D004002	Clodronic Acid	Clodronic Acid affects the activity of PPARG protein	25596134
D002994	Clofibrate	Clofibrate results in increased expression of PPARG mRNA	24880017
D002994	Clofibrate	Clofibrate results in increased expression of PPARG protein	15964169
D002994	Clofibrate	Clofibrate results in increased activity of [PPARG protein alternative form binds to RXRA protein]	11779144
D002994	Clofibrate	[Clofibrate co-treated with PPARG] results in increased expression of FABP4 mRNA	9543393
D002994	Clofibrate	[Clofibrate co-treated with PPARG] results in increased expression of RORA mRNA	9543393
D002994	Clofibrate	[Clofibrate co-treated with PPARG] results in increased expression of RORC mRNA	9543393
D002994	Clofibrate	Clofibrate results in increased expression of PPARG mRNA	12699904
D002994	Clofibrate	Clofibrate results in increased expression of PPARG protein	12604186\|1269990
D002994	Clofibrate	PPARG protein affects the susceptibility to Clofibrate	12604186
D002994	Clofibrate	PPARG protein promotes the reaction [Clofibrate results in decreased expression of ALDH3A1 mRNA]	12604186
D002994	Clofibrate	PPARG results in increased susceptibility to Clofibrate	12699904
D002994	Clofibrate	Clofibrate results in increased expression of PPARG	24880017
D002995	Clofibric Acid	Clofibric Acid binds to PPARG protein	11779144
D003024	Clozapine	Berberine inhibits the reaction [Clozapine results in increased expression of PPARG mRNA]	20564506
D003024	Clozapine	Berberine inhibits the reaction [Clozapine results in increased expression of PPARG protein]	20564506
D003024	Clozapine	Clozapine results in increased expression of PPARG mRNA	20564506
D003024	Clozapine	Clozapine results in increased expression of PPARG protein	20564506
C007095	cobaltiprotoporphyrin	cobaltiprotoporphyrin affects the expression of PPARG protein	23497794
C018021	cobaltous chloride	cobaltous chloride results in decreased expression of PPARG mRNA	15708366
C018021	cobaltous chloride	cobaltous chloride results in decreased expression of PPARG mRNA	20594416
D005576	Colforsin	Colforsin promotes the reaction [tributyltin results in decreased expression of PPARG mRNA]	20211155
D019327	Copper Sulfate	Copper Sulfate results in increased expression of PPARG mRNA	26368670
D019327	Copper Sulfate	Copper Sulfate results in decreased expression of PPARG mRNA	23660017
C470995	corexit 9500	corexit 9500 results in increased activity of PPARG protein	26135921
D003348	Cortisone	"2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone inhibits the reaction [Cortisone results in increased expression of PPARG mRNA]"	21315688
D003348	Cortisone	Cortisone results in increased expression of PPARG mRNA	21315688
C532131	CR8 compound	CR8 compound inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]	24481447
C532131	CR8 compound	CR8 compound inhibits the reaction [troglitazone results in increased phosphorylation of PPARG protein]	24481447
C041246	cucurbitacin B	cucurbitacin B results in decreased expression of PPARG mRNA	24316209
C041246	cucurbitacin B	STAT3 protein affects the reaction [cucurbitacin B results in decreased expression of PPARG mRNA]	24316209
C038106	cucurbitacin I	cucurbitacin I results in decreased expression of PPARG mRNA	24316209
D003474	Curcumin	Curcumin binds to PPARG protein	15713005
D003474	Curcumin	Curcumin results in decreased expression of PPARG protein modified form	15486348
D003474	Curcumin	Curcumin results in increased activity of PPARG protein	15486348
D003474	Curcumin	PPARG protein promotes the reaction [Curcumin results in decreased expression of CTGF mRNA]	17965732
D003474	Curcumin	Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]	28595985
D003474	Curcumin	Curcumin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	19297423
D003474	Curcumin	Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	28595985
D003474	Curcumin	Curcumin results in decreased expression of and results in decreased activity of PPARG protein	23603106
D003474	Curcumin	Curcumin results in decreased expression of PPARG mRNA	23603106
D003474	Curcumin	2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased expression of PPARG mRNA]	17531121
D003474	Curcumin	2-chloro-5-nitrobenzanilide inhibits the reaction [Curcumin results in increased expression of PPARG protein]	17531121
D003474	Curcumin	Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of PPARG mRNA]	17602960
D003474	Curcumin	Buthionine Sulfoximine inhibits the reaction [Curcumin results in increased expression of PPARG protein]	17602960
D003474	Curcumin	Curcumin affects the localization of PPARG protein	17531121
D003474	Curcumin	Curcumin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	18006644
D003474	Curcumin	Curcumin inhibits the reaction [EGF protein results in decreased expression of PPARG mRNA]	17372590
D003474	Curcumin	Curcumin inhibits the reaction [EGF protein results in decreased expression of PPARG protein]	17372590
D003474	Curcumin	Curcumin inhibits the reaction [[SMAD4 protein binds to SMAD3 protein] which binds to PPARG promoter]	16959952
D003474	Curcumin	Curcumin inhibits the reaction [TGFB1 protein results in decreased expression of PPARG mRNA]	16959952
D003474	Curcumin	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]	16782535
D003474	Curcumin	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]	16782535
D003474	Curcumin	Curcumin results in decreased expression of PPARG protein	19225048
D003474	Curcumin	Curcumin results in increased activity of PPARG protein	18332871
D003474	Curcumin	Curcumin results in increased expression of PPARG mRNA	16959952\|1753112
D003474	Curcumin	Curcumin results in increased expression of PPARG protein	16959952\|1753112
D003474	Curcumin	Curcumin results in increased expression of PPARG	18462866
D003484	Cyanamide	Cyanamide inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
C114438	cyanidin 3-O-glucoside	[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin 3-O-glucoside] results in increased expression of PPARG protein	27818126
C114438	cyanidin 3-O-glucoside	Mesalamine inhibits the reaction [[IL1A protein co-treated with TNF protein co-treated with IFNG protein co-treated with cyanidin 3-O-glucoside] results in increased expression of PPARG protein]	27818126
D003513	Cycloheximide	Cycloheximide inhibits the reaction [rosiglitazone results in increased expression of PPARG protein]	17622750
C500528	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester results in increased expression of PPARG mRNA	27659731
D003520	Cyclophosphamide	Cyclophosphamide results in decreased expression of PPARG mRNA	25446862
D003520	Cyclophosphamide	Cyclophosphamide results in increased expression of PPARG mRNA	27281708
D003520	Cyclophosphamide	Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of PPARG mRNA]	25446862
D016572	Cyclosporine	Cyclosporine affects the activity of PPARG protein	25596134
D016572	Cyclosporine	Cyclosporine results in increased expression of PPARG mRNA	20106945
D016572	Cyclosporine	[Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein	17016853
D016572	Cyclosporine	Cyclosporine affects the activity of PPARG protein	25596134
D016572	Cyclosporine	Cyclosporine inhibits the reaction [rosiglitazone results in increased expression of PPARG protein]	17461532
D016572	Cyclosporine	Cyclosporine results in decreased expression of PPARG mRNA	17461532
D016572	Cyclosporine	Cyclosporine results in decreased expression of PPARG protein	17461532
D016572	Cyclosporine	rosiglitazone inhibits the reaction [Cyclosporine results in decreased expression of PPARG mRNA]	17461532
D016572	Cyclosporine	rosiglitazone inhibits the reaction [Cyclosporine results in decreased expression of PPARG protein]	17461532
C037304	cyhalothrin	cyhalothrin results in increased expression of PPARG mRNA	27348886
D003561	Cytarabine	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cytarabine results in increased expression of PPARG mRNA]"	23264188
D003561	Cytarabine	Cytarabine results in increased expression of PPARG mRNA	23264188
C411602	dalcetrapib	dalcetrapib results in increased expression of PPARG mRNA	25617244
C089948	darglitazone	darglitazone binds to and results in increased activity of PPARG protein	21557540
D003630	Daunorubicin	Daunorubicin results in decreased activity of PPARG protein	25257666
D003630	Daunorubicin	Daunorubicin results in increased expression of PPARG protein	20888384
D003630	Daunorubicin	telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein]	20888384
D003634	DDT	DDT results in increased expression of PPARG mRNA	25014179
D003634	DDT	DDT results in increased activity of and results in increased localization of PPARG protein	11911853
C017180	decamethrin	decamethrin results in decreased expression of PPARG protein	27553674
C017180	decamethrin	decamethrin results in decreased expression of PPARG mRNA	23401056
C017180	decamethrin	decamethrin results in increased expression of PPARG protein	28119079
C031071	decanoic acid	decanoic acid binds to PPARG protein	24998974
C031071	decanoic acid	decanoic acid results in increased activity of PPARG protein	24998974
C014347	decitabine	decitabine affects the expression of PPARG mRNA	23300844
C014347	decitabine	decitabine results in increased expression of PPARG mRNA	16763620
C548688	dehydroglyasperin C	dehydroglyasperin C binds to PPARG protein	14608046
C551630	dehydroglyasperin D	dehydroglyasperin D binds to PPARG protein	14608046
D015230	Prostaglandin D2	Prostaglandin D2 affects the localization of and results in increased expression of PPARG protein	23943857
D015230	Prostaglandin D2	Prostaglandin D2 affects the localization of PPARG protein	23220503
D015230	Prostaglandin D2	Prostaglandin D2 binds to and results in increased activity of PPARG protein	18387855
D013759	Dronabinol	[RXRA co-treated with Dronabinol] results in increased expression of PPARG mRNA	16213464
D013759	Dronabinol	Dronabinol results in increased activity of PPARG	19285060
C479072	delta-tocopherol	[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]	22389237
C479072	delta-tocopherol	[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]	22389237
C050229	demethoxycurcumin	demethoxycurcumin binds to PPARG protein	15713005
D015255	Idarubicin	Idarubicin results in decreased activity of PPARG protein	25257666
D003840	Deoxycholic Acid	Deoxycholic Acid results in decreased expression of PPARG mRNA	23911798
D003847	Deoxyglucose	PPARG gene polymorphism results in increased uptake of Deoxyglucose	18083318
D003847	Deoxyglucose	PPARG protein affects the uptake of Deoxyglucose	18083318
C007262	deoxynivalenol	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [deoxynivalenol results in increased expression of PPARG protein]"	18485432
C007262	deoxynivalenol	deoxynivalenol results in decreased activity of PPARG protein	27481073
C007262	deoxynivalenol	deoxynivalenol results in increased expression of PPARG mRNA	18485432
C007262	deoxynivalenol	EGR1 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA]	18485432
C007262	deoxynivalenol	"lipopolysaccharide, E coli O55-B5 affects the reaction [deoxynivalenol results in increased expression of PPARG mRNA]"	18485432
C007262	deoxynivalenol	MAPK1 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA]	18485432
C007262	deoxynivalenol	MAPK3 protein promotes the reaction [deoxynivalenol results in increased expression of PPARG mRNA]	18485432
C007262	deoxynivalenol	PPARG protein affects the reaction [deoxynivalenol results in decreased degradation of CXCL8 mRNA]	18485432
C007262	deoxynivalenol	U 0126 inhibits the reaction [deoxynivalenol results in increased expression of PPARG mRNA]	18485432
D003907	Dexamethasone	[Ascorbic Acid co-treated with beta-glycerophosphoric acid co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA	25932594
D003907	Dexamethasone	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA	19186324
D003907	Dexamethasone	[Dexamethasone co-treated with INS protein co-treated with pioglitazone] results in increased expression of PPARG protein	17290005
D003907	Dexamethasone	[Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein	17290005
D003907	Dexamethasone	Dexamethasone results in increased expression of PPARG mRNA	16569937\|1985301
D003907	Dexamethasone	Dexamethasone results in increased expression of PPARG protein	16569937
D003907	Dexamethasone	[Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA	26200599
D003907	Dexamethasone	[Indomethacin co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA	20206132
D003907	Dexamethasone	[Indomethacin co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG protein	20206132
D003907	Dexamethasone	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PPARG mRNA	28628672
D003907	Dexamethasone	PPARG protein results in decreased susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]	26670611
D003907	Dexamethasone	[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA	20206132
D003907	Dexamethasone	[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein	20206132
D003907	Dexamethasone	rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	19186324
D003907	Dexamethasone	TGFB1 protein inhibits the reaction [[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]	20206132
D003907	Dexamethasone	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA	23503329
D003907	Dexamethasone	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein	25559859\|2747571
D003907	Dexamethasone	"3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]"	22298784
D003907	Dexamethasone	"3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]"	22298784
D003907	Dexamethasone	AG 1879 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
D003907	Dexamethasone	andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]	27475717
D003907	Dexamethasone	APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]	28242765
D003907	Dexamethasone	bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]	22197818
D003907	Dexamethasone	bisphenol A promotes the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]	26944108
D003907	Dexamethasone	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]	28285642
D003907	Dexamethasone	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]	28285642
D003907	Dexamethasone	butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	28595985
D003907	Dexamethasone	butylparaben promotes the reaction [Dexamethasone results in increased expression of PPARG mRNA]	22956630
D003907	Dexamethasone	CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]	28285642
D003907	Dexamethasone	CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]	28285642
D003907	Dexamethasone	Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]	28595985
D003907	Dexamethasone	Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	28595985
D003907	Dexamethasone	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA	23152186
D003907	Dexamethasone	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein	18586010
D003907	Dexamethasone	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA	22298784\|2803146
D003907	Dexamethasone	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein	22298784\|2828564
D003907	Dexamethasone	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein	16971554
D003907	Dexamethasone	[Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA	9543393
D003907	Dexamethasone	[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein	17290005
D003907	Dexamethasone	[Dexamethasone co-treated with INS protein co-treated with pioglitazone] results in increased expression of PPARG protein	17290005
D003907	Dexamethasone	[Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein	17290005
D003907	Dexamethasone	[Dexamethasone co-treated with Oxygen deficiency] results in increased expression of PPARG mRNA alternative form	16814746
D003907	Dexamethasone	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA	16054899
D003907	Dexamethasone	Dexamethasone results in decreased expression of PPARG mRNA	16889531
D003907	Dexamethasone	Dexamethasone results in increased expression of PPARG mRNA	22956630\|2506808
D003907	Dexamethasone	Dexamethasone results in increased expression of PPARG mRNA alternative form	16814746
D003907	Dexamethasone	Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]	22197818
D003907	Dexamethasone	Diethylstilbestrol inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]	26944108
D003907	Dexamethasone	EGF protein inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]	16971554
D003907	Dexamethasone	EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]	16971554
D003907	Dexamethasone	EGF protein promotes the reaction [Vanadates inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]	16971554
D003907	Dexamethasone	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein	26117538
D003907	Dexamethasone	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA	26972250
D003907	Dexamethasone	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein	11101056\|2457644
D003907	Dexamethasone	[INS1 protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA	11812925
D003907	Dexamethasone	[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein	26944108
D003907	Dexamethasone	[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein	26944108
D003907	Dexamethasone	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA	28595985
D003907	Dexamethasone	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein	28242765
D003907	Dexamethasone	JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	26117538
D003907	Dexamethasone	(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	26117538
D003907	Dexamethasone	(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	26972250
D003907	Dexamethasone	(+)-JQ1 compound inhibits the reaction [rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]	26972250
D003907	Dexamethasone	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA	29288687
D003907	Dexamethasone	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein	29288687
D003907	Dexamethasone	methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
D003907	Dexamethasone	[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form	14984747
D003907	Dexamethasone	potassium chromate(VI) inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]	24576443
D003907	Dexamethasone	Quercetin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein]	18586010
D003907	Dexamethasone	Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein]	11101056
D003907	Dexamethasone	[rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA	29288687
D003907	Dexamethasone	[rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein	29288687
D003907	Dexamethasone	rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	26972250
D003907	Dexamethasone	rosiglitazone promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	28595985
D003907	Dexamethasone	[SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form]	14984747
D003907	Dexamethasone	silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]	25559859
D003907	Dexamethasone	sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]	23152186
D003907	Dexamethasone	sodium arsenite inhibits the reaction [[INS1 protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]	11812925
D003907	Dexamethasone	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]	28285642
D003907	Dexamethasone	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]	28285642
D003907	Dexamethasone	T 0070907 inhibits the reaction [[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein]	26944108
D003907	Dexamethasone	[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]	16054899
D003907	Dexamethasone	Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]	16971554
D003907	Dexamethasone	Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]	16054899
D003907	Dexamethasone	TGFB1 inhibits the reaction [[Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]	9543393
D003907	Dexamethasone	TNF inhibits the reaction [[Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA]	9543393
D003907	Dexamethasone	tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]	22197818
D003907	Dexamethasone	U 0126 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]	16782535
D003907	Dexamethasone	Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]	16782535
D003907	Dexamethasone	Dexamethasone results in increased expression of PPARG mRNA	14568882\|1911856
D003907	Dexamethasone	Dexamethasone results in increased expression of PPARG protein	14568882
D003907	Dexamethasone	[INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA	21350315
D003907	Dexamethasone	Dexamethasone results in increased expression of PPARG	19852296
D003907	Dexamethasone	[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA	27602593
D003907	Dexamethasone	Environmental Pollutants inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]	27602593
D003907	Dexamethasone	mono-(2-ethylhexyl)phthalate promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]	27602593
D016264	Dextran Sulfate	Dextran Sulfate results in increased expression of PPARG protein	23261717
C042577	diallyl trisulfide	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [diallyl trisulfide results in decreased expression of and results in decreased activity of PPARG protein]	22137902
C042577	diallyl trisulfide	diallyl trisulfide results in decreased activity of PPARG protein	22137902
C042577	diallyl trisulfide	diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]	22137902
C042577	diallyl trisulfide	[diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]] which results in decreased expression of FASN	22137902
C042577	diallyl trisulfide	[diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]] which results in increased abundance of Lipids	22137902
C042577	diallyl trisulfide	diallyl trisulfide results in decreased expression of PPARG mRNA	22137902
C042577	diallyl trisulfide	diallyl trisulfide results in decreased expression of PPARG protein	22137902
D003993	Dibutyl Phthalate	Dibutyl Phthalate binds to and results in increased activity of PPARG protein	24155963\|2763390
D003993	Dibutyl Phthalate	Dibutyl Phthalate binds to PPARG protein	23843199
D003993	Dibutyl Phthalate	Dibutyl Phthalate results in increased activity of PPARG protein	26172262
D003993	Dibutyl Phthalate	Dibutyl Phthalate results in increased expression of PPARG protein	29061543
D003994	Bucladesine	Bucladesine results in increased expression of PPARG protein	19698295
D003994	Bucladesine	[ciglitazone co-treated with Bucladesine] affects the expression of PPARG mRNA	19698295
D003994	Bucladesine	[ciglitazone co-treated with Bucladesine] results in increased expression of PPARG protein	19698295
D003999	Dichloroacetic Acid	Dichloroacetic Acid results in increased expression of PPARG mRNA	28962523
D002945	Cisplatin	Cisplatin affects the activity of PPARG protein	25596134
D002945	Cisplatin	Cisplatin affects the expression of PPARG mRNA	23300844
D002945	Cisplatin	Cisplatin results in decreased expression of PPARG protein	27417252
D002945	Cisplatin	PPARG protein results in increased susceptibility to [rosiglitazone co-treated with Cisplatin]	27417252
D002945	Cisplatin	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to Cisplatin	21781307
D002945	Cisplatin	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Cisplatin	21781307
D002945	Cisplatin	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA]"	22989705
D002945	Cisplatin	Cisplatin results in decreased expression of PPARG mRNA	22989705
D002945	Cisplatin	pioglitazone inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA]	22989705
D003633	Dichlorodiphenyl Dichloroethylene	[Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA	26200599
D003633	Dichlorodiphenyl Dichloroethylene	Dichlorodiphenyl Dichloroethylene inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
D003633	Dichlorodiphenyl Dichloroethylene	[Polychlorinated Biphenyls analog co-treated with Dichlorodiphenyl Dichloroethylene analog] inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
D004008	Diclofenac	Diclofenac affects the expression of PPARG mRNA	24752500
D004008	Diclofenac	Diclofenac results in increased activity of PPARG protein	12065695\|1527325
C036042	dicyclohexyl phthalate	dicyclohexyl phthalate results in increased expression of PPARG mRNA	26924002
C027718	didecyl phthalate	didecyl phthalate binds to PPARG protein	23843199
D018119	Stavudine	Stavudine results in decreased expression of PPARG mRNA	14518702
D018119	Stavudine	Stavudine results in decreased expression of PPARG mRNA	17926646
D018119	Stavudine	Stavudine results in decreased expression of PPARG protein	15722030
D004040	Dietary Carbohydrates	Dietary Carbohydrates results in increased expression of PPARG mRNA	20110567
D004041	Dietary Fats	[Bezafibrate co-treated with Dietary Fats] results in increased expression of PPARG mRNA	24759758
D004041	Dietary Fats	[resveratrol analog co-treated with Dietary Fats] results in increased expression of PPARG mRNA	24759758
D004041	Dietary Fats	Curcumin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	19297423
D004041	Dietary Fats	Dietary Fats affects the expression of PPARG mRNA	19680557
D004041	Dietary Fats	[Dietary Fats co-treated with Aurothioglucose] results in decreased expression of PPARG protein	21382165
D004041	Dietary Fats	[Dietary Fats co-treated with bis(4-hydroxyphenyl)sulfone] affects the expression of PPARG mRNA	27241191
D004041	Dietary Fats	"[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG mRNA"	20835264
D004041	Dietary Fats	"[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG protein"	20835264
D004041	Dietary Fats	[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA	18302760
D004041	Dietary Fats	[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA	18991162
D004041	Dietary Fats	[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein	18991162
D004041	Dietary Fats	[Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPARG mRNA	21462320\|2843392
D004041	Dietary Fats	[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA	27769711
D004041	Dietary Fats	Dietary Fats promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA]	27713108
D004041	Dietary Fats	Dietary Fats results in decreased expression of PPARG mRNA	18042831\|2651925
D004041	Dietary Fats	Dietary Fats results in increased expression of PPARG mRNA	18457598\|1929742
D004041	Dietary Fats	Dietary Fats results in increased expression of PPARG protein	28283972
D004041	Dietary Fats	Diosgenin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	26408789
D004041	Dietary Fats	esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA]	27769711
D004041	Dietary Fats	[hexabromocyclododecane co-treated with Dietary Fats] results in increased expression of PPARG mRNA	24398136
D004041	Dietary Fats	Losartan inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA]	18302760
D004041	Dietary Fats	naringin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	22198281
D004041	Dietary Fats	Plant Extracts inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	22967722
D004041	Dietary Fats	Quercetin inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPARG mRNA]	21462320
D004041	Dietary Fats	Quercetin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	22447684\|2402568
D004041	Dietary Fats	[resveratrol co-treated with Dietary Fats] results in decreased expression of PPARG mRNA	24985011
D004041	Dietary Fats	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA]	18302760
D004041	Dietary Fats	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA]	18991162
D004041	Dietary Fats	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein]	18991162
D004041	Dietary Fats	"Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG mRNA]"	20835264
D004041	Dietary Fats	"Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG protein]"	20835264
D004041	Dietary Fats	sodium arsenite inhibits the reaction [Dietary Fats results in increased expression of PPARG protein]	28283972
D004041	Dietary Fats	Tetrachlorodibenzodioxin promotes the reaction [Dietary Fats results in increased expression of PPARG mRNA]	27713108
D004041	Dietary Fats	Capsaicin inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA]	20359164
D004041	Dietary Fats	Catechin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	23365609
D004041	Dietary Fats	Celecoxib inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA]	19247274
D004041	Dietary Fats	[Dietary Fats co-treated with bisphenol A] results in increased expression of PPARG mRNA	25112833
D004041	Dietary Fats	[Dietary Fats co-treated with Quercetin] affects the expression of PPARG mRNA	20580672
D004041	Dietary Fats	Dietary Fats results in decreased expression of PPARG mRNA	19247274\|2445087
D004041	Dietary Fats	Dietary Fats results in increased expression of PPARG mRNA	20359164\|2325115
D004041	Dietary Fats	Dietary Fats results in increased expression of PPARG protein	27171397
D004041	Dietary Fats	Ficusin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]	27350165
D004041	Dietary Fats	Genistein inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	27171397
D004041	Dietary Fats	Genistein inhibits the reaction [Dietary Fats results in increased expression of PPARG protein]	27171397
D004041	Dietary Fats	nimesulide inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA]	19247274
D004041	Dietary Fats	[pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Diglycerides]	19403437
D004041	Dietary Fats	[pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Phospholipids]	19403437
D004041	Dietary Fats	[pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Triglycerides]	19403437
D004041	Dietary Fats	pioglitazone inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]	27350165
D004041	Dietary Fats	Plant Extracts inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	23365609
D004041	Dietary Fats	[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA	27350165
D004041	Dietary Fats	[Thioctic Acid co-treated with Dietary Fats] results in increased expression of PPARG mRNA	22464149
D004041	Dietary Fats	Dietary Fats results in decreased expression of PPARG protein	21739664
D004041	Dietary Fats	resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein]	21739664
D019422	Dietary Sucrose	[Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPARG mRNA	21462320\|2843392
D019422	Dietary Sucrose	Quercetin inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPARG mRNA]	21462320
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate binds to and results in decreased activity of PPARG protein	27633901
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate binds to PPARG protein	23843199
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate metabolite binds to PPARG protein	25314719
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in increased expression of PPARG protein	28025108\|2906154
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate affects the expression of PPARG mRNA	22588786
D004051	Diethylhexyl Phthalate	[Diethylhexyl Phthalate co-treated with Chlorodiphenyl (54% Chlorine)] results in increased expression of PPARG mRNA	23804495
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]	22197818
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in increased expression of PPARG protein	21856391
D004051	Diethylhexyl Phthalate	[Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG mRNA	20920559
D004051	Diethylhexyl Phthalate	[Benzo(a)pyrene co-treated with Diethylhexyl Phthalate] results in increased expression of PPARG protein	20920559
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in decreased expression of PPARG protein	16690193
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in increased expression of PPARG mRNA	15647598\|2092055
D004051	Diethylhexyl Phthalate	Diethylhexyl Phthalate results in increased expression of PPARG protein	15647598\|2092055
D004052	Diethylnitrosamine	PPARG protein results in decreased susceptibility to Diethylnitrosamine	20512989
D004052	Diethylnitrosamine	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA	28935427
D004052	Diethylnitrosamine	[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG protein	28935427
D004052	Diethylnitrosamine	Diethylnitrosamine results in decreased expression of PPARG mRNA	24954034
D004052	Diethylnitrosamine	Diethylnitrosamine results in decreased expression of PPARG protein	24954034
D004052	Diethylnitrosamine	Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA]	28935427
D004052	Diethylnitrosamine	Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG protein]	28935427
C007379	diethyl phthalate	diethyl phthalate binds to PPARG protein	23843199
D004054	Diethylstilbestrol	2-chloro-5-nitrobenzanilide inhibits the reaction [Diethylstilbestrol results in increased expression of PPARG protein]	22710028
D004054	Diethylstilbestrol	Diethylstilbestrol inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]	26944108
D004054	Diethylstilbestrol	Diethylstilbestrol results in increased activity of PPARG protein	22710028
D004054	Diethylstilbestrol	Diethylstilbestrol results in increased expression of PPARG mRNA	22710028
D004054	Diethylstilbestrol	Diethylstilbestrol results in increased expression of PPARG protein	22710028
D004054	Diethylstilbestrol	fulvestrant inhibits the reaction [Diethylstilbestrol results in increased activity of PPARG protein]	22710028
D004054	Diethylstilbestrol	[troglitazone co-treated with Diethylstilbestrol] results in increased expression of PPARG protein	22710028
D004075	Diglycerides	[pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Diglycerides]	19403437
D004075	Diglycerides	[pioglitazone results in increased activity of PPARG protein] which results in increased abundance of Diglycerides	19439812
C089799	diheptyl phthalate	diheptyl phthalate binds to PPARG protein	23843199
D002117	Calcitriol	Calcitriol results in decreased expression of PPARG mRNA	15036392\|1636878
D002117	Calcitriol	Calcitriol results in decreased expression of PPARG protein	15036392
C025605	diisobutyl phthalate	diisobutyl phthalate binds to and results in increased activity of PPARG protein	24155963\|2763390
C025605	diisobutyl phthalate	diisobutyl phthalate results in increased activity of PPARG protein	26172262
C025605	diisobutyl phthalate	diisobutyl phthalate results in increased expression of PPARG protein	29061543
C042080	diisodecyl phthalate	diisodecyl phthalate binds to PPARG protein	23843199
C042080	diisodecyl phthalate	diisodecyl phthalate results in increased expression of PPARG mRNA	25825955
C012125	diisononyl phthalate	diisononyl phthalate affects the activity of PPARG protein	26172262
C012125	diisononyl phthalate	diisononyl phthalate binds to PPARG protein	23843199
D004128	Dimethylnitrosamine	Dimethylnitrosamine results in decreased expression of PPARG mRNA	12055599\|1509947
C024629	dimethyl phthalate	dimethyl phthalate binds to PPARG protein	23843199
D004121	Dimethyl Sulfoxide	Dimethyl Sulfoxide results in decreased expression of PPARG mRNA	21878375
C027387	di-n-hexyl phthalate	di-n-hexyl phthalate binds to PPARG protein	23843199
C019174	dinonylphthalate	dinonylphthalate binds to PPARG protein	23843199
C034171	di-n-pentyl phthalate	di-n-pentyl phthalate binds to PPARG protein	23843199
C106479	di-n-propylphthalate	di-n-propylphthalate binds to PPARG protein	23843199
D004143	Dioctyl Sulfosuccinic Acid	Dioctyl Sulfosuccinic Acid binds to and results in increased activity of PPARG protein	26135921
D004143	Dioctyl Sulfosuccinic Acid	Dioctyl Sulfosuccinic Acid results in increased activity of PPARG protein	26135921
D004144	Diosgenin	Diosgenin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	26408789
D004144	Diosgenin	Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]	26408789
D004144	Diosgenin	[Diosgenin inhibits the reaction [RXRA protein binds to PPARG protein]] which results in decreased activity of PPARG protein	26408789
D004144	Diosgenin	Diosgenin results in decreased expression of PPARG mRNA	26408789
D004144	Diosgenin	Diosgenin results in increased expression of PPARG protein	24001619
D004144	Diosgenin	fulvestrant inhibits the reaction [Diosgenin results in decreased expression of PPARG mRNA]	26408789
D004144	Diosgenin	PPARG protein inhibits the reaction [Diosgenin results in decreased expression of FABP4 mRNA]	26408789
D004144	Diosgenin	PPARG protein inhibits the reaction [Diosgenin results in decreased expression of PPARG mRNA]	26408789\|2640878
D004144	Diosgenin	PPARG protein results in decreased susceptibility to Diosgenin	26408789
C550453	dioxinodehydroeckol	dioxinodehydroeckol results in decreased expression of PPARG mRNA	20385110
C550453	dioxinodehydroeckol	dioxinodehydroeckol results in decreased expression of PPARG protein	20385110
C086664	diphenyltin chloride	diphenyltin chloride binds to and results in increased activity of PPARG protein	19497422
C086664	diphenyltin chloride	diphenyltin chloride inhibits the reaction [rosiglitazone binds to PPARG protein]	19497422
C086664	diphenyltin chloride	diphenyltin chloride inhibits the reaction [triphenyltin chloride binds to PPARG protein]	19497422
C076126	disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate	"disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate results in increased expression of PPARG mRNA"	20184727
C076126	disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate	"disodium (R,R)-5-(2-((2-(3-chlorophenyl)-2-hydroxyethyl)-amino)propyl)-1,3-benzodioxole-2,3-dicarboxylate results in increased expression of PPARG mRNA alternative form"	20184727
D004237	Diuron	Diuron results in increased expression of PPARG mRNA	21551480
C067311	docetaxel	[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to docetaxel	23964924
C067311	docetaxel	[Celecoxib co-treated with docetaxel] results in increased expression of PPARG protein	16052515
D004281	Docosahexaenoic Acids	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Docosahexaenoic Acids results in increased activity of PPARG protein]"	15698426
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids results in increased activity of PPARG protein	15698426
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids results in increased expression of PPARG mRNA	15698426
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids promotes the reaction [Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]]	27329536
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids promotes the reaction [Benzo(a)pyrene results in increased activity of PPARG protein]	27329536
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]	27329536
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids results in decreased expression of PPARG mRNA	21569430
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids results in increased activity of PPARG protein	27329536
D004281	Docosahexaenoic Acids	Docosahexaenoic Acids results in increased expression of PPARG mRNA	21164549
C001114	dodecylbenzenesulfonic acid	2-chloro-5-nitrobenzanilide inhibits the reaction [dodecylbenzenesulfonic acid binds to and results in increased activity of PPARG protein]	24025786
C001114	dodecylbenzenesulfonic acid	dodecylbenzenesulfonic acid binds to and results in increased activity of PPARG protein	24025786
D004317	Doxorubicin	[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in increased susceptibility to Doxorubicin	23964924
D004317	Doxorubicin	Doxorubicin results in decreased activity of PPARG protein	25257666
D004317	Doxorubicin	Doxorubicin results in decreased expression of PPARG protein	27417252
D004317	Doxorubicin	[nimesulide co-treated with Doxorubicin] results in increased expression of PPARG	14567645
C495944	DRF 2519	DRF 2519 results in increased activity of PPARG protein	21543282
C495944	DRF 2519	DRF 2519 results in increased activity of PPARG protein alternative form	23563205
D004365	Drugs, Chinese Herbal	"Drugs, Chinese Herbal results in increased expression of PPARG mRNA"	23262642
D004365	Drugs, Chinese Herbal	"Silymarin inhibits the reaction [Drugs, Chinese Herbal results in decreased expression of PPARG mRNA]"	24582681
D004391	Dust	Dust analog binds to and results in decreased activity of PPARG protein	23398518
D004391	Dust	Dust analog binds to and results in increased activity of PPARG protein	23398518
D004391	Dust	Dust analog results in increased activity of PPARG protein	26172262
D004391	Dust	Dust binds to PPARG protein	25314719
D004391	Dust	Dust metabolite binds to PPARG protein	25314719
D004391	Dust	Dust results in increased expression of PPARG mRNA	15735009
C510342	efatutazone	efatutazone results in increased activity of PPARG protein alternative form	23563205
C098320	efavirenz	efavirenz results in decreased expression of PPARG mRNA	21619898
D015118	Eicosapentaenoic Acid	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eicosapentaenoic Acid results in increased activity of PPARG protein]"	15698426
D015118	Eicosapentaenoic Acid	Eicosapentaenoic Acid results in increased activity of PPARG protein	15698426
D015118	Eicosapentaenoic Acid	Eicosapentaenoic Acid results in increased expression of PPARG mRNA	11172467\|1569842
D015118	Eicosapentaenoic Acid	Eicosapentaenoic Acid results in increased expression of PPARG protein	11172467
D015118	Eicosapentaenoic Acid	Eicosapentaenoic Acid binds to and results in increased activity of PPARG protein	10753628
C004934	eleostearic acid	eleostearic acid results in increased expression of PPARG mRNA	15961301
C004934	eleostearic acid	eleostearic acid results in increased expression of PPARG protein	15961301
D004610	Ellagic Acid	Ellagic Acid results in increased expression of PPARG protein	23811531
D004642	Emodin	Emodin results in increased expression of PPARG protein	25448808
D004642	Emodin	Emodin results in increased stability of and results in increased expression of PPARG mRNA	25448808
D004656	Enalapril	Enalapril results in decreased expression of PPARG protein	19225048
D004726	Endosulfan	Endosulfan results in decreased expression of PPARG mRNA	19874912
D004726	Endosulfan	Endosulfan inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
D004732	Endrin	Endrin results in decreased expression of PPARG protein	10385688
C066021	englitazone	englitazone results in increased activity of PPARG protein alternative form	23563205
D004785	Environmental Pollutants	Environmental Pollutants inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]	27602593
C551471	EPI 001	PPARG protein affects the reaction [EPI 001 results in decreased expression of AR mRNA]	25669987
C045651	epigallocatechin gallate	epigallocatechin gallate results in decreased expression of PPARG mRNA	20706672
C078846	epoxomicin	epoxomicin inhibits the reaction [resveratrol results in decreased expression of PPARG protein]	18555852
C078846	epoxomicin	epoxomicin inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein]	18555852
C007628	esculetin	esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA]	27769711
C007628	esculetin	esculetin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]	21450970
C007628	esculetin	esculetin inhibits the reaction [Streptozocin results in increased expression of PPARG protein]	21450970
D004967	Estrogens	Estrogens results in increased expression of PPARG mRNA	25014179
D000431	Ethanol	Cyanamide inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
D000431	Ethanol	Ethanol inhibits the reaction [9-deoxy-delta-9-prostaglandin D2 results in increased activity of PPARG protein]	17030193
D000431	Ethanol	Ethanol inhibits the reaction [pioglitazone results in increased activity of PPARG protein]	17030193
D000431	Ethanol	Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	17030193
D000431	Ethanol	Ethanol results in decreased expression of PPARG protein	28062356
D000431	Ethanol	Ethanol results in increased expression of PPARG mRNA	24144995
D000431	Ethanol	fomepizole inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
D000431	Ethanol	PER1 protein promotes the reaction [Ethanol results in increased expression of PPARG mRNA]	24144995
D000431	Ethanol	acanthoic acid inhibits the reaction [Ethanol results in increased expression of PPARG protein]	28964808
D000431	Ethanol	[ADORA1 gene mutant form results in increased susceptibility to Ethanol] which results in increased expression of PPARG mRNA	23692951
D000431	Ethanol	Ethanol affects the expression of PPARG mRNA	19167417
D000431	Ethanol	Ethanol results in decreased expression of PPARG mRNA	22173916
D000431	Ethanol	Ethanol results in increased expression of PPARG mRNA	18620774\|1875580
D000431	Ethanol	Ethanol results in increased expression of PPARG protein	20007851\|2896480
D000431	Ethanol	PER1 gene mutant form inhibits the reaction [Ethanol results in increased expression of PPARG mRNA]	24144995
D000431	Ethanol	resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA]	18755807
D000431	Ethanol	[rosiglitazone co-treated with Ethanol] results in increased expression of PPARG mRNA	20007851
D000431	Ethanol	rosiglitazone inhibits the reaction [Ethanol results in decreased expression of PPARG mRNA]	22173916
D000431	Ethanol	[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA	15318101
D000431	Ethanol	Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]	26854922
D000431	Ethanol	Ethanol results in decreased expression of PPARG mRNA	24412557
D000431	Ethanol	Ethanol results in decreased expression of PPARG protein	24412557
D000431	Ethanol	[Ethanol results in decreased expression of PPARG protein] which results in decreased expression of ADIPOQ protein	24412557
D000431	Ethanol	Ethanol results in increased expression of PPARG mRNA	18793633\|2622051
D000431	Ethanol	[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA]	26854922
D000431	Ethanol	pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA]	15318101
D000431	Ethanol	resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA]	18793633
D000431	Ethanol	SB 203580 inhibits the reaction [Ethanol results in decreased expression of PPARG protein]	24412557
D004997	Ethinyl Estradiol	ESR1 gene mutant form inhibits the reaction [Ethinyl Estradiol results in increased expression of PPARG mRNA]	29112739
D004997	Ethinyl Estradiol	Ethinyl Estradiol results in increased expression of PPARG mRNA	29112739
C504648	ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate	"ethyl(E,E,E)-7-(2-n-propoxy-5,5,8,8-tetramethyl-5,6,7,8-tetrahydro-naphthalen-3-yl)-6-fluorp-3-methylocta-2,4,6-trienoate results in increased activity of [RXRA protein binds to PPARG protein]"	15997096
C032396	ethyl myristate	ethyl myristate binds to and results in decreased activity of PPARG protein	27633901
C012313	ethyl-p-hydroxybenzoate	ethyl-p-hydroxybenzoate results in increased expression of PPARG mRNA	22956630
C018063	ethyl protocatechuate	ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]	24338020
C098546	ethyl tert-butyl ether	ethyl tert-butyl ether results in increased expression of PPARG mRNA	24090815
D005054	Eugenol	Eugenol analog binds to and results in increased activity of PPARG protein	20064974
D005054	Eugenol	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Eugenol analog binds to and results in increased activity of PPARG protein]"	20064974
D005054	Eugenol	Eugenol analog binds to and results in increased activity of PPARG protein	20064974
D005054	Eugenol	Eugenol results in increased expression of PPARG mRNA	21870829
C049639	evodiamine	evodiamine results in decreased expression of PPARG	17884939
C574336	excavatolide B	excavatolide B results in increased expression of PPARG protein	26790859
C063007	exoenzyme C3, Clostridium botulinum	"exoenzyme C3, Clostridium botulinum results in increased expression of PPARG mRNA"	20578043
D015025	Zearalenone	Zearalenone results in decreased activity of PPARG protein	27481073
C422415	farglitazar	farglitazar results in increased expression of PPARG mRNA	15475592
C422415	farglitazar	farglitazar binds to and results in increased activity of PPARG protein	15475592
C422415	farglitazar	farglitazar binds to [PPARG protein binds to RXRA protein]	10882139
D005227	Fatty Acids	PPARG protein affects the metabolism of Fatty Acids	20075336
D005230	Fatty Acids, Nonesterified	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of PPARG mRNA]"	14625208
D005230	Fatty Acids, Nonesterified	"FASN protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]]"	26670611
D005230	Fatty Acids, Nonesterified	"Fatty Acids, Nonesterified results in decreased expression of PPARG mRNA"	14625208
D005230	Fatty Acids, Nonesterified	"PPARG protein mutant form results in increased abundance of Fatty Acids, Nonesterified"	26670611
D005230	Fatty Acids, Nonesterified	"PPARG protein results in increased abundance of Fatty Acids, Nonesterified"	26670611
D005230	Fatty Acids, Nonesterified	"rosiglitazone inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of PPARG mRNA]"	14625208
D005230	Fatty Acids, Nonesterified	"rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]"	26670611
D005230	Fatty Acids, Nonesterified	"UCP1 protein promotes the reaction [PPARG protein mutant form results in increased abundance of Fatty Acids, Nonesterified]"	26670611
D005230	Fatty Acids, Nonesterified	"UCP1 protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]]"	26670611
C027327	fenchone	fenchone binds to and results in decreased activity of PPARG protein	27633901
D011345	Fenofibrate	Fenofibrate affects the activity of PPARG protein	25596134
D011345	Fenofibrate	Fenofibrate results in increased expression of PPARG mRNA	19201410\|2803480
D011345	Fenofibrate	[Oleic Acid co-treated with Fenofibrate] results in increased expression of PPARG mRNA	24534255
D011345	Fenofibrate	Fenofibrate results in increased expression of PPARG mRNA	19201410
D011345	Fenofibrate	Fenofibrate affects the activity of PPARG protein	25596134
C006012	fenofibric acid	fenofibric acid binds to PPARG protein	11779144
C006012	fenofibric acid	fenofibric acid results in increased activity of PPARG protein	15273253
C006012	fenofibric acid	fenofibric acid results in increased activity of [PPARG protein alternative form binds to RXRA protein]	11779144
D005279	Fenoprofen	Fenoprofen binds to and results in increased activity of PPARG protein	9013583
C004999	ferulic acid	ferulic acid results in increased expression of PPARG mRNA	21870829
D005363	Ficusin	Ficusin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]	27350165
C082360	fipronil	fipronil results in increased expression of PPARG mRNA	27103584
C082360	fipronil	fipronil results in increased expression of PPARG protein	27103584
C000591741	Firemaster 550	Firemaster 550 binds to and results in increased activity of PPARG protein	25062436
C000591741	Firemaster 550	Firemaster 550 metabolite binds to PPARG protein	25314719
C000591741	Firemaster 550	Firemaster 550 metabolite results in increased activity of PPARG protein	26172262
C000591741	Firemaster 550	Firemaster 550 results in increased activity of PPARG protein	26172262
C000591741	Firemaster 550	Firemaster 550 results in increased expression of PPARG mRNA	25062436
D005395	Fish Oils	PPARG protein inhibits the reaction [Fish Oils results in increased secretion of ADIPOQ protein]	16567512
D005395	Fish Oils	Fish Oils inhibits the reaction [Ozone results in increased expression of PPARG mRNA]	29329427
D005411	Flame Retardants	Flame Retardants binds to and results in decreased activity of PPARG protein	23398518
D005411	Flame Retardants	Flame Retardants binds to and results in increased activity of PPARG protein	24786373
D005411	Flame Retardants	ESR1 gene mutant form inhibits the reaction [Flame Retardants results in increased expression of PPARG mRNA]	29112739
D005411	Flame Retardants	Flame Retardants results in increased expression of PPARG mRNA	29112739
C028610	flavanone	flavanone results in increased expression of PPARG protein	22056764
D005419	Flavonoids	Flavonoids results in decreased expression of PPARG mRNA	23238999
D015725	Fluconazole	Fluconazole results in increased expression of PPARG mRNA	20623750
C024352	fludarabine	fludarabine results in increased expression of PPARG mRNA	21352814
C024352	fludarabine	fludarabine results in increased expression of PPARG protein	21352814
C024352	fludarabine	fludarabine inhibits the reaction [LEP protein inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]]	21352814
D005439	Flufenamic Acid	Flufenamic Acid binds to and results in increased activity of PPARG protein	9013583
D005439	Flufenamic Acid	Flufenamic Acid results in increased activity of PPARG protein	10866999
D005439	Flufenamic Acid	[Flufenamic Acid results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein	10866999
D005472	Fluorouracil	Fluorouracil results in decreased expression of PPARG protein	15352031
D005472	Fluorouracil	PPARG protein affects the susceptibility to Fluorouracil	15352031
D005473	Fluoxetine	Fluoxetine inhibits the reaction [Serotonin results in increased localization of PPARG protein]	25766885
C006326	fluprostenol	fluprostenol inhibits the reaction [Niacin results in increased expression of PPARG mRNA]	21236357
D000068298	Fluticasone	Fluticasone promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]]	15531761
C475882	flutolanil	flutolanil results in increased activity of PPARG protein	20143881
C010238	fomepizole	fomepizole inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
C007768	formononetin	formononetin results in increased activity of PPARG protein	19924040
D002955	Leucovorin	[Methotrexate co-treated with Leucovorin] results in increased expression of PPARG mRNA	25187349
D002955	Leucovorin	[Methotrexate co-treated with Leucovorin] results in increased expression of PPARG protein	25187349
D005632	Fructose	Fructose results in increased expression of PPARG mRNA	19196556
D005632	Fructose	rosiglitazone promotes the reaction [Fructose results in increased expression of PPARG mRNA]	19196556
C025164	fucoxanthin	fucoxanthin results in decreased expression of PPARG mRNA	20519145
C070081	fulvestrant	fulvestrant inhibits the reaction [Diethylstilbestrol results in increased activity of PPARG protein]	22710028
C070081	fulvestrant	fulvestrant inhibits the reaction [Diosgenin results in decreased expression of PPARG mRNA]	26408789
C056934	fumonisin B2	fumonisin B2 results in decreased activity of PPARG protein	27481073
C039281	furan	furan results in decreased expression of PPARG mRNA	25539665\|2619464
C002469	fusarenon-X	fusarenon-X results in decreased activity of PPARG protein	27481073
D005707	Gallic Acid	Gallic Acid results in increased expression of PPARG protein	24036142
D005707	Gallic Acid	Gallic Acid results in increased activity of PPARG protein	24433871
C057580	gallocatechol	gallocatechol results in decreased expression of PPARG mRNA	21877759
D017965	gamma-Linolenic Acid	gamma-Linolenic Acid binds to and results in increased activity of PPARG protein	15318936
D017965	gamma-Linolenic Acid	gamma-Linolenic Acid results in increased expression of PPARG mRNA	25560393
D024504	gamma-Tocopherol	gamma-Tocopherol results in increased expression of PPARG mRNA	14521714
D024504	gamma-Tocopherol	gamma-Tocopherol results in increased expression of PPARG protein	14521714
D024504	gamma-Tocopherol	[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG mRNA]	22389237
D024504	gamma-Tocopherol	[alpha-Tocopherol co-treated with beta-Tocopherol co-treated with gamma-Tocopherol co-treated with delta-tocopherol] affects the reaction [Estradiol affects the expression of PPARG protein]	22389237
C056507	gemcitabine	gemcitabine affects the expression of PPARG mRNA	19427843
D015248	Gemfibrozil	Gemfibrozil results in increased expression of PPARG mRNA	19201410
D015248	Gemfibrozil	Gemfibrozil results in increased expression of PPARG mRNA	19201410
D019833	Genistein	Genistein results in decreased expression of PPARG mRNA	20706672
D019833	Genistein	Genistein results in decreased expression of PPARG mRNA	18359623
D019833	Genistein	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Genistein results in increased activity of PPARG protein]"	19903033
D019833	Genistein	2-chloro-5-nitrobenzanilide inhibits the reaction [Genistein results in increased activity of PPARG protein]	19903033
D019833	Genistein	Genistein inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	27171397
D019833	Genistein	Genistein inhibits the reaction [Dietary Fats results in increased expression of PPARG protein]	27171397
D019833	Genistein	Genistein results in increased activity of PPARG protein	19903033
D019833	Genistein	Genistein results in increased expression of PPARG mRNA	24361872
C002963	geranylgeranyl pyrophosphate	geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA]	20578043
C102521	GGTI 298	GGTI 298 results in increased expression of PPARG mRNA	20578043
C007845	gingerol	gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG mRNA]	22285432
C007845	gingerol	gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein]	22285432
C007845	gingerol	gingerol results in decreased expression of PPARG mRNA	26498061
C007845	gingerol	gingerol results in decreased expression of PPARG protein	26498061
C007845	gingerol	GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG mRNA]	26498061
C007845	gingerol	GSK3B protein promotes the reaction [gingerol results in decreased expression of PPARG protein]	26498061
C049864	ginsenoside Re	ginsenoside Re results in increased expression of PPARG mRNA	23545455
C576694	GKT137831	GKT137831 inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA]	25617244
D005938	Glucocorticoids	Glucocorticoids promotes the reaction [NR3C1 protein binds to PPARG protein]	24811171
D005944	Glucosamine	Glucosamine promotes the reaction [IL1B results in increased expression of PPARG]	22089456
D005944	Glucosamine	Glucosamine results in increased expression of PPARG	22089456
D005944	Glucosamine	Glucosamine results in increased expression of PPARG mRNA	15694357
D005944	Glucosamine	Glucosamine results in increased expression of PPARG mRNA	15694357
C046905	glucosamine 6-O-sulfate	glucosamine 6-O-sulfate results in decreased expression of PPARG mRNA	19520133
C046905	glucosamine 6-O-sulfate	glucosamine 6-O-sulfate results in decreased expression of PPARG protein	19520133
C001293	glucosamine 6-phosphate	glucosamine 6-phosphate results in decreased expression of PPARG protein	19427183
D005947	Glucose	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]]	21333731
D005947	Glucose	Glucose results in decreased expression of PPARG protein	21333731
D005947	Glucose	rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]	21333731
D005947	Glucose	[ciglitazone binds to and results in increased activity of PPARG protein] which results in increased transport of Glucose	18063688
D005947	Glucose	Glucose results in decreased expression of PPARG mRNA	19609456
D005947	Glucose	Glucose results in decreased expression of PPARG protein	19609456
D005947	Glucose	PPARG protein inhibits the reaction [Glucose results in increased secretion of INS1 protein]	15878969
D005905	Glyburide	Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]	29223569
D005905	Glyburide	Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]	29223569
D005990	Glycerol	ciglitazone inhibits the reaction [Glycerol results in decreased expression of PPARG protein]	16820301
D005990	Glycerol	Glycerol results in decreased expression of PPARG protein	16820301
C094503	glyceryl 2-arachidonate	glyceryl 2-arachidonate metabolite binds to PPARG protein	21511917
C094503	glyceryl 2-arachidonate	glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA	21511917
C094503	glyceryl 2-arachidonate	T 0070907 inhibits the reaction [glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA]	21511917
C094503	glyceryl 2-arachidonate	glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein]	26209559
C094503	glyceryl 2-arachidonate	PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased expression of PTGS2 protein]]	26209559
C094503	glyceryl 2-arachidonate	PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased phosphorylation of RELA protein]]	26209559
C515155	glycycoumarin	glycycoumarin binds to PPARG protein	14608046
C575740	gnetin C	gnetin C binds to and results in increased activity of PPARG protein	24454499
D006064	Gonadotropins, Equine	"Gonadotropins, Equine results in increased expression of PPARG mRNA"	15767042
D006064	Gonadotropins, Equine	"Gonadotropins, Equine results in increased expression of PPARG protein"	15767042
C059922	gossypetin	PPARG protein affects the susceptibility to gossypetin	23845592
D006118	Griseofulvin	Griseofulvin results in increased expression of PPARG mRNA	9548566
C577920	GSK126	GSK126 results in decreased expression of PPARG mRNA	26424790
C119543	GW0072	GW0072 results in increased activity of PPARG protein	15273253
C119543	GW0072	GW0072 binds to and results in decreased activity of PPARG protein	14586007
C119543	GW0072	GW0072 binds to and results in increased activity of PPARG protein	12897060
C120099	GW 1929	[GW 1929 binds to and results in increased activity of PPARG protein] promotes the reaction [TNF protein results in decreased susceptibility to FSHB protein]	21734263
C120099	GW 1929	GW 1929 binds to PPARG protein	20008677
C120099	GW 1929	GW 1929 results in increased activity of PPARG protein	21543282
C120099	GW 1929	GW 1929 results in increased activity of [PPARG protein binds to RXRA protein]	20008677
C120099	GW 1929	ZNF366 protein promotes the reaction [GW 1929 results in increased activity of [PPARG protein binds to RXRA protein]]	20008677
C120099	GW 1929	4-chloro-N-(2-((5-trifluoromethyl-2-pyridyl)sulfonyl)ethyl)benzamide inhibits the reaction [GW 1929 results in increased expression of PPARG mRNA]	20516370
C120099	GW 1929	GW 1929 binds to and results in increased activity of PPARG protein	12847270\|1829220
C120099	GW 1929	GW 1929 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]	12847270
C120099	GW 1929	GW 1929 results in increased expression of PPARG mRNA	20516370
C120099	GW 1929	GW 1929 results in increased expression of PPARG mRNA	19420904
C120099	GW 1929	GW 1929 binds to and results in increased activity of PPARG protein	15809511\|2003208
C120099	GW 1929	GW 1929 results in increased activity of [RXRA protein binds to PPARG protein]	11752099
C105715	GW 2331	GW 2331 results in increased activity of PPARG protein	15273253
C412815	GW 4064	GW 4064 results in increased expression of PPARG mRNA	15980055
C425931	GW 501516	GW 501516 results in increased activity of PPARG protein	16386710
C425931	GW 501516	GW 501516 results in increased expression of PPARG mRNA	19201410
C425931	GW 501516	GW 501516 results in increased expression of PPARG mRNA	19201410
C453899	GW 7647	GW 7647 binds to and results in increased activity of PPARG protein	19036883
C453899	GW 7647	GW 7647 results in increased activity of PPARG protein	20143881
C453899	GW 7647	PPARG protein promotes the reaction [GW 7647 results in increased activity of DIO2 protein]	19036883
C453899	GW 7647	[PPARA protein co-treated with GW 7647] results in increased expression of PPARG mRNA	21324916
C401311	GW 7845	PPARG protein promotes the reaction [GW 7845 results in increased expression of ADIPOQ mRNA]	20519739
C401311	GW 7845	GW 7845 binds to and results in increased activity of PPARG protein	12670479\|1740058
D006218	Halofenate	Halofenate binds to and results in increased activity of PPARG protein	20307981
D055768	Halogenated Diphenyl Ethers	"[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]"	27602593
D055768	Halogenated Diphenyl Ethers	"[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] results in decreased expression of PPARG mRNA"	27602593
D006247	Harmine	Harmine results in increased expression of PPARG protein	27805061
D006247	Harmine	[phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA	20519739
D006538	Heptanoic Acids	Heptanoic Acids results in increased activity of PPARG protein	23391484
C013015	hesperetin	hesperetin results in decreased expression of PPARG mRNA	25345581
C013015	hesperetin	hesperetin results in decreased expression of PPARG protein	25345581
C013015	hesperetin	hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]	28428136
C013015	hesperetin	hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]	28428136
C013015	hesperetin	hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of JAK1 protein]]	28428136
C013015	hesperetin	hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of STAT1 protein]]	28428136
C013015	hesperetin	[hesperetin analog co-treated with PPARG protein] affects the reaction [Lipopolysaccharides results in increased expression of TNF protein]	28428136
C013015	hesperetin	hesperetin analog inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	28428136
C013015	hesperetin	hesperetin analog inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein]	28428136
C013015	hesperetin	hesperetin analog inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]	28428136
C013015	hesperetin	hesperetin analog inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG protein]	28428136
D006569	Hesperidin	Hesperidin affects the reaction [LEPR protein affects the expression of PPARG protein]	16427799
D006569	Hesperidin	Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]]	24954035
D006569	Hesperidin	Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG mRNA]	28935427
D006569	Hesperidin	Hesperidin inhibits the reaction [[Carbon Tetrachloride co-treated with Diethylnitrosamine] results in decreased expression of PPARG protein]	28935427
D006569	Hesperidin	Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]	24954035
D019377	12-Hydroxy-5,8,10,14-eicosatetraenoic Acid	"12-Hydroxy-5,8,10,14-eicosatetraenoic Acid binds to and results in increased activity of PPARG protein"	12069687
C517828	hexabrominated diphenyl ether 153	hexabrominated diphenyl ether 153 results in increased activity of PPARG protein	27602593
C089796	hexabromocyclododecane	[hexabromocyclododecane co-treated with Dietary Fats] results in increased expression of PPARG mRNA	24398136
C089796	hexabromocyclododecane	hexabromocyclododecane inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
C018959	hexadecafluoro-nonanoic acid	hexadecafluoro-nonanoic acid results in increased expression of PPARG mRNA	18583369
C005499	honokiol	ALOX15 protein promotes the reaction [honokiol results in decreased expression of PPARG protein]	20649594
C005499	honokiol	honokiol binds to and results in increased activity of PPARG protein	23811337
C005499	honokiol	honokiol results in decreased expression of PPARG mRNA	20649594
C005499	honokiol	honokiol results in decreased expression of PPARG protein	20649594
C005499	honokiol	honokiol results in decreased expression of PPARG protein	20649594
D017313	Fenretinide	Fenretinide results in increased activity of PPARG protein	16274795
D017313	Fenretinide	Fenretinide results in decreased expression of PPARG mRNA	28973697
D012701	Serotonin	Fluoxetine inhibits the reaction [Serotonin results in increased localization of PPARG protein]	25766885
D012701	Serotonin	[Serotonin results in increased localization of and results in increased activity of PPARG protein] which results in increased expression of AQP3 mRNA	25766885
D012701	Serotonin	Serotonin results in increased localization of PPARG protein	25766885
D012701	Serotonin	Serotonin binds to PPARG protein	25766885
C029424	hydrazine	hydrazine results in decreased expression of PPARG mRNA	15370871
D006834	Hydrazines	Hydrazines results in decreased expression of PPARG mRNA	21647536
D006834	Hydrazines	Hydrazines results in decreased expression of PPARG protein	21647536
D006835	Hydrazones	Hydrazones results in increased expression of PPARG protein	22056764
D006843	Hydrocarbons, Chlorinated	"[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]"	27602593
D006843	Hydrocarbons, Chlorinated	"[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] results in decreased expression of PPARG mRNA"	27602593
D006861	Hydrogen Peroxide	Hydrogen Peroxide inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	17622750
D006861	Hydrogen Peroxide	[rosiglitazone co-treated with Hydrogen Peroxide] results in increased expression of PPARG protein	17622750
D006861	Hydrogen Peroxide	Hydrogen Peroxide affects the expression of PPARG mRNA	20044591
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in decreased expression of PPARG protein	27417252
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in increased degradation of PPARG protein	25305479
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in increased expression of PPARG mRNA	25130202
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in increased phosphorylation of and results in decreased activity of PPARG protein	17030193
D006861	Hydrogen Peroxide	myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of PPARG mRNA]	25130202
D006861	Hydrogen Peroxide	Plant Extracts inhibits the reaction [Hydrogen Peroxide results in increased degradation of PPARG protein]	25305479
D006861	Hydrogen Peroxide	Polysaccharides inhibits the reaction [Hydrogen Peroxide results in increased degradation of PPARG protein]	25305479
D006861	Hydrogen Peroxide	PPARG gene polymorphism results in decreased abundance of Hydrogen Peroxide	18083318
D006861	Hydrogen Peroxide	PPARG protein affects the abundance of Hydrogen Peroxide	18083318
D006861	Hydrogen Peroxide	Hydrogen Peroxide results in decreased expression of PPARG protein	17302992
D006861	Hydrogen Peroxide	stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein]	17302992
C085278	hydroxysafflor yellow A	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein]]	24192212
C085278	hydroxysafflor yellow A	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in decreased expression of PPARG protein]]	24192212
C085278	hydroxysafflor yellow A	hydroxysafflor yellow A inhibits the reaction [Particulate Matter results in decreased expression of PPARG protein]	24192212
C085278	hydroxysafflor yellow A	hydroxysafflor yellow A inhibits the reaction [Vehicle Emissions results in decreased expression of PPARG protein]	24192212
C475919	hydroxytamoxifen	hydroxytamoxifen inhibits the reaction [PPARG protein binds to CD36 promoter]	27358406
C475919	hydroxytamoxifen	hydroxytamoxifen inhibits the reaction [PPARG protein results in increased expression of CD36 mRNA]	27358406
C475919	hydroxytamoxifen	hydroxytamoxifen results in decreased expression of and results in increased phosphorylation of PPARG protein	27358406
C475919	hydroxytamoxifen	PPARG mRNA promotes the reaction [hydroxytamoxifen results in decreased expression of CD36 protein]	27358406
D007052	Ibuprofen	Ibuprofen affects the activity of PPARG protein	25596134
D007052	Ibuprofen	Ibuprofen binds to and results in increased activity of PPARG protein	9013583
D007052	Ibuprofen	Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of PPARG protein]	18946735
D007052	Ibuprofen	Ibuprofen inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA]	16407166
D007052	Ibuprofen	Ibuprofen results in increased expression of PPARG mRNA	16407166
D007052	Ibuprofen	Ibuprofen affects the activity of PPARG protein	25596134
D007052	Ibuprofen	Ibuprofen analog results in increased activity of PPARG protein	11755111
D007052	Ibuprofen	Ibuprofen binds to PPARG protein	18946735
D007069	Ifosfamide	Ifosfamide affects the activity of PPARG protein	25596134
D000068877	Imatinib Mesylate	Imatinib Mesylate inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]	17030193
D019469	Indinavir	Indinavir results in decreased expression of PPARG mRNA	17926646
C016517	indole-3-carbinol	indole-3-carbinol affects the expression of PPARG mRNA	21396975
D007213	Indomethacin	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [Indomethacin results in increased activity of PPARG protein]"	12485869
D007213	Indomethacin	Indomethacin affects the localization of PPARG protein	15899809
D007213	Indomethacin	Indomethacin analog results in increased activity of PPARG protein	17602619
D007213	Indomethacin	Indomethacin binds to and results in increased activity of PPARG protein	9013583
D007213	Indomethacin	[Indomethacin co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG mRNA	20206132
D007213	Indomethacin	[Indomethacin co-treated with Dexamethasone co-treated with INS protein] results in increased expression of PPARG protein	20206132
D007213	Indomethacin	[Indomethacin co-treated with MK-886] affects the localization of PPARG protein	15899809
D007213	Indomethacin	Indomethacin inhibits the reaction [rosiglitazone binds to PPARG protein]	9013583
D007213	Indomethacin	Indomethacin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in decreased expression of PPARG mRNA]	16407166
D007213	Indomethacin	Indomethacin promotes the reaction [MK-886 results in increased activity of PPARG protein]	15899809
D007213	Indomethacin	Indomethacin results in increased activity of PPARG protein	12065695\|1248586
D007213	Indomethacin	Indomethacin results in increased expression of PPARG mRNA	12483719
D007213	Indomethacin	Indomethacin results in increased expression of PPARG protein	17341418
D007213	Indomethacin	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PPARG mRNA	28628672
D007213	Indomethacin	Indomethacin results in increased activity of PPARG protein	11683414
D007213	Indomethacin	Indomethacin inhibits the reaction [rosiglitazone binds to and affects the activity of PPARG protein]	12897060
D007213	Indomethacin	Indomethacin results in increased activity of PPARG protein	11755111
C011875	ingenol dibenzoate	ingenol dibenzoate results in increased activity of PPARG protein	15707588
D007306	Insecticides	Insecticides results in decreased expression of PPARG mRNA	23401056
C541917	INT 131	[INT 131 binds to MED1 protein modified form] which binds to PPARG protein	19452630
C541917	INT 131	INT 131 binds to PPARG protein	19452630
C541917	INT 131	INT 131 inhibits the reaction [[rosiglitazone binds to MED1 protein modified form] which binds to PPARG protein]	19452630
C541917	INT 131	INT 131 inhibits the reaction [rosiglitazone binds to PPARG protein]	19452630
C541917	INT 131	INT 131 inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]	19452630
C541917	INT 131	INT 131 results in increased expression of PPARG mRNA	19452630
C541917	INT 131	INT 131 results in increased expression of PPARG mRNA	28611668
C033148	iprodione	iprodione results in increased activity of PPARG protein	20143881
C045762	Irganox 1010	Irganox 1010 binds to and results in decreased activity of PPARG protein	27633901
C045762	Irganox 1010	Irganox 1010 binds to and results in increased activity of PPARG protein	27633901
D007501	Iron	Iron deficiency results in increased expression of PPARG mRNA	20368581
C051140	iron(II)-ascorbic acid complex	Butylated Hydroxytoluene inhibits the reaction [iron(II)-ascorbic acid complex results in decreased expression of PPARG mRNA]	17070507
C051140	iron(II)-ascorbic acid complex	iron(II)-ascorbic acid complex results in decreased expression of PPARG mRNA	17070507
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with troglitazone co-treated with INS protein] results in increased expression of PPARG mRNA	27003841
D015056	1-Methyl-3-isobutylxanthine	1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA	22645054
D015056	1-Methyl-3-isobutylxanthine	aloe emodin inhibits the reaction [1-Methyl-3-isobutylxanthine results in increased expression of PPARG mRNA]	22645054
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA	19186324
D015056	1-Methyl-3-isobutylxanthine	[Dichlorodiphenyl Dichloroethylene co-treated with [1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS protein]] results in increased expression of PPARG mRNA	26200599
D015056	1-Methyl-3-isobutylxanthine	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin] results in increased expression of PPARG mRNA	28628672
D015056	1-Methyl-3-isobutylxanthine	PPARG protein results in decreased susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]	26670611
D015056	1-Methyl-3-isobutylxanthine	[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA	20206132
D015056	1-Methyl-3-isobutylxanthine	[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein	20206132
D015056	1-Methyl-3-isobutylxanthine	rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	19186324
D015056	1-Methyl-3-isobutylxanthine	TGFB1 protein inhibits the reaction [[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]	20206132
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with bisphenol A co-treated with INS protein] results in increased expression of PPARG protein	26820058
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG mRNA	26820058
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with butylbenzyl phthalate co-treated with INS protein] results in increased expression of PPARG protein	26820058
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG mRNA	23503329
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein	25559859\|2747571
D015056	1-Methyl-3-isobutylxanthine	"3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]"	22298784
D015056	1-Methyl-3-isobutylxanthine	"3,3',4,5'-tetrahydroxystilbene inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]"	22298784
D015056	1-Methyl-3-isobutylxanthine	AG 1879 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
D015056	1-Methyl-3-isobutylxanthine	andrographolide inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]	27475717
D015056	1-Methyl-3-isobutylxanthine	APCDD1 protein promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]	28242765
D015056	1-Methyl-3-isobutylxanthine	[bis(4-hydroxyphenyl)sulfone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA	27273607
D015056	1-Methyl-3-isobutylxanthine	[bisphenol A co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA	27273607
D015056	1-Methyl-3-isobutylxanthine	bisphenol A inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]	22197818
D015056	1-Methyl-3-isobutylxanthine	bisphenol A promotes the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]	26944108
D015056	1-Methyl-3-isobutylxanthine	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]	28285642
D015056	1-Methyl-3-isobutylxanthine	boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]	28285642
D015056	1-Methyl-3-isobutylxanthine	butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	28595985
D015056	1-Methyl-3-isobutylxanthine	CTNNB1 protein promotes the reaction [boric acid inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]	28285642
D015056	1-Methyl-3-isobutylxanthine	CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]	28285642
D015056	1-Methyl-3-isobutylxanthine	Curcumin inhibits the reaction [butylbenzyl phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]	28595985
D015056	1-Methyl-3-isobutylxanthine	Curcumin inhibits the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	28595985
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA	23152186
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein	18586010
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA	22298784\|2803146
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein	22298784\|2828564
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein	16971554
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with INS protein co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein	17290005
D015056	1-Methyl-3-isobutylxanthine	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA	16054899
D015056	1-Methyl-3-isobutylxanthine	Diethylhexyl Phthalate promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]	22197818
D015056	1-Methyl-3-isobutylxanthine	Diethylstilbestrol inhibits the reaction [[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein]	26944108
D015056	1-Methyl-3-isobutylxanthine	EGF protein inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]	16971554
D015056	1-Methyl-3-isobutylxanthine	EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]	16971554
D015056	1-Methyl-3-isobutylxanthine	EGF protein promotes the reaction [Vanadates inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]	16971554
D015056	1-Methyl-3-isobutylxanthine	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein	26117538
D015056	1-Methyl-3-isobutylxanthine	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA	26972250
D015056	1-Methyl-3-isobutylxanthine	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein	11101056\|2457644
D015056	1-Methyl-3-isobutylxanthine	[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein	26944108
D015056	1-Methyl-3-isobutylxanthine	[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased activity of PPARG protein	26944108
D015056	1-Methyl-3-isobutylxanthine	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA	28595985
D015056	1-Methyl-3-isobutylxanthine	[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein	28242765
D015056	1-Methyl-3-isobutylxanthine	JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	26117538
D015056	1-Methyl-3-isobutylxanthine	(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	26117538
D015056	1-Methyl-3-isobutylxanthine	(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	26972250
D015056	1-Methyl-3-isobutylxanthine	(+)-JQ1 compound inhibits the reaction [rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]	26972250
D015056	1-Methyl-3-isobutylxanthine	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA	29288687
D015056	1-Methyl-3-isobutylxanthine	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein	29288687
D015056	1-Methyl-3-isobutylxanthine	methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
D015056	1-Methyl-3-isobutylxanthine	potassium chromate(VI) inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]	24576443
D015056	1-Methyl-3-isobutylxanthine	Quercetin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein]	18586010
D015056	1-Methyl-3-isobutylxanthine	Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein]	11101056
D015056	1-Methyl-3-isobutylxanthine	[rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA	29288687
D015056	1-Methyl-3-isobutylxanthine	[rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein	29288687
D015056	1-Methyl-3-isobutylxanthine	rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	26972250
D015056	1-Methyl-3-isobutylxanthine	rosiglitazone promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	28595985
D015056	1-Methyl-3-isobutylxanthine	silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]	25559859
D015056	1-Methyl-3-isobutylxanthine	sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]	23152186
D015056	1-Methyl-3-isobutylxanthine	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]	28285642
D015056	1-Methyl-3-isobutylxanthine	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]	28285642
D015056	1-Methyl-3-isobutylxanthine	T 0070907 inhibits the reaction [[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein]	26944108
D015056	1-Methyl-3-isobutylxanthine	[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]	16054899
D015056	1-Methyl-3-isobutylxanthine	Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]	16971554
D015056	1-Methyl-3-isobutylxanthine	Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]	16054899
D015056	1-Methyl-3-isobutylxanthine	tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]	22197818
D015056	1-Methyl-3-isobutylxanthine	U 0126 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
D015056	1-Methyl-3-isobutylxanthine	[INS co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG mRNA	21350315
D015056	1-Methyl-3-isobutylxanthine	[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA	27602593
D015056	1-Methyl-3-isobutylxanthine	Environmental Pollutants inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]	27602593
D015056	1-Methyl-3-isobutylxanthine	mono-(2-ethylhexyl)phthalate promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]	27602593
C040920	isoliquiritigenin	isoliquiritigenin inhibits the reaction [INS1 protein results in increased expression of PPARG protein]	27117918
D007538	Isoniazid	Isoniazid results in decreased expression of PPARG mRNA	24128855
D007538	Isoniazid	Isoniazid results in decreased expression of PPARG mRNA	24128855
D007538	Isoniazid	Isoniazid results in decreased expression of PPARG protein	24128855
C027681	isonicotinamide	isonicotinamide results in decreased expression of PPARG mRNA	16813520
C005940	isophorone	isophorone binds to and results in decreased activity of PPARG protein	27633901
D007545	Isoproterenol	Isoproterenol results in decreased expression of PPARG mRNA	21854795
D007545	Isoproterenol	osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA]	21854795
D007545	Isoproterenol	2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]	24954035
D007545	Isoproterenol	Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]]	24954035
D007545	Isoproterenol	Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]	24954035
D007545	Isoproterenol	Isoproterenol results in decreased expression of PPARG mRNA	24286936
D007545	Isoproterenol	[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein	24954035
C561695	(+)-JQ1 compound	(+)-JQ1 compound results in decreased expression of PPARG mRNA	25961927\|2675264
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [BRD4 protein binds to PPARG enhancer]	26117538
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [BRD4 protein binds to PPARG gene]	26117538
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	26117538
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	26972250
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [JMJD6 protein binds to PPARG enhancer]	26117538
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [JMJD6 protein binds to PPARG gene]	26117538
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [POLR2E protein binds to PPARG enhancer]	26117538
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [POLR2E protein binds to PPARG gene]	26117538
C561695	(+)-JQ1 compound	(+)-JQ1 compound inhibits the reaction [rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]	26972250
C534333	JZL 184	JZL 184 inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein]	26209559
C006552	kaempferol	kaempferol results in increased expression of PPARG mRNA	25765892
C006552	kaempferol	kaempferol results in increased expression of PPARG protein	25765892
C006552	kaempferol	kaempferol binds to and results in increased activity of PPARG protein	11343698\|1826257
C006552	kaempferol	kaempferol inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]	18262572
C006552	kaempferol	PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]	11343698
C006552	kaempferol	PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]	11343698
C468270	Kangen-karyu	Kangen-karyu results in decreased expression of PPARG mRNA	25031044
C468270	Kangen-karyu	Kangen-karyu results in decreased expression of PPARG protein	25031044
C060285	lacidipine	lacidipine results in increased activity of PPARG protein	25257666
C029310	lard	Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA]	24440342
C029310	lard	[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA	24440342
C089549	lauric acid methyl ester	lauric acid methyl ester binds to and results in decreased activity of PPARG protein	27633901
D007854	Lead	Lead results in increased expression of PPARG	23086611
D007854	Lead	Lead results in increased expression of PPARG mRNA	26518054
D007854	Lead	Lead results in increased expression of PPARG mRNA	23086611
C008261	lead acetate	CR8 compound inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]	24481447
C008261	lead acetate	[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein]	24481447
C008261	lead acetate	[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [PPARG protein binds to GFAP promoter]	24481447
C008261	lead acetate	[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein	24481447
C008261	lead acetate	[[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein	24481447
C008261	lead acetate	T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of PPARG protein]	24481447
C008261	lead acetate	T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]	24481447
C045463	leflunomide	leflunomide results in increased expression of PPARG mRNA	28988120
C052901	lemongrass oil	lemongrass oil results in increased expression of PPARG mRNA	25660481
C095104	LG 100268	LG 100268 binds to and results in increased activity of PPARG protein	15729575
C533894	LG 100815	LG 100815 results in increased expression of PPARG mRNA	16951191
C432503	licarin A	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA	29288687
C432503	licarin A	[licarin A affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein	29288687
C420162	linoleamide	linoleamide analog results in increased activity of PPARG protein	29288688
D044243	Linoleic Acids, Conjugated	"Linoleic Acids, Conjugated results in decreased activity of PPARG protein"	18776171
D044243	Linoleic Acids, Conjugated	"Linoleic Acids, Conjugated results in decreased expression of PPARG protein"	16933788
D044243	Linoleic Acids, Conjugated	"Linoleic Acids, Conjugated results in increased expression of PPARG mRNA"	15961301
D044243	Linoleic Acids, Conjugated	"Linoleic Acids, Conjugated results in increased expression of PPARG protein"	15961301
D044243	Linoleic Acids, Conjugated	"Linoleic Acids, Conjugated results in increased phosphorylation of and results in increased activity of PPARG protein"	18776171
D044243	Linoleic Acids, Conjugated	"resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in decreased activity of PPARG protein]"	18776171
D044243	Linoleic Acids, Conjugated	"resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased phosphorylation of and results in increased activity of PPARG protein]"	18776171
D044243	Linoleic Acids, Conjugated	"Linoleic Acids, Conjugated results in increased expression of PPARG mRNA"	17322064
C026562	linoleoyl-coenzyme A	linoleoyl-coenzyme A binds to and results in increased activity of PPARG protein	11139385
D008055	Lipids	PPARG protein promotes the reaction [Thiazolidinediones results in increased abundance of Lipids]	20079722
D008055	Lipids	[diallyl trisulfide results in decreased expression of [CEBPA protein co-treated with CEBPB protein co-treated with PPARG protein]] which results in increased abundance of Lipids	22137902
C482199	lipopolysaccharide, E coli O55-B5	"lipopolysaccharide, E coli O55-B5 affects the reaction [deoxynivalenol results in increased expression of PPARG mRNA]"	18485432
C440499	lipopolysaccharide, Escherichia coli O111 B4	"lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of PPARG protein"	17439952
C440499	lipopolysaccharide, Escherichia coli O111 B4	"PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]]"	17439952
C440499	lipopolysaccharide, Escherichia coli O111 B4	"Selenium promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of PPARG protein]"	17439952
D008070	Lipopolysaccharides	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]"	12604364
D008070	Lipopolysaccharides	ciglitazone inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]	12604364
D008070	Lipopolysaccharides	Lipopolysaccharides results in decreased expression of PPARG mRNA	12604364
D008070	Lipopolysaccharides	pirinixic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]	12604364
D008070	Lipopolysaccharides	PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]	22124178
D008070	Lipopolysaccharides	PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]	22124178
D008070	Lipopolysaccharides	[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 mRNA]	21617575
D008070	Lipopolysaccharides	[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 protein]	21617575
D008070	Lipopolysaccharides	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]"	12847270
D008070	Lipopolysaccharides	Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]	27329536
D008070	Lipopolysaccharides	ciglitazone inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]	12847270
D008070	Lipopolysaccharides	Docosahexaenoic Acids promotes the reaction [Benzo(a)pyrene promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]]	27329536
D008070	Lipopolysaccharides	Docosahexaenoic Acids promotes the reaction [Lipopolysaccharides results in increased activity of PPARG protein]	27329536
D008070	Lipopolysaccharides	GW 1929 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]	12847270
D008070	Lipopolysaccharides	hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B protein]]	28428136
D008070	Lipopolysaccharides	hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL6 protein]]	28428136
D008070	Lipopolysaccharides	hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of JAK1 protein]]	28428136
D008070	Lipopolysaccharides	hesperetin analog affects the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of STAT1 protein]]	28428136
D008070	Lipopolysaccharides	[hesperetin analog co-treated with PPARG protein] affects the reaction [Lipopolysaccharides results in increased expression of TNF protein]	28428136
D008070	Lipopolysaccharides	hesperetin analog inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]	28428136
D008070	Lipopolysaccharides	hesperetin analog inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG protein]	28428136
D008070	Lipopolysaccharides	Lipopolysaccharides results in decreased expression of PPARG mRNA	16847310\|2224066
D008070	Lipopolysaccharides	Lipopolysaccharides results in decreased expression of PPARG protein	16847310\|2842813
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased activity of PPARG protein	27329536
D008070	Lipopolysaccharides	PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]	11343698
D008070	Lipopolysaccharides	PPARG protein affects the reaction [Apigenin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]	11343698
D008070	Lipopolysaccharides	PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]	11343698
D008070	Lipopolysaccharides	PPARG protein affects the reaction [chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]	11343698
D008070	Lipopolysaccharides	PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]	11343698
D008070	Lipopolysaccharides	PPARG protein affects the reaction [kaempferol inhibits the reaction [Lipopolysaccharides results in increased expression of PTGS2 mRNA]]	11343698
D008070	Lipopolysaccharides	PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]	12847270
D008070	Lipopolysaccharides	PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL1B mRNA]	28428136
D008070	Lipopolysaccharides	PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL6 mRNA]	28428136
D008070	Lipopolysaccharides	PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of IL6 protein]	28428136
D008070	Lipopolysaccharides	PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]	28428136
D008070	Lipopolysaccharides	PPARG protein affects the reaction [Lipopolysaccharides results in increased expression of TNF protein]	28428136
D008070	Lipopolysaccharides	PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of JAK1 protein]	28428136
D008070	Lipopolysaccharides	PPARG protein affects the reaction [Lipopolysaccharides results in increased phosphorylation of STAT1 protein]	28428136
D008070	Lipopolysaccharides	PPARG protein promotes the reaction [Carbon Monoxide inhibits the reaction [Lipopolysaccharides results in increased expression of NOS2 mRNA]]	22046279
D008070	Lipopolysaccharides	PPARG protein promotes the reaction [Lipopolysaccharides results in increased expression of EGR1 mRNA]	22046279
D008070	Lipopolysaccharides	Silymarin inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]	28428136
D008070	Lipopolysaccharides	Silymarin inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG protein]	28428136
D008070	Lipopolysaccharides	2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]	21153920
D008070	Lipopolysaccharides	2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]	21153920
D008070	Lipopolysaccharides	baicalin inhibits the reaction [Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein]	24312512
D008070	Lipopolysaccharides	[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA	15318101
D008070	Lipopolysaccharides	Lipopolysaccharides results in increased expression of and results in increased phosphorylation of and results in decreased activity of PPARG protein	24312512
D008070	Lipopolysaccharides	pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA]	15318101
D008070	Lipopolysaccharides	[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]	21153920
D008070	Lipopolysaccharides	[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]	21153920
D008070	Lipopolysaccharides	[troglitazone results in increased activity of PPARG protein] which results in decreased susceptibility to Lipopolysaccharides	21153920
C040527	lipoxin A4	lipoxin A4 binds to and results in increased activity of PPARG protein	19321784
D018021	Lithium Chloride	Lithium Chloride results in increased expression of PPARG mRNA	23527032
D019808	Losartan	Losartan inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA]	18302760
D019808	Losartan	Losartan inhibits the reaction [AGT protein results in increased expression of PPARG mRNA]	19109942
D008148	Lovastatin	2-chloro-5-nitrobenzanilide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein]	26863638
D008148	Lovastatin	Lovastatin analog affects the localization of PPARG protein	26863638
D008148	Lovastatin	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein]	26863638
D008148	Lovastatin	PPARG protein affects the reaction [Lovastatin results in increased expression of PTEN protein]	16425225
D008148	Lovastatin	PPARG affects the reaction [Lovastatin results in increased expression of PTEN protein]	16425225
D008148	Lovastatin	geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA]	20578043
D008148	Lovastatin	Lovastatin results in increased expression of and affects the localization of PPARG protein	20578043
D008148	Lovastatin	Lovastatin results in increased expression of PPARG mRNA	20578043
D008148	Lovastatin	Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA]	20578043
D008148	Lovastatin	PPARG protein affects the reaction [Lovastatin results in increased expression of MBP mRNA]	20578043
D008148	Lovastatin	PPARG protein affects the reaction [Lovastatin results in increased expression of SOX10 mRNA]	20578043
C044660	LY 171883	LY 171883 results in increased activity of [PPARG protein co-treated with RXRA protein]	8700121
C453901	LY 465608	LY 465608 binds to and results in increased activity of PPARG protein	17255113
C479889	LY 518674	LY 518674 results in increased expression of PPARG mRNA	19201410
C479889	LY 518674	LY 518674 results in increased expression of PPARG mRNA	19201410
C032881	lysophosphatidic acid	lysophosphatidic acid analog binds to and results in increased activity of PPARG protein	16321982
D058185	Magnetite Nanoparticles	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PPARG mRNA	26378955
C005498	magnolol	magnolol binds to and results in increased activity of PPARG protein	20064974
C005498	magnolol	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [magnolol binds to and results in increased activity of PPARG protein]"	20064974
C005498	magnolol	magnolol binds to and results in increased activity of PPARG protein	20064974
D008345	Manganese	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide]"	18041089
C025340	manganese chloride	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with IFNG protein co-treated with TNF protein] results in increased expression of BAX protein]"	18041089
C025340	manganese chloride	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] promotes the reaction [NCOR2 protein binds to NOS2 enhancer]]"	18041089
C025340	manganese chloride	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] promotes the reaction [RELA protein binds to NOS2 promoter]]"	18041089
C025340	manganese chloride	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 mRNA]"	18041089
C025340	manganese chloride	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [[manganese chloride co-treated with TNF protein co-treated with IFNG protein] results in increased expression of NOS2 protein]"	18041089
C025340	manganese chloride	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [manganese chloride promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]]"	18041089
C025340	manganese chloride	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] results in decreased susceptibility to [manganese chloride co-treated with IFNG protein co-treated with TNF protein]"	18041089
C025340	manganese chloride	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] promotes the reaction [manganese chloride promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]]	18041089
C013592	mangiferin	mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]	29223569
C013592	mangiferin	mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]	29223569
C054218	manidipine	manidipine results in decreased activity of PPARG protein	25257666
C586321	mansonone G	mansonone G analog results in decreased expression of PPARG mRNA	28625492
C586321	mansonone G	mansonone G analog results in decreased expression of PPARG protein	28625492
C586321	mansonone G	mansonone G results in decreased expression of PPARG mRNA	28625492
C586321	mansonone G	mansonone G analog results in decreased activity of PPARG protein	28625492
D008550	Melatonin	Melatonin results in decreased expression of PPARG mRNA	20738756
C000600817	mercaptosteroid 6	mercaptosteroid 6 results in increased expression of PPARG mRNA	25851902
D008627	Mercuric Chloride	Mercuric Chloride results in decreased expression of PPARG mRNA	22019852
D008627	Mercuric Chloride	Mercuric Chloride results in decreased expression of PPARG protein	12883084
D008687	Metformin	Metformin results in decreased expression of PPARG mRNA	20956498
D008687	Metformin	Metformin inhibits the reaction [IL13 protein results in increased expression of PPARG mRNA]	26497364
D008687	Metformin	Metformin results in increased expression of PPARG mRNA	21870829
D008687	Metformin	Metformin affects the activity of PPARG protein	25596134
D008687	Metformin	Metformin inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]	25108154
D008687	Metformin	Metformin results in increased expression of PPARG mRNA	20724125
D008694	Methamphetamine	2-chloro-5-nitrobenzanilide promotes the reaction [PPARG protein results in increased susceptibility to Methamphetamine]	17019405
D008694	Methamphetamine	ciglitazone inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]	17019405
D008694	Methamphetamine	Ibuprofen inhibits the reaction [Methamphetamine results in decreased expression of PPARG protein]	18946735
D008694	Methamphetamine	Methamphetamine results in decreased expression of PPARG protein	18946735
D008694	Methamphetamine	Methamphetamine results in increased activity of PPARG protein	17019405
D008694	Methamphetamine	Methamphetamine results in increased expression of PPARG protein	17019405
D008694	Methamphetamine	[pioglitazone co-treated with alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]	17019405
D008694	Methamphetamine	pioglitazone inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]	17019405
D008694	Methamphetamine	PPARG protein results in increased susceptibility to Methamphetamine	17019405
C019003	methaneselenol	methaneselenol results in increased expression of PPARG mRNA	19625696
D008713	Methimazole	Methimazole results in decreased expression of PPARG mRNA	17403546
D008715	Methionine	"3,4,5,3',4'-pentachlorobiphenyl promotes the reaction [[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PPARG mRNA]"	28973532
D008715	Methionine	[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA	18991162
D008715	Methionine	[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein	18991162
D008715	Methionine	[Methionine deficiency co-treated with Choline deficiency] results in decreased expression of PPARG mRNA	28973532
D008715	Methionine	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA]	18991162
D008715	Methionine	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein]	18991162
D008727	Methotrexate	18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG mRNA]	28414158
D008727	Methotrexate	18alpha-glycyrrhetinic acid inhibits the reaction [Methotrexate results in decreased expression of PPARG protein]	28414158
D008727	Methotrexate	[Methotrexate co-treated with Leucovorin] results in increased expression of PPARG mRNA	25187349
D008727	Methotrexate	[Methotrexate co-treated with Leucovorin] results in increased expression of PPARG protein	25187349
D008727	Methotrexate	Methotrexate results in decreased expression of PPARG mRNA	28414158
D008727	Methotrexate	Methotrexate results in decreased expression of PPARG protein	28414158
D008727	Methotrexate	Methotrexate results in increased expression of PPARG protein	25187349
C445068	methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate	"methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased expression of PPARG mRNA"	21289052
C445068	methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate	"methyl 2-cyano-3,12-dioxoolean-1,9-dien-28-oate results in increased expression of PPARG protein"	21289052
C108732	methyl-beta-cyclodextrin	methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
D008770	Methylnitrosourea	PPARG gene mutant form results in increased susceptibility to Methylnitrosourea	15930296
C005576	methyl oleate	methyl oleate binds to and results in increased activity of PPARG protein	27633901
C015358	methylparaben	methylparaben binds to and results in increased activity of PPARG protein	24155963
C015358	methylparaben	PPARG protein promotes the reaction [methylparaben results in decreased expression of BGLAP mRNA]	28527915
C015358	methylparaben	PPARG protein results in increased susceptibility to methylparaben	28527915
D015655	1-Methyl-4-phenylpyridinium	1-Methyl-4-phenylpyridinium affects the expression of PPARG mRNA	24767308
D008777	Methyltestosterone	Methyltestosterone results in decreased expression of PPARG mRNA	29191790
D008798	Mevalonic Acid	Mevalonic Acid inhibits the reaction [Lovastatin results in increased expression of PPARG mRNA]	20578043
C423917	MG 262	"MG 262 promotes the reaction [15-deoxy-delta(12,14)-prostaglandin J2 results in increased activity of PPARG protein]"	15707588
C423917	MG 262	MG 262 promotes the reaction [alitretinoin results in increased activity of PPARG protein]	15707588
C423917	MG 262	MG 262 results in increased activity of PPARG protein	15707588
C580737	MHY966	MHY966 binds to and results in increased activity of PPARG protein	24130794
D015735	Mifepristone	Mifepristone inhibits the reaction [bisphenol A results in increased expression of PPARG mRNA]	27145005
D015735	Mifepristone	Mifepristone inhibits the reaction [butylparaben results in increased expression of PPARG mRNA]	22956630
D015735	Mifepristone	Mifepristone results in decreased expression of PPARG mRNA	25972201
C051602	mifobate	mifobate results in decreased activity of PPARG protein	22108913
C060893	MK-886	[Indomethacin co-treated with MK-886] affects the localization of PPARG protein	15899809
C060893	MK-886	Indomethacin promotes the reaction [MK-886 results in increased activity of PPARG protein]	15899809
C060893	MK-886	MK-886 affects the localization of PPARG protein	15899809
C060893	MK-886	MK-886 results in increased activity of PPARG protein	15899809
C060893	MK-886	MK-886 results in increased expression of PPARG mRNA	15899809
C517880	monascin	monascin affects the localization of PPARG protein	23954466
C517880	monascin	monascin results in decreased phosphorylation of PPARG protein	22381257
C517880	monascin	monascin results in increased expression of PPARG protein	22381257
C517880	monascin	"PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]"	23954466
C517880	monascin	PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of IL1B protein]]	23954466
C517880	monascin	PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of TNF protein]]	23954466
C517880	monascin	PPARG mutant form inhibits the reaction [monascin results in increased expression of NFE2L2 mRNA]	23954466
C517880	monascin	PPARG protein results in increased susceptibility to monascin	23954466
C517880	monascin	monascin binds to and results in increased activity of PPARG protein	23954466
C016599	mono-(2-ethylhexyl)phthalate	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]"	12927354
C016599	mono-(2-ethylhexyl)phthalate	2-chloro-5-nitrobenzanilide inhibits the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]	12927354
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein	16326050
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate binds to PPARG protein	23843199
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA	23118965
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein	10581215\|1292735
C016599	mono-(2-ethylhexyl)phthalate	PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in decreased expression of MMP9 protein]	28416457
C016599	mono-(2-ethylhexyl)phthalate	PPARG mRNA promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased expression of TIMP1 protein]	28416457
C016599	mono-(2-ethylhexyl)phthalate	PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]	12927354
C016599	mono-(2-ethylhexyl)phthalate	rosiglitazone promotes the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]	12927354
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate analog results in increased activity of PPARG protein	25777084
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in decreased expression of PPARG mRNA	25543134
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein	10581215\|1532217
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in increased expression of PPARG mRNA	15647598
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in increased expression of PPARG protein	15647598
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate promotes the reaction [[1-Methyl-3-isobutylxanthine co-treated with INS protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]	27602593
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate results in increased activity of PPARG protein	21561829
C016599	mono-(2-ethylhexyl)phthalate	mono-(2-ethylhexyl)phthalate binds to and results in increased activity of PPARG protein	17400580
C103325	mono-benzyl phthalate	mono-benzyl phthalate binds to PPARG protein	23843199
C103325	mono-benzyl phthalate	mono-benzyl phthalate results in increased activity of PPARG protein	27551952
C028577	monobutyl phthalate	monobutyl phthalate binds to PPARG protein	23843199
C028577	monobutyl phthalate	monobutyl phthalate inhibits the reaction [ciglitazone binds to and results in increased activity of PPARG protein]	16326050
C581825	monoethyl phthalate	monoethyl phthalate binds to PPARG protein	23843199
C471400	monoisononylphthalate	monoisononylphthalate binds to PPARG protein	23843199
C471400	monoisononylphthalate	monoisononylphthalate results in increased activity of PPARG protein	27551952
C517284	monomethyl phthalate	monomethyl phthalate binds to PPARG protein	23843199
C049841	mono-n-hexyl phthalate	mono-n-hexyl phthalate binds to PPARG protein	23843199
C041260	mono-n-octyl phthalate	mono-n-octyl phthalate binds to PPARG protein	23843199
C568376	MT19c compound	MT19c compound results in increased expression of PPARG mRNA	21781307
C568376	MT19c compound	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to MT19c compound	21781307
C500085	muraglitazar	muraglitazar binds to and results in increased activity of PPARG protein	17426106\|1767565
C500085	muraglitazar	muraglitazar binds to and results in increased activity of PPARG protein	17675651
C500085	muraglitazar	muraglitazar results in decreased expression of PPARG mRNA	21515302
C500085	muraglitazar	muraglitazar affects the activity of PPARG protein	16168052
C500085	muraglitazar	muraglitazar binds to and results in increased activity of PPARG protein	17132713\|2151530
C500085	muraglitazar	muraglitazar results in increased activity of PPARG protein	16506266
C008577	myricitrin	myricitrin inhibits the reaction [Hydrogen Peroxide results in increased expression of PPARG mRNA]	25130202
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Cannabidiol affects the localization of PPARG protein]	23220503
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Celecoxib affects the localization of PPARG protein]	23943857
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [ciglitazone results in increased expression of PPARG mRNA]	11840453
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [Lovastatin analog affects the localization of PPARG protein]	26863638
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA]	11840453
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in decreased expression of PPARG mRNA	11840453
C080955	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide results in increased localization of PPARG protein	12517972
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in increased expression of PPARG mRNA"	23634900
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in increased expression of PPARG protein"	23634900
D037742	Nanotubes, Carbon	"Nanotubes, Carbon analog results in decreased expression of PPARG mRNA"	25554681
D037742	Nanotubes, Carbon	"Nanotubes, Carbon analog results in increased expression of PPARG mRNA"	25620056
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in decreased expression of PPARG mRNA"	25554681
D037742	Nanotubes, Carbon	"Nanotubes, Carbon results in increased expression of PPARG mRNA"	25926378
D009288	Naproxen	Naproxen results in increased activity of PPARG protein	11755111
C005273	naringenin	naringenin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]	29223569
C005273	naringenin	naringenin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]	29223569
C005274	naringin	naringin affects the reaction [LEPR protein affects the expression of PPARG protein]	16427799
C005274	naringin	naringin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	22198281
C517861	naveglitazar	naveglitazar binds to and results in increased activity of PPARG protein	19700659
C065565	N-butylbenzenesulfonamide	N-butylbenzenesulfonamide binds to and results in decreased activity of PPARG protein	27633901
C115174	netoglitazone	netoglitazone results in increased expression of PPARG mRNA	21354099
C115174	netoglitazone	netoglitazone binds to and results in increased activity of PPARG protein	14977855\|1611210
D019829	Nevirapine	Nevirapine results in increased expression of PPARG mRNA	21619898
D009525	Niacin	4-benzhydryloxy-1-(3-(1H-tetrazol-5-yl-)-propyl)piperidine inhibits the reaction [Niacin results in increased activity of PPARG protein]	16386710
D009525	Niacin	Aspirin inhibits the reaction [Niacin results in increased activity of PPARG protein]	16386710
D009525	Niacin	HCAR2 protein promotes the reaction [Niacin results in increased expression of and results in increased activity of PPARG protein]	16386710
D009525	Niacin	HCAR3 protein promotes the reaction [Niacin results in increased activity of PPARG protein]	16386710
D009525	Niacin	Niacin results in increased expression of and results in increased activity of PPARG protein	15037193\|1638671
D009525	Niacin	Niacin results in increased expression of PPARG mRNA	15037193\|1913106
D009525	Niacin	PPARG protein promotes the reaction [Niacin results in increased expression of NR1H3 mRNA]	15037193
D009525	Niacin	PTGDS protein promotes the reaction [Niacin results in increased activity of PPARG protein]	16386710
D009525	Niacin	PTGS1 protein promotes the reaction [Niacin results in increased activity of PPARG protein]	16386710
D009525	Niacin	fluprostenol inhibits the reaction [Niacin results in increased expression of PPARG mRNA]	21236357
D009525	Niacin	[Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG mRNA	21236357
D009525	Niacin	[Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG protein	21236357
D009525	Niacin	Niacin results in increased expression of PPARG mRNA	19797938
D009525	Niacin	PPARG protein promotes the reaction [Niacin promotes the reaction [APOA1 protein results in increased export of Cholesterol]]	19797938
D009525	Niacin	PPARG protein promotes the reaction [Niacin results in increased expression of ABCA1 mRNA]	19797938
D009525	Niacin	PPARG protein promotes the reaction [Niacin results in increased expression of NR1H3 mRNA]	19797938
D009525	Niacin	Niacin inhibits the reaction [Cholesterol results in decreased expression of PPARG mRNA]	18402819
D009525	Niacin	Niacin results in increased expression of PPARG mRNA	17395297\|1796363
D009525	Niacin	[Niacin results in increased expression of PPARG mRNA] which results in increased export of Cholesterol	17395297\|1796363
D009529	Nicardipine	Nicardipine results in decreased activity of PPARG protein	25257666
D009532	Nickel	Nickel results in decreased expression of PPARG mRNA	24768652\|2558310
C028007	nickel monoxide	nickel monoxide results in increased expression of PPARG mRNA	19167457
C029938	nickel sulfate	nickel sulfate results in increased expression of PPARG mRNA	16314067
D009544	Niflumic Acid	Niflumic Acid results in increased expression of PPARG protein	21067863
C012655	nimesulide	2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide promotes the reaction [PPARG binds to PPARG promoter]]	15705899
C012655	nimesulide	[nimesulide co-treated with Doxorubicin] results in increased expression of PPARG	14567645
C012655	nimesulide	nimesulide inhibits the reaction [ciglitazone promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]]	11840453
C012655	nimesulide	nimesulide inhibits the reaction [ciglitazone results in increased expression of PPARG mRNA]	11840453
C012655	nimesulide	nimesulide inhibits the reaction [pirinixic acid promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]]	11840453
C012655	nimesulide	nimesulide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA]	11840453
C012655	nimesulide	nimesulide promotes the reaction [PPARG binds to PPARG promoter]	15705899
C012655	nimesulide	nimesulide results in decreased expression of PPARG mRNA	11840453
C012655	nimesulide	nimesulide results in increased expression of PPARG protein	14977856
C012655	nimesulide	PPARG mutant form inhibits the reaction [nimesulide results in increased expression of PPARG mRNA]	15705899\|1570589
C012655	nimesulide	2-chloro-5-nitrobenzanilide inhibits the reaction [nimesulide results in increased expression of PPARG mRNA]	15705899
C012655	nimesulide	nimesulide results in increased expression of PPARG mRNA	15705899
C012655	nimesulide	nimesulide inhibits the reaction [Dietary Fats results in decreased expression of PPARG mRNA]	19247274
D009569	Nitric Oxide	[rosiglitazone binds to and affects the activity of PPARG protein] which results in increased abundance of Nitric Oxide	16527820
D009569	Nitric Oxide	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]"	12847270
D009569	Nitric Oxide	ciglitazone inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]	12847270
D009569	Nitric Oxide	GW 1929 inhibits the reaction [PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]]	12847270
D009569	Nitric Oxide	PPARG protein affects the reaction [[IFNG protein results in increased expression of NOS2 protein] which results in increased chemical synthesis of Nitric Oxide]	12847270
D009569	Nitric Oxide	PPARG protein affects the reaction [Lipopolysaccharides results in increased abundance of Nitric Oxide]	12847270
D009569	Nitric Oxide	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [Manganese results in increased chemical synthesis of Nitric Oxide]"	18041089
D009569	Nitric Oxide	Nitric Oxide deficiency results in increased expression of PPARG protein	17063326
D009569	Nitric Oxide	"[1,1-bis(3'-indolyl)-1-(4-trifluoromethylphenyl)methane binds to and results in increased activity of PPARG protein] inhibits the reaction [manganese chloride promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]]"	18041089
D009569	Nitric Oxide	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] promotes the reaction [manganese chloride promotes the reaction [[IFNG protein co-treated with TNF protein] results in increased chemical synthesis of Nitric Oxide]]	18041089
C007350	nitrofen	nitrofen results in decreased expression of PPARG mRNA	22595559
C007350	nitrofen	nitrofen results in decreased expression of PPARG protein	22595559
C038405	nivalenol	nivalenol results in decreased activity of PPARG protein	27481073
C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of and results in increased activity of PPARG protein]"	14519784
C044387	N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine	"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of PPARG mRNA]"	14519784
C025256	nonylphenol	[nonylphenol co-treated with 4-tert-octylphenol] results in increased expression of PPARG mRNA	28208108
C025256	nonylphenol	[nonylphenol co-treated with bisphenol A] results in increased expression of PPARG mRNA	28208108
C025256	nonylphenol	nonylphenol results in increased expression of PPARG mRNA	26382854
C069053	norathyriol	norathyriol inhibits the reaction [ciglitazone results in increased activity of PPARG protein]	18393431
D009638	Norepinephrine	Norepinephrine results in increased expression of PPARG mRNA	19109942
C072936	notoginsenoside R1	2-chloro-5-nitrobenzanilide inhibits the reaction [notoginsenoside R1 results in increased expression of PPARG]	25714973
C072936	notoginsenoside R1	notoginsenoside R1 results in increased expression of PPARG	25714973
C464660	obeticholic acid	obeticholic acid results in increased expression of PPARG mRNA	15980055
C464660	obeticholic acid	obeticholic acid results in increased expression of PPARG protein	15980055
C025589	ochratoxin A	ochratoxin A results in decreased activity of PPARG protein	20590410\|2748107
C025589	ochratoxin A	ochratoxin A results in decreased expression of PPARG	20590410
C025589	ochratoxin A	ochratoxin A results in increased phosphorylation of PPARG protein	20590410
C025589	ochratoxin A	"15-deoxy-delta(12,14)-prostaglandin J2 inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]"	15994020
C025589	ochratoxin A	8-Bromo Cyclic Adenosine Monophosphate inhibits the reaction [ochratoxin A results in increased expression of PPARG mRNA]	15994020
C025589	ochratoxin A	ochratoxin A results in increased expression of PPARG mRNA	15994020
C062198	octa-2,4,6-trienoic acid	"octa-2,4,6-trienoic acid results in increased expression of PPARG mRNA"	16951191
D019787	Linoleic Acid	Linoleic Acid binds to PPARG protein	23843199
D019787	Linoleic Acid	Linoleic Acid results in decreased expression of PPARG mRNA	11172467\|1570836
D019787	Linoleic Acid	Linoleic Acid results in decreased expression of PPARG protein	11172467
D019787	Linoleic Acid	Linoleic Acid results in increased activity of PPARG protein	25786526
D019787	Linoleic Acid	Linoleic Acid results in increased expression of PPARG protein	25672876
D019787	Linoleic Acid	resveratrol inhibits the reaction [Linoleic Acid results in increased expression of PPARG protein]	25672876
D019787	Linoleic Acid	Linoleic Acid binds to and results in increased activity of PPARG protein	16731579
D019787	Linoleic Acid	Linoleic Acid binds to PPARG protein	12021203
D019787	Linoleic Acid	Linoleic Acid results in increased expression of PPARG mRNA	18154422
D019787	Linoleic Acid	Linoleic Acid binds to and results in increased activity of PPARG protein	16731579
D019787	Linoleic Acid	Linoleic Acid results in increased activity of PPARG protein	15051824
D019787	Linoleic Acid	PPARG protein promotes the reaction [Linoleic Acid results in increased activity of RELA protein]	14519784
D019787	Linoleic Acid	PPARG protein promotes the reaction [Linoleic Acid results in increased expression of IL6 protein]	14519784
D019787	Linoleic Acid	Quercetin inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein]	15051824
D019787	Linoleic Acid	Vitamin E inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein]	15051824
D019301	Oleic Acid	Oleic Acid binds to and results in increased activity of PPARG protein	27131391
D019301	Oleic Acid	Oleic Acid binds to PPARG protein	24998974
D019301	Oleic Acid	[Oleic Acid co-treated with Fenofibrate] results in increased expression of PPARG mRNA	24534255
D019301	Oleic Acid	Oleic Acid results in increased expression of PPARG mRNA	11172467
D019301	Oleic Acid	Oleic Acid results in increased expression of PPARG protein	11172467
D019301	Oleic Acid	Oleic Acid results in increased expression of PPARG mRNA	18154422
D019301	Oleic Acid	Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]	26854922
D019301	Oleic Acid	[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA]	26854922
D019301	Oleic Acid	[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA	26190035\|2685492
C031492	octanoic acid	[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form	14984747
C031492	octanoic acid	[SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form]	14984747
C118580	octylmethoxycinnamate	octylmethoxycinnamate binds to and results in decreased activity of PPARG protein	27633901
C076029	olanzapine	olanzapine results in increased expression of PPARG protein alternative form	17651982
C017585	oleoyl-coenzyme A	oleoyl-coenzyme A binds to and results in increased activity of PPARG protein	11139385
C108709	oleoyl-estrone	oleoyl-estrone results in decreased expression of PPARG mRNA alternative form	20184727
C002769	oleuropein	"oleuropein inhibits the reaction [Cholesterol, Dietary results in increased expression of PPARG protein]"	27019295
C029407	oleylamide	oleylamide analog results in increased activity of PPARG protein	29288688
D000069463	Olive Oil	Olive Oil inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]	25246140
C405603	Omacor	Omacor results in increased activity of PPARG protein	24597798
D015525	Fatty Acids, Omega-3	"Fatty Acids, Omega-3 results in increased expression of PPARG mRNA"	22464816
D010755	Organophosphates	Organophosphates binds to PPARG protein	25314719
C485800	osajin	osajin results in decreased expression of PPARG mRNA	20706672
C046627	osthol	osthol inhibits the reaction [Isoproterenol results in decreased expression of PPARG mRNA]	21854795
C046627	osthol	osthol results in increased expression of PPARG mRNA	19682441
C046627	osthol	osthol results in increased expression of PPARG protein	19682441
C046627	osthol	osthol results in increased activity of PPARG protein	19682441
C030110	oxaliplatin	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPARG mRNA	25729387
C030110	oxaliplatin	oxaliplatin results in increased expression of PPARG mRNA	25729387
C008729	oxaprozin	oxaprozin results in increased activity of PPARG protein	12065695
D010081	Oxazolone	Oxazolone results in increased expression of PPARG protein	22200888
D010081	Oxazolone	tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein]	22200888
C008743	oxychlordane	oxychlordane inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
D010100	Oxygen	Oxygen deficiency affects the activity of PPARG protein	25596134
D010100	Oxygen	Oxygen deficiency results in decreased expression of PPARG protein	19520921
D010100	Oxygen	Oxygen deficiency results in increased expression of PPARG mRNA	26516004
D010100	Oxygen	[Dexamethasone co-treated with Oxygen deficiency] results in increased expression of PPARG mRNA alternative form	16814746
D010100	Oxygen	Oxygen deficiency results in decreased expression of PPARG mRNA	21531777
D010100	Oxygen	Oxygen deficiency results in decreased expression of PPARG protein	21531777
D010100	Oxygen	Oxygen deficiency results in increased expression of PPARG protein	21113404
D010100	Oxygen	Oxygen results in increased expression of PPARG mRNA	22535284
D010100	Oxygen	[resveratrol co-treated with Oxygen deficiency] results in increased expression of PPARG protein	21113404
D010100	Oxygen	rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG mRNA]	21531777
D010100	Oxygen	rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG protein]	21531777
D010100	Oxygen	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]]"	27274199
D010100	Oxygen	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]]	16617452
D010100	Oxygen	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]]	16617452
D010100	Oxygen	[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein	27274199
D010100	Oxygen	Oxygen results in decreased expression of PPARG mRNA	16617452
D010100	Oxygen	Oxygen results in decreased expression of PPARG protein	16617452
D010100	Oxygen	rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]	16617452
D010100	Oxygen	rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]	16617452
D010100	Oxygen	ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]	27274199
D010126	Ozone	Fish Oils inhibits the reaction [Ozone results in increased expression of PPARG mRNA]	29329427
D010126	Ozone	Ozone results in increased expression of PPARG mRNA	16716893\|2932942
C053370	paclobutrazol	paclobutrazol results in increased expression of PPARG mRNA	23202249
D010168	Palmitates	Palmitates results in increased expression of PPARG mRNA	16620699
D010168	Palmitates	rosiglitazone inhibits the reaction [Palmitates results in increased expression of PPARG mRNA]	16620699
D019308	Palmitic Acid	Palmitic Acid results in increased expression of PPARG mRNA	18154422
D019308	Palmitic Acid	AICA ribonucleotide inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]	25108154
D019308	Palmitic Acid	Ethanol inhibits the reaction [[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA]	26854922
D019308	Palmitic Acid	Metformin inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]	25108154
D019308	Palmitic Acid	[Oleic Acid co-treated with Palmitic Acid] inhibits the reaction [Ethanol results in increased expression of PPARG mRNA]	26854922
D019308	Palmitic Acid	[Oleic Acid co-treated with Palmitic Acid] results in increased expression of PPARG mRNA	26190035\|2685492
D019308	Palmitic Acid	Palmitic Acid results in decreased expression of PPARG mRNA	25108154
D019308	Palmitic Acid	resveratrol inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]	25108154
D019308	Palmitic Acid	Salicylic Acid inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]	25108154
D010171	Palmitoyl Coenzyme A	Palmitoyl Coenzyme A binds to and results in increased activity of PPARG protein	11139385
D000073878	Palm Oil	Palm Oil results in decreased expression of PPARG mRNA	18042831
D010269	Paraquat	PPARG gene polymorphism results in decreased susceptibility to Paraquat	18083318
D010269	Paraquat	PPARG protein results in increased susceptibility to Paraquat	18083318
C084656	paricalcitol	[Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein	17715259
D052638	Particulate Matter	Particulate Matter results in increased expression of PPARG mRNA	23085030
D052638	Particulate Matter	Particulate Matter results in decreased expression of PPARG mRNA	21873646\|2414911
D052638	Particulate Matter	2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein]	24192212
D052638	Particulate Matter	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Particulate Matter results in decreased expression of PPARG protein]]	24192212
D052638	Particulate Matter	hydroxysafflor yellow A inhibits the reaction [Particulate Matter results in decreased expression of PPARG protein]	24192212
D052638	Particulate Matter	Particulate Matter results in decreased expression of PPARG protein	24192212
C568608	PCI 5002	[PCI 5002 co-treated with Zinc] results in increased expression of PPARG mRNA	18593933
C506614	PD 0325901	PD 0325901 inhibits the reaction [Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein]	26670611
C430895	PD 068235	PD 068235 binds to and results in decreased activity of PPARG protein	11416043
C430895	PD 068235	PD 068235 inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	11416043
C517827	pentabrominated diphenyl ether 100	pentabrominated diphenyl ether 100 results in increased activity of PPARG protein	27602593
C494474	perchlorate	perchlorate results in decreased expression of PPARG mRNA	17403546
C108042	perfluorobutane	perfluorobutane binds to PPARG protein	24998974
C033094	perfluorobutyric acid	perfluorobutyric acid results in increased activity of PPARG protein	24998974
C036567	perfluorodecanoic acid	perfluorodecanoic acid results in increased activity of PPARG protein	23391484\|2499897
C522391	perfluorododecanoic acid	perfluorododecanoic acid results in increased activity of PPARG protein	23391484\|2499897
C471071	perfluorohexanesulfonic acid	perfluorohexanesulfonic acid binds to PPARG protein	24998974
C471071	perfluorohexanesulfonic acid	perfluorohexanesulfonic acid results in increased expression of PPARG mRNA	28049043
C479228	perfluorohexanoic acid	perfluorohexanoic acid results in increased activity of PPARG protein	23391484
C101816	perfluoro-n-nonanoic acid	perfluoro-n-nonanoic acid results in increased expression of PPARG mRNA	19196829\|1987870
C584865	perfluorononanoic acid	perfluorononanoic acid results in increased expression of PPARG mRNA	28558994
C063900	perfluorooctanesulfonamide	perfluorooctanesulfonamide results in increased expression of PPARG mRNA	22594583
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased activity of PPARG protein	24998974
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased expression of PPARG mRNA	22269386\|2654859
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased expression of PPARG mRNA	23500012\|2654859
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in decreased acetylation of PPARG protein	28973641
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased expression of PPARG mRNA	23500012
C076994	perfluorooctane sulfonic acid	perfluorooctane sulfonic acid results in increased expression of PPARG mRNA	18424238\|1974756
C023036	perfluorooctanoic acid	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to perfluorooctanoic acid	23978332
C023036	perfluorooctanoic acid	perfluorooctanoic acid binds to and results in increased activity of PPARG protein	16731579
C023036	perfluorooctanoic acid	perfluorooctanoic acid binds to PPARG protein	24998974
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased activity of PPARG protein	23391484\|2499897
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased expression of PPARG mRNA	25868421\|2855899
C023036	perfluorooctanoic acid	perfluorooctanoic acid affects the expression of PPARG mRNA	22154759
C023036	perfluorooctanoic acid	perfluorooctanoic acid binds to and results in increased activity of PPARG protein	16731579
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in decreased expression of PPARG mRNA	22154759
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased expression of PPARG mRNA	18281256\|2149989
C023036	perfluorooctanoic acid	perfluorooctanoic acid results in increased expression of PPARG protein	22154759
C023036	perfluorooctanoic acid	PPARA protein inhibits the reaction [perfluorooctanoic acid results in increased expression of PPARG mRNA]	18281256
C023036	perfluorooctanoic acid	perfluorooctanoic acid binds to and results in increased activity of PPARG protein	16731579
C586085	perfluoroundecanoic acid	perfluoroundecanoic acid binds to and affects the folding of PPARG protein	24998974
D026023	Permethrin	Permethrin results in increased expression of PPARG mRNA	24911977
D026023	Permethrin	Permethrin results in increased expression of PPARG protein	24911977
D010634	Phenobarbital	Phenobarbital affects the expression of PPARG mRNA	19159669
D010634	Phenobarbital	NR1I3 protein affects the reaction [Phenobarbital results in increased expression of PPARG mRNA]	19482888
D010634	Phenobarbital	Phenobarbital affects the expression of PPARG mRNA	23091169
D010634	Phenobarbital	Phenobarbital results in increased expression of PPARG mRNA	19482888
D010634	Phenobarbital	Phenobarbital results in increased expression of PPARG mRNA	24090815
D019800	Phenol	Phenol results in increased expression of PPARG mRNA	17547211
C047088	phenylamil	[phenylamil co-treated with Harmine] results in increased expression of PPARG mRNA	20519739
C047088	phenylamil	phenylamil results in increased expression of PPARG mRNA	20519739
C047088	phenylamil	PPARG protein affects the susceptibility to phenylamil	20519739
C047088	phenylamil	PPARG protein promotes the reaction [phenylamil results in increased expression of ADIPOQ mRNA]	20519739
C047088	phenylamil	PPARG protein promotes the reaction [phenylamil results in increased expression of AQP7 mRNA]	20519739
C047088	phenylamil	PPARG protein promotes the reaction [phenylamil results in increased expression of FABP4 mRNA]	20519739
D010666	Phenylpropionates	Phenylpropionates analog results in increased expression of PPARG mRNA	16626515
D010713	Phosphatidylcholines	Phosphatidylcholines results in increased expression of PPARG mRNA	23911798
D010743	Phospholipids	[pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Phospholipids]	19403437
D010758	Phosphorus	[Phosphorus co-treated with paricalcitol] results in increased localization of PPARG protein	17715259
C032279	phthalic acid	phthalic acid binds to PPARG protein	23843199
D010795	Phthalic Acids	Phthalic Acids binds to and results in increased activity of PPARG protein	27358237
D010831	Phytanic Acid	Phytanic Acid binds to PPARG protein	23843199
C060836	pioglitazone	[Dexamethasone co-treated with INS protein co-treated with pioglitazone] results in increased expression of PPARG protein	17290005
C060836	pioglitazone	Ethanol inhibits the reaction [pioglitazone results in increased activity of PPARG protein]	17030193
C060836	pioglitazone	pioglitazone binds to and results in increased activity of PPARG protein	15729575\|1903688
C060836	pioglitazone	pioglitazone binds to PPARG protein	11779144\|2207060
C060836	pioglitazone	pioglitazone promotes the reaction [PPARG protein binds to NPHS1 promoter]	16687628
C060836	pioglitazone	pioglitazone promotes the reaction [PPARG protein results in increased expression of PCSK9 mRNA]	22593575
C060836	pioglitazone	pioglitazone results in increased activity of PPARG protein	15273253\|1632491
C060836	pioglitazone	pioglitazone results in increased activity of [PPARG protein alternative form binds to RXRA protein]	11779144
C060836	pioglitazone	pioglitazone results in increased expression of PPARG mRNA	11172467\|1920141
C060836	pioglitazone	pioglitazone results in increased expression of PPARG mRNA alternative form	20860658
C060836	pioglitazone	pioglitazone results in increased expression of PPARG protein	11172467\|2664307
C060836	pioglitazone	PPARG protein affects the reaction [pioglitazone results in increased expression of CD36 protein]	26643070
C060836	pioglitazone	PPARG protein promotes the reaction [pioglitazone results in increased activity of DIO2 protein]	19036883
C060836	pioglitazone	Ro 41-5253 inhibits the reaction [pioglitazone results in increased activity of PPARG protein]	17290005
C060836	pioglitazone	[ANGPT2 protein binds to and results in increased activity of AGTR2 protein] promotes the reaction [pioglitazone binds to and results in increased activity of PPARG protein]	15992368
C060836	pioglitazone	[Dexamethasone co-treated with INS protein co-treated with pioglitazone] results in increased expression of PPARG protein	17290005
C060836	pioglitazone	pioglitazone affects the expression of PPARG	21962020
C060836	pioglitazone	pioglitazone affects the expression of PPARG mRNA	19048458
C060836	pioglitazone	pioglitazone binds to and results in increased activity of PPARG protein	11991651\|1708487
C060836	pioglitazone	[pioglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of RETSAT mRNA	19139408
C060836	pioglitazone	[pioglitazone co-treated with alitretinoin] inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]	17019405
C060836	pioglitazone	pioglitazone inhibits the reaction [PPARG protein results in increased susceptibility to Methamphetamine]	17019405
C060836	pioglitazone	pioglitazone promotes the reaction [PPARG protein binds to SCNN1G intron]	16007095
C060836	pioglitazone	"pioglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein]"	17015710
C060836	pioglitazone	pioglitazone results in increased activity of and results in decreased expression of PPARG protein	17290005
C060836	pioglitazone	pioglitazone results in increased expression of PPARG mRNA	11991651\|1640716
C060836	pioglitazone	PPARG protein affects the reaction [pioglitazone results in increased expression of ADIPOQ mRNA]	12927809
C060836	pioglitazone	PPARG protein affects the susceptibility to pioglitazone	16007095
C060836	pioglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone affects the expression of PPARG mRNA]	28744220
C060836	pioglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [pioglitazone affects the expression of PPARG protein]	28744220
C060836	pioglitazone	pioglitazone affects the expression of PPARG mRNA	28744220
C060836	pioglitazone	pioglitazone affects the expression of PPARG protein	28744220
C060836	pioglitazone	pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein]	16598202
C060836	pioglitazone	pioglitazone binds to and results in increased activity of PPARG protein	15150131\|1675179
C060836	pioglitazone	[pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Diglycerides]	19403437
C060836	pioglitazone	[pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Phospholipids]	19403437
C060836	pioglitazone	[pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Triglycerides]	19403437
C060836	pioglitazone	pioglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	12055599
C060836	pioglitazone	pioglitazone inhibits the reaction [Cisplatin results in decreased expression of PPARG mRNA]	22989705
C060836	pioglitazone	pioglitazone inhibits the reaction [[Ethanol co-treated with Lipopolysaccharides] results in decreased expression of PPARG mRNA]	15318101
C060836	pioglitazone	pioglitazone inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]	27350165
C060836	pioglitazone	pioglitazone results in increased activity of PPARG protein	19439812
C060836	pioglitazone	[pioglitazone results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides	19439812
C060836	pioglitazone	[pioglitazone results in increased activity of PPARG protein] which results in increased abundance of Diglycerides	19439812
C060836	pioglitazone	T 0070907 inhibits the reaction [pioglitazone affects the expression of PPARG mRNA]	28744220
C060836	pioglitazone	T 0070907 inhibits the reaction [pioglitazone affects the expression of PPARG protein]	28744220
C060836	pioglitazone	pioglitazone results in increased activity of PPARG protein	17065204
C060836	pioglitazone	troglitazone inhibits the reaction [pioglitazone results in increased activity of PPARG protein]	17065204
C060836	pioglitazone	pioglitazone binds to and results in decreased activity of PPARG protein	12676649
C060836	pioglitazone	pioglitazone binds to and results in increased activity of PPARG protein	11172467\|1168758
C060836	pioglitazone	pioglitazone binds to PPARG protein	16573735\|1827462
C060836	pioglitazone	pioglitazone results in increased activity of PPARG protein	16023994\|2148456
C006253	pirinixic acid	N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA]	11840453
C006253	pirinixic acid	nimesulide inhibits the reaction [pirinixic acid promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]]	11840453
C006253	pirinixic acid	nimesulide inhibits the reaction [pirinixic acid results in increased expression of PPARG mRNA]	11840453
C006253	pirinixic acid	pirinixic acid analog binds to and affects the activity of PPARG protein	17610302
C006253	pirinixic acid	pirinixic acid analog binds to and results in increased activity of PPARG protein	18275039\|2030798
C006253	pirinixic acid	pirinixic acid binds to and results in increased activity of PPARG protein	17610302\|1827503
C006253	pirinixic acid	pirinixic acid inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]	12604364
C006253	pirinixic acid	pirinixic acid promotes the reaction [PPARG protein results in increased expression of PTGS2 mRNA]	11840453
C006253	pirinixic acid	pirinixic acid results in increased activity of PPARG protein	16386710\|2613592
C006253	pirinixic acid	pirinixic acid results in increased expression of PPARG mRNA	11840453
C006253	pirinixic acid	pirinixic acid promotes the reaction [PPARG protein binds to NFKBIA promoter]	19438714
C006253	pirinixic acid	pirinixic acid results in increased activity of PPARG protein	12401884\|9703482
C006253	pirinixic acid	pirinixic acid results in increased activity of [PPARG protein co-treated with RXRA protein]	8700121
C006253	pirinixic acid	[pirinixic acid results in increased activity of PPARG protein] which results in increased expression of NFKBIA mRNA	19438714
C006253	pirinixic acid	pirinixic acid affects the localization of and results in increased activity of PPARG protein	16912651
C006253	pirinixic acid	pirinixic acid results in increased expression of PPARG mRNA	22539621
D010936	Plant Extracts	Plant Extracts binds to and results in increased activity of PPARG protein	24454499
D010936	Plant Extracts	Plant Extracts binds to PPARG protein	14608046
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Hydrogen Peroxide results in increased degradation of PPARG protein]	25305479
D010936	Plant Extracts	Plant Extracts results in increased activity of PPARG protein	24371453
D010936	Plant Extracts	Plant Extracts results in increased expression of PPARG mRNA	24446304
D010936	Plant Extracts	Plant Extracts affects the expression of PPARG mRNA	25086370
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	22967722
D010936	Plant Extracts	Plant Extracts results in decreased expression of PPARG mRNA	21511020\|2244573
D010936	Plant Extracts	Plant Extracts results in decreased expression of PPARG protein	19330881\|2151102
D010936	Plant Extracts	Plant Extracts results in increased activity of PPARG protein	23993593
D010936	Plant Extracts	Plant Extracts results in increased expression of PPARG mRNA	18534569\|2139256
D010936	Plant Extracts	Plant Extracts results in increased expression of PPARG protein	24036142
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Cyclophosphamide results in decreased expression of PPARG mRNA]	25446862
D010936	Plant Extracts	Plant Extracts inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	23365609
D010936	Plant Extracts	Plant Extracts results in decreased expression of PPARG mRNA	23306787\|2368475
D010936	Plant Extracts	Plant Extracts binds to PPARG protein	14643306
D010938	Plant Oils	Plant Oils results in increased expression of PPARG mRNA	15961301
D010938	Plant Oils	Plant Oils results in increased expression of PPARG protein	15961301
D028321	Plant Preparations	Plant Preparations results in increased expression of PPARG mRNA	24973489\|2694572
D011078	Polychlorinated Biphenyls	[Polychlorinated Biphenyls analog co-treated with Dichlorodiphenyl Dichloroethylene analog] inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
D011078	Polychlorinated Biphenyls	"[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]"	27602593
D011078	Polychlorinated Biphenyls	"[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] results in decreased expression of PPARG mRNA"	27602593
D011084	Polycyclic Aromatic Hydrocarbons	Polycyclic Aromatic Hydrocarbons results in decreased methylation of PPARG gene	25347678
D011084	Polycyclic Aromatic Hydrocarbons	Polycyclic Aromatic Hydrocarbons results in increased expression of PPARG mRNA	25347678
D011134	Polysaccharides	Polysaccharides inhibits the reaction [Hydrogen Peroxide results in increased degradation of PPARG protein]	25305479
C474837	pomiferin	pomiferin results in decreased expression of PPARG mRNA	20706672
C027373	potassium chromate(VI)	potassium chromate(VI) inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]	24576443
D017035	Pravastatin	Pravastatin inhibits the reaction [[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol]	12044893
D011374	Progesterone	Progesterone results in increased expression of PPARG mRNA	16954335
D011429	Propolis	Propolis results in decreased expression of PPARG mRNA	20706672
C006068	propylparaben	propylparaben binds to and results in increased activity of PPARG protein	24155963
C006068	propylparaben	PPARG protein promotes the reaction [propylparaben binds to and results in increased activity of PPARG protein]	24155963
C006068	propylparaben	propylparaben results in increased expression of PPARG mRNA	22956630
D011441	Propylthiouracil	Propylthiouracil results in decreased expression of PPARG mRNA	24780913
D011441	Propylthiouracil	Propylthiouracil results in decreased expression of PPARG mRNA	17403546
D015237	Dinoprost	[Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG mRNA	21236357
D015237	Dinoprost	[Niacin results in decreased abundance of Dinoprost] which results in increased expression of PPARG protein	21236357
D047428	Protein Kinase Inhibitors	PD 0325901 inhibits the reaction [Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein]	26670611
D047428	Protein Kinase Inhibitors	Protein Kinase Inhibitors results in increased phosphorylation of and results in decreased activity of PPARG protein	26670611
C033607	puerarin	puerarin results in decreased expression of PPARG mRNA	20706672
C033607	puerarin	puerarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein]	23500774
D011692	Puromycin Aminonucleoside	pioglitazone affects the reaction [Puromycin Aminonucleoside results in increased expression of PPARG protein]	16598202
D011692	Puromycin Aminonucleoside	Puromycin Aminonucleoside results in increased expression of PPARG protein	16598202
C024070	pycnogenols	pycnogenols results in decreased expression of PPARG mRNA	21796705
C513428	pyrachlostrobin	pyrachlostrobin results in decreased expression of PPARG mRNA	29127035
C043940	pyranoprofen	pyranoprofen results in increased activity of PPARG protein	12065695
C432165	pyrazolanthrone	pyrazolanthrone results in increased expression of PPARG mRNA	17372590
C432165	pyrazolanthrone	pyrazolanthrone results in increased expression of PPARG protein	17372590
C031280	pyrazole	pyrazole results in increased expression of PPARG mRNA	17945193
D011765	Pyruvaldehyde	"PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]"	23954466
D011765	Pyruvaldehyde	PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of IL1B protein]]	23954466
D011765	Pyruvaldehyde	PPARG mutant form inhibits the reaction [monascin inhibits the reaction [Pyruvaldehyde results in increased expression of TNF protein]]	23954466
D011765	Pyruvaldehyde	"PPARG mutant form inhibits the reaction [rosiglitazone inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]"	23954466
D011765	Pyruvaldehyde	PPARG mutant form inhibits the reaction [rosiglitazone inhibits the reaction [Pyruvaldehyde results in increased expression of IL1B protein]]	23954466
D011765	Pyruvaldehyde	PPARG mutant form inhibits the reaction [rosiglitazone inhibits the reaction [Pyruvaldehyde results in increased expression of TNF protein]]	23954466
D011794	Quercetin	Quercetin inhibits the reaction [ciglitazone results in increased activity of PPARG protein]	18393431
D011794	Quercetin	Quercetin promotes the reaction [rosiglitazone results in increased expression of PPARG protein]	25765892
D011794	Quercetin	Quercetin results in increased expression of PPARG mRNA	25765892
D011794	Quercetin	Quercetin results in increased expression of PPARG protein	25765892
D011794	Quercetin	Quercetin binds to and results in increased activity of PPARG protein	18262572
D011794	Quercetin	Quercetin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG protein]	18586010
D011794	Quercetin	Quercetin inhibits the reaction [[Dietary Fats co-treated with Dietary Sucrose] results in increased expression of PPARG mRNA]	21462320
D011794	Quercetin	Quercetin inhibits the reaction [Dietary Fats results in increased expression of PPARG mRNA]	22447684\|2402568
D011794	Quercetin	Quercetin inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]	18262572
D011794	Quercetin	[Dietary Fats co-treated with Quercetin] affects the expression of PPARG mRNA	20580672
D011794	Quercetin	PPARG protein affects the reaction [Quercetin inhibits the reaction [AGT protein results in increased expression of FOS protein]]	24039778
D011794	Quercetin	PPARG protein affects the reaction [Quercetin inhibits the reaction [AGT protein results in increased expression of JUN protein]]	24039778
D011794	Quercetin	PPARG protein affects the reaction [Quercetin inhibits the reaction [AGT protein results in increased expression of NPPA mRNA]]	24039778
D011794	Quercetin	PPARG protein affects the reaction [Quercetin inhibits the reaction [AGT protein results in increased expression of NPPB mRNA]]	24039778
D011794	Quercetin	Quercetin inhibits the reaction [AGT protein results in decreased expression of PPARG protein]	24039778
D011794	Quercetin	Quercetin inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein]	15051824
D011794	Quercetin	Quercetin inhibits the reaction [TNF protein results in decreased activity of and results in decreased expression of PPARG protein]	20943792
C443401	quercetin 3-O-glucuronide	quercetin 3-O-glucuronide results in increased expression of PPARG mRNA	25765892
C037219	quinoline	quinoline analog binds to and affects the activity of PPARG protein	17610302
C005805	quintozene	quintozene results in increased activity of PPARG protein	20143881
C432703	ragaglitazar	ragaglitazar binds to and results in increased activity of PPARG protein	15655531
D017382	Reactive Oxygen Species	[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species	23964924
D017382	Reactive Oxygen Species	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [troglitazone results in increased abundance of Reactive Oxygen Species]	22108328
D017382	Reactive Oxygen Species	2-chloro-5-nitrobenzanilide inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species]	23964924
D017382	Reactive Oxygen Species	Acetylcysteine inhibits the reaction [[[15-deoxyprostaglandin J2 results in increased activity of PPARG protein] which results in decreased expression of SOD2 protein] which results in increased abundance of Reactive Oxygen Species]	23964924
D017382	Reactive Oxygen Species	Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]	16945329
D017382	Reactive Oxygen Species	Acetylcysteine inhibits the reaction [[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein]	22046279
D017382	Reactive Oxygen Species	[Carbon Monoxide results in increased abundance of Reactive Oxygen Species] which results in increased sumoylation of PPARG protein	22046279
D017382	Reactive Oxygen Species	PPARG protein affects the reaction [Cadmium results in increased abundance of Reactive Oxygen Species]	16737744
D017382	Reactive Oxygen Species	PPARG protein affects the reaction [Zinc results in increased abundance of Reactive Oxygen Species]	16737744
C025474	rebaudioside A	rebaudioside A affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA]	25554529
C100036	resmethrin	resmethrin results in increased activity of PPARG protein	20143881
C059514	resveratrol	resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein]	22539994
C059514	resveratrol	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in decreased abundance of Cholesterol]	20372816
C059514	resveratrol	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [resveratrol results in increased expression of AGER protein]	20372816
C059514	resveratrol	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to resveratrol	20372816
C059514	resveratrol	2-chloro-5-nitrobenzanilide inhibits the reaction [resveratrol results in increased expression of PPARG mRNA]	23041272
C059514	resveratrol	"(6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine inhibits the reaction [resveratrol results in decreased expression of PPARG mRNA]"	24584901
C059514	resveratrol	PPARG protein promotes the reaction [resveratrol results in increased expression of ABCA1 mRNA]	23041272
C059514	resveratrol	PPARG protein promotes the reaction [resveratrol results in increased expression of ABCA1 protein]	23041272
C059514	resveratrol	PPARG protein promotes the reaction [resveratrol results in increased expression of ABCG1 mRNA]	23041272
C059514	resveratrol	PPARG protein promotes the reaction [resveratrol results in increased expression of CYP27A1 mRNA]	23041272
C059514	resveratrol	PPARG protein promotes the reaction [resveratrol results in increased expression of CYP27A1 protein]	23041272
C059514	resveratrol	resveratrol analog results in increased expression of PPARG mRNA	24759758
C059514	resveratrol	resveratrol binds to and results in increased activity of PPARG protein	24454499
C059514	resveratrol	resveratrol inhibits the reaction [Linoleic Acid results in increased expression of PPARG protein]	25672876
C059514	resveratrol	"resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in decreased activity of PPARG protein]"	18776171
C059514	resveratrol	"resveratrol inhibits the reaction [Linoleic Acids, Conjugated results in increased phosphorylation of and results in increased activity of PPARG protein]"	18776171
C059514	resveratrol	resveratrol results in decreased expression of PPARG mRNA	20706672\|2171399
C059514	resveratrol	resveratrol results in decreased expression of PPARG protein	25672876
C059514	resveratrol	resveratrol results in increased activity of PPARG protein	16849586\|1700735
C059514	resveratrol	[resveratrol results in increased activity of PPARG protein] which results in decreased expression of AGER protein	20372816
C059514	resveratrol	resveratrol results in increased expression of PPARG mRNA	23041272\|2375055
C059514	resveratrol	resveratrol results in increased expression of PPARG protein	20372816\|2070995
C059514	resveratrol	[resveratrol analog co-treated with Dietary Fats] results in increased expression of PPARG mRNA	24759758
C059514	resveratrol	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [resveratrol results in decreased expression of PPARG protein]	18555852
C059514	resveratrol	epoxomicin inhibits the reaction [resveratrol results in decreased expression of PPARG protein]	18555852
C059514	resveratrol	PPARG protein affects the susceptibility to resveratrol	23525482
C059514	resveratrol	resveratrol affects the activity of PPARG protein	23525482
C059514	resveratrol	resveratrol analog results in decreased expression of PPARG mRNA	23748787\|2477919
C059514	resveratrol	[resveratrol co-treated with Dietary Fats] results in decreased expression of PPARG mRNA	24985011
C059514	resveratrol	[resveratrol co-treated with Oxygen deficiency] results in increased expression of PPARG protein	21113404
C059514	resveratrol	resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA]	18755807
C059514	resveratrol	resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein]	22539994
C059514	resveratrol	resveratrol metabolite results in decreased expression of PPARG mRNA	22945685
C059514	resveratrol	resveratrol results in decreased expression of PPARG mRNA	16813520\|1855585
C059514	resveratrol	resveratrol results in decreased expression of PPARG protein	18555852\|1893033
C059514	resveratrol	resveratrol results in decreased stability of and results in decreased activity of PPARG protein	18555852
C059514	resveratrol	resveratrol results in increased degradation of and results in increased ubiquitination of PPARG protein	18555852
C059514	resveratrol	resveratrol results in increased expression of PPARG protein	24036142
C059514	resveratrol	rosiglitazone inhibits the reaction [resveratrol analog results in decreased expression of PPARG mRNA]	24779192
C059514	resveratrol	splitomicin promotes the reaction [resveratrol results in decreased expression of PPARG mRNA]	23525482
C059514	resveratrol	splitomicin promotes the reaction [resveratrol results in decreased expression of PPARG protein]	23525482
C059514	resveratrol	resveratrol inhibits the reaction [Ethanol results in increased expression of PPARG mRNA]	18793633
C059514	resveratrol	resveratrol inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]	25108154
C059514	resveratrol	resveratrol results in decreased acetylation of and results in decreased activity of PPARG protein	28973641
C059514	resveratrol	resveratrol results in decreased expression of PPARG mRNA	23848300
C059514	resveratrol	resveratrol inhibits the reaction [Dietary Fats results in decreased expression of PPARG protein]	21739664
C059514	resveratrol	resveratrol results in decreased expression of PPARG mRNA	17851734
C059514	resveratrol	resveratrol results in decreased expression of PPARG protein	21575630
C059514	resveratrol	resveratrol analog binds to PPARG protein	24759758
C059514	resveratrol	resveratrol binds to PPARG protein	24796862
C059514	resveratrol	resveratrol inhibits the reaction [rosiglitazone binds to PPARG protein]	24796862
C059514	resveratrol	resveratrol inhibits the reaction [TNF protein results in decreased activity of and results in decreased expression of PPARG protein]	20943792
C059514	resveratrol	resveratrol metabolite binds to PPARG protein	24796862
C059514	resveratrol	[resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [Niacinamide results in increased expression of PPARG]	22539994
C059514	resveratrol	[resveratrol results in decreased acetylation of RUNX2 protein] inhibits the reaction [Niacinamide results in increased expression of PPARG]	22539994
C059514	resveratrol	[resveratrol results in increased activity of SIRT1 protein] which results in decreased activity of PPARG protein	22539994
C499731	resveratrol-4'-O-glucuronide	resveratrol-4'-O-glucuronide binds to PPARG protein	24796862
D015474	Isotretinoin	Isotretinoin results in increased expression of PPARG mRNA	19041696\|1921200
C072026	rhodostomin	rhodostomin results in decreased expression of PPARG mRNA	16197920
C013672	riddelliine	riddelliine results in decreased expression of PPARG mRNA	18047727
D012293	Rifampin	Rifampin results in increased expression of and affects the localization of PPARG protein	27806127
D012293	Rifampin	Rifampin results in increased expression of PPARG mRNA	27806127
C042734	rifaximin	[NR1I2 results in increased susceptibility to rifaximin] which results in increased expression of PPARG mRNA	22790967
C089032	rimonabant	rimonabant affects the expression of PPARG mRNA	20110567
D018967	Risperidone	Berberine inhibits the reaction [Risperidone results in increased expression of PPARG mRNA]	20564506
D018967	Risperidone	Berberine inhibits the reaction [Risperidone results in increased expression of PPARG protein]	20564506
D018967	Risperidone	Risperidone results in increased expression of PPARG mRNA	20564506
D018967	Risperidone	Risperidone results in increased expression of PPARG protein	20564506
D019438	Ritonavir	Ritonavir results in increased expression of PPARG mRNA	17879945
D019438	Ritonavir	Ritonavir inhibits the reaction [[INS1 protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] results in increased expression of PPARG protein]	11101056
C084904	Ro 41-5253	[Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein	17290005
C084904	Ro 41-5253	Ro 41-5253 binds to and results in increased activity of PPARG protein	17290005
C084904	Ro 41-5253	Ro 41-5253 inhibits the reaction [pioglitazone results in increased activity of PPARG protein]	17290005
C084904	Ro 41-5253	Ro 41-5253 inhibits the reaction [rosiglitazone binds to PPARG protein]	17290005
C084904	Ro 41-5253	[Dexamethasone co-treated with INS protein co-treated with Ro 41-5253] results in increased expression of PPARG protein	17290005
C084904	Ro 41-5253	Ro 41-5253 results in increased activity of and results in decreased expression of PPARG protein	17290005
C529148	rosavin	rosavin results in decreased expression of PPARG mRNA	20706672
C089730	rosiglitazone	Cycloheximide inhibits the reaction [rosiglitazone results in increased expression of PPARG protein]	17622750
C089730	rosiglitazone	Hydrogen Peroxide inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	17622750
C089730	rosiglitazone	[rosiglitazone co-treated with Hydrogen Peroxide] results in increased expression of PPARG protein	17622750
C089730	rosiglitazone	rosiglitazone results in increased expression of and results in increased activity of PPARG protein	17622750
C089730	rosiglitazone	rosiglitazone results in increased expression of PPARG mRNA	17622750
C089730	rosiglitazone	rosiglitazone binds to and results in increased activity of PPARG protein	16239165
C089730	rosiglitazone	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Acetaldehyde inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide affects the reaction [rosiglitazone affects the localization of PPARG protein]	22321707
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]]	21333731
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	21660147\|2396492
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]	18949406\|2135409
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased expression of PPARG protein]	22321707\|2479381
C089730	rosiglitazone	5-(5-(3-chloro-5-ethoxy-4-hydroxybenzylidene)-3-methyl-4-oxothiazolidin-2-ylideneamino)-2-chlorobenzoic acid inhibits the reaction [rosiglitazone promotes the reaction [PPARG protein binds to CREBBP protein]]	21296151
C089730	rosiglitazone	Acetaldehyde inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	17030193
C089730	rosiglitazone	Cyanamide inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
C089730	rosiglitazone	diphenyltin chloride inhibits the reaction [rosiglitazone binds to PPARG protein]	19497422
C089730	rosiglitazone	Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	17030193
C089730	rosiglitazone	FASN protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]]	26670611
C089730	rosiglitazone	"FASN protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]]"	26670611
C089730	rosiglitazone	fomepizole inhibits the reaction [Ethanol inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
C089730	rosiglitazone	HMOX1 protein promotes the reaction [rosiglitazone results in increased activity of PPARG protein]	21660147
C089730	rosiglitazone	Indomethacin inhibits the reaction [rosiglitazone binds to PPARG protein]	9013583
C089730	rosiglitazone	INT 131 inhibits the reaction [[rosiglitazone binds to MED1 protein modified form] which binds to PPARG protein]	19452630
C089730	rosiglitazone	INT 131 inhibits the reaction [rosiglitazone binds to PPARG protein]	19452630
C089730	rosiglitazone	INT 131 inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]	19452630
C089730	rosiglitazone	NFE2L2 protein promotes the reaction [rosiglitazone results in increased expression of PPARG protein]	22684020
C089730	rosiglitazone	PPARG gene polymorphism affects the susceptibility to rosiglitazone	16084854
C089730	rosiglitazone	PPARG mRNA affects the susceptibility to rosiglitazone	17535976\|2066332
C089730	rosiglitazone	PPARG promotes the reaction [rosiglitazone results in increased expression of CD36 mRNA]	27358406
C089730	rosiglitazone	PPARG protein affects the reaction [rosiglitazone results in increased expression of PTEN protein]	16425225
C089730	rosiglitazone	[PPARG protein co-treated with rosiglitazone] results in decreased expression of AKR1B10 protein	27417252
C089730	rosiglitazone	PPARG protein promotes the reaction [rosiglitazone results in decreased expression of FN1 protein]	15908479
C089730	rosiglitazone	PPARG protein promotes the reaction [rosiglitazone results in decreased expression of ICAM1 mRNA]	19417127
C089730	rosiglitazone	PPARG protein promotes the reaction [rosiglitazone results in decreased expression of TPM3 protein alternative form]	19369484
C089730	rosiglitazone	PPARG protein results in increased susceptibility to [rosiglitazone co-treated with Cisplatin]	27417252
C089730	rosiglitazone	Quercetin promotes the reaction [rosiglitazone results in increased expression of PPARG protein]	25765892
C089730	rosiglitazone	Ro 41-5253 inhibits the reaction [rosiglitazone binds to PPARG protein]	17290005
C089730	rosiglitazone	rosiglitazone affects the activity of PPARG protein	25596134
C089730	rosiglitazone	rosiglitazone affects the expression of PPARG	15254749
C089730	rosiglitazone	rosiglitazone affects the localization of PPARG protein	22321707
C089730	rosiglitazone	rosiglitazone binds to and affects the activity of PPARG protein	16527820
C089730	rosiglitazone	[rosiglitazone binds to and affects the activity of PPARG protein] which results in increased abundance of Nitric Oxide	16527820
C089730	rosiglitazone	rosiglitazone binds to and results in increased activity of PPARG protein	10871190\|1113938
C089730	rosiglitazone	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to Cisplatin	21781307
C089730	rosiglitazone	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased susceptibility to MT19c compound	21781307
C089730	rosiglitazone	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of ANGPTL4 mRNA	28962521
C089730	rosiglitazone	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to arsenic trioxide	22684020
C089730	rosiglitazone	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to Cisplatin	21781307
C089730	rosiglitazone	[rosiglitazone binds to MED1 protein modified form] which binds to PPARG protein	19452630
C089730	rosiglitazone	rosiglitazone binds to PPARG protein	11779144\|1283993
C089730	rosiglitazone	[rosiglitazone binds to PPARG protein] which affects the localization of NCOA1 protein	10871190
C089730	rosiglitazone	[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA	20206132
C089730	rosiglitazone	[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein	20206132
C089730	rosiglitazone	[rosiglitazone co-treated with Rotenone] results in increased expression of PPARG protein	24374061
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Chlorpyrifos results in decreased expression of PPARG protein]	24793810
C089730	rosiglitazone	"rosiglitazone inhibits the reaction [Fatty Acids, Nonesterified results in decreased expression of PPARG mRNA]"	14625208
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Glucose results in decreased expression of PPARG protein]	21333731
C089730	rosiglitazone	rosiglitazone inhibits the reaction [[PPARG protein co-treated with RXRA protein] binds to SLC2A4 promoter]	12777391
C089730	rosiglitazone	rosiglitazone promotes the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	19186324
C089730	rosiglitazone	rosiglitazone promotes the reaction [PPARG protein binds to CREBBP protein]	21296151
C089730	rosiglitazone	rosiglitazone promotes the reaction [PPARG protein promotes the reaction [mono-(2-ethylhexyl)phthalate results in increased activity of CASP3 protein]]	12927354
C089730	rosiglitazone	rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]	26670611
C089730	rosiglitazone	"rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]"	26670611
C089730	rosiglitazone	rosiglitazone promotes the reaction [PPARG protein results in increased expression of FASN protein]	26670611
C089730	rosiglitazone	rosiglitazone results in increased activity of PPARG protein	12814394\|1527325
C089730	rosiglitazone	rosiglitazone results in increased activity of PPARG protein alternative form	23563205
C089730	rosiglitazone	[rosiglitazone results in increased activity of PPARG protein] which results in increased abundance of Tretinoin	16982809
C089730	rosiglitazone	rosiglitazone results in increased expression of PPARG	17018897
C089730	rosiglitazone	rosiglitazone results in increased expression of PPARG mRNA	15277403\|1679978
C089730	rosiglitazone	rosiglitazone results in increased expression of PPARG mRNA alternative form	20860658
C089730	rosiglitazone	rosiglitazone results in increased expression of PPARG protein	17030193\|1746144
C089730	rosiglitazone	[RXRA co-treated with rosiglitazone] results in increased expression of PPARG mRNA	16213464
C089730	rosiglitazone	T 0070907 inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]	21354099
C089730	rosiglitazone	tetrabutyltin inhibits the reaction [rosiglitazone binds to PPARG protein]	19497422
C089730	rosiglitazone	TGFB1 protein inhibits the reaction [[rosiglitazone co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]	20206132
C089730	rosiglitazone	tributyltin inhibits the reaction [rosiglitazone binds to PPARG protein]	19497422
C089730	rosiglitazone	triphenylarsine inhibits the reaction [rosiglitazone binds to PPARG protein]	27725436
C089730	rosiglitazone	triphenyl bismuth inhibits the reaction [rosiglitazone binds to PPARG protein]	27725436
C089730	rosiglitazone	triphenyltin chloride inhibits the reaction [rosiglitazone binds to PPARG protein]	19497422
C089730	rosiglitazone	troglitazone inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]	10871190
C089730	rosiglitazone	U 0126 inhibits the reaction [Acetaldehyde inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
C089730	rosiglitazone	UCP1 protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in decreased abundance of Adenosine Triphosphate]]	26670611
C089730	rosiglitazone	"UCP1 protein promotes the reaction [rosiglitazone promotes the reaction [PPARG protein results in increased abundance of Fatty Acids, Nonesterified]]"	26670611
C089730	rosiglitazone	zinc protoporphyrin inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	21660147
C089730	rosiglitazone	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] which results in decreased susceptibility to rosiglitazone	17394460
C089730	rosiglitazone	benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein]	18555852
C089730	rosiglitazone	bis(4-hydroxyphenyl)sulfone inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27273607
C089730	rosiglitazone	[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA	16054899
C089730	rosiglitazone	epoxomicin inhibits the reaction [rosiglitazone results in decreased expression of PPARG protein]	18555852
C089730	rosiglitazone	ethyl protocatechuate inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]	24338020
C089730	rosiglitazone	(+)-JQ1 compound inhibits the reaction [rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]]	26972250
C089730	rosiglitazone	kaempferol inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]	18262572
C089730	rosiglitazone	PPARG affects the reaction [rosiglitazone results in decreased expression of CX3CR1 mRNA]	19850645
C089730	rosiglitazone	PPARG affects the reaction [rosiglitazone results in increased expression of PTEN protein]	16425225
C089730	rosiglitazone	PPARG affects the susceptibility to rosiglitazone	17463185\|1907504
C089730	rosiglitazone	[PPARG protein co-treated with RXRA protein] promotes the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA]	16513826
C089730	rosiglitazone	PPARG protein promotes the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]	24155963
C089730	rosiglitazone	PPARG protein promotes the reaction [rosiglitazone results in increased expression of PPARGC1A mRNA]	16513826
C089730	rosiglitazone	Quercetin inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]	18262572
C089730	rosiglitazone	[rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG mRNA	29288687
C089730	rosiglitazone	[rosiglitazone affects the susceptibility to [INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone]] which results in increased expression of PPARG protein	29288687
C089730	rosiglitazone	rosiglitazone binds to and affects the localization of PPARG protein	15174093
C089730	rosiglitazone	rosiglitazone binds to and results in increased activity of PPARG protein	10871190\|1275805
C089730	rosiglitazone	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of GDF15 mRNA	20512989
C089730	rosiglitazone	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of GDF15 protein	20512989
C089730	rosiglitazone	rosiglitazone binds to and results in increased sumoylation of PPARG protein	22046279
C089730	rosiglitazone	[rosiglitazone co-treated with Ethanol] results in increased expression of PPARG mRNA	20007851
C089730	rosiglitazone	[rosiglitazone co-treated with TNFSF11 protein] results in increased expression of PPARG mRNA	22286232
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Bleomycin results in decreased expression of PPARG mRNA]	19147827
C089730	rosiglitazone	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Cholesterol] results in increased expression of PPARG mRNA]	18302760
C089730	rosiglitazone	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG mRNA]	18991162
C089730	rosiglitazone	rosiglitazone inhibits the reaction [[Dietary Fats co-treated with Choline deficiency co-treated with Methionine deficiency] results in decreased expression of PPARG protein]	18991162
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Ethanol results in decreased expression of PPARG mRNA]	22173916
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG mRNA]	21531777
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Oxygen deficiency results in decreased expression of PPARG protein]	21531777
C089730	rosiglitazone	rosiglitazone inhibits the reaction [resveratrol analog results in decreased expression of PPARG mRNA]	24779192
C089730	rosiglitazone	rosiglitazone promotes the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	26972250
C089730	rosiglitazone	rosiglitazone promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA]	28595985
C089730	rosiglitazone	rosiglitazone promotes the reaction [[PPARG protein binds to EDNRB promoter] which results in increased expression of EDNRB mRNA]	20516393
C089730	rosiglitazone	rosiglitazone promotes the reaction [PPARG protein binds to EGLN1 promoter]	24338020
C089730	rosiglitazone	rosiglitazone promotes the reaction [PPARG protein binds to EGLN3 promoter]	24338020
C089730	rosiglitazone	rosiglitazone promotes the reaction [PPARG protein results in increased expression of FABP4 mRNA]	10871190
C089730	rosiglitazone	rosiglitazone promotes the reaction [PPARG protein results in increased expression of SORBS1 mRNA]	10871190
C089730	rosiglitazone	"rosiglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein]"	17015710
C089730	rosiglitazone	rosiglitazone results in decreased expression of PPARG mRNA	18555852
C089730	rosiglitazone	rosiglitazone results in decreased expression of PPARG protein	18555852
C089730	rosiglitazone	rosiglitazone results in increased activity of PPARG protein	18555852\|1941712
C089730	rosiglitazone	[rosiglitazone results in increased activity of PPARG protein] inhibits the reaction [TNF protein results in increased expression of CXCL1 mRNA]	19417127
C089730	rosiglitazone	[rosiglitazone results in increased activity of PPARG protein] inhibits the reaction [TNF protein results in increased expression of ICAM1 mRNA]	19417127
C089730	rosiglitazone	[rosiglitazone results in increased activity of PPARG protein] inhibits the reaction [Triclosan results in decreased phosphorylation of AKT1 protein]	28973666
C089730	rosiglitazone	rosiglitazone results in increased activity of [RXRA protein binds to PPARG protein]	15997096
C089730	rosiglitazone	rosiglitazone results in increased degradation of and results in increased ubiquitination of PPARG protein	18555852
C089730	rosiglitazone	rosiglitazone results in increased expression of PPARG mRNA	18534569\|2000785
C089730	rosiglitazone	rosiglitazone results in increased expression of PPARG protein	20007851
C089730	rosiglitazone	T 0070907 inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]	24155963
C089730	rosiglitazone	[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]	16054899
C089730	rosiglitazone	Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]	16054899
C089730	rosiglitazone	Tungsten promotes the reaction [rosiglitazone results in increased expression of PPARG mRNA]	26865663
C089730	rosiglitazone	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG mRNA]]"	24612634
C089730	rosiglitazone	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG protein]]"	24612634
C089730	rosiglitazone	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] which results in decreased susceptibility to rosiglitazone	19732122
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]]	16617452
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]]	16617452
C089730	rosiglitazone	Cyclosporine inhibits the reaction [rosiglitazone results in increased expression of PPARG protein]	17461532
C089730	rosiglitazone	Indomethacin inhibits the reaction [rosiglitazone binds to and affects the activity of PPARG protein]	12897060
C089730	rosiglitazone	PPARG mRNA affects the susceptibility to rosiglitazone	20404217
C089730	rosiglitazone	PPARG mutant form inhibits the reaction [rosiglitazone inhibits the reaction [AGT protein results in increased expression of KLF5 protein]]	25874449
C089730	rosiglitazone	"PPARG mutant form inhibits the reaction [rosiglitazone inhibits the reaction [Pyruvaldehyde results in decreased uptake of 2-(N-(7-nitrobenz-2-oxa-1,3-diazol-4-yl)amino)-2-deoxyglucose]]"	23954466
C089730	rosiglitazone	PPARG mutant form inhibits the reaction [rosiglitazone inhibits the reaction [Pyruvaldehyde results in increased expression of IL1B protein]]	23954466
C089730	rosiglitazone	PPARG mutant form inhibits the reaction [rosiglitazone inhibits the reaction [Pyruvaldehyde results in increased expression of TNF protein]]	23954466
C089730	rosiglitazone	rosiglitazone affects the activity of PPARG protein	25596134
C089730	rosiglitazone	rosiglitazone binds to and results in increased activity of PPARG protein	15150131\|1673157
C089730	rosiglitazone	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of GFAP mRNA	18543250
C089730	rosiglitazone	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of MBP mRNA	18543250
C089730	rosiglitazone	[rosiglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of MOG mRNA	18543250
C089730	rosiglitazone	rosiglitazone binds to PPARG protein	15726020
C089730	rosiglitazone	[rosiglitazone co-treated with AGT protein] results in increased expression of PPARG protein	25874449
C089730	rosiglitazone	rosiglitazone inhibits the reaction [AGT protein results in decreased activity of PPARG protein]	25874449
C089730	rosiglitazone	rosiglitazone inhibits the reaction [AGT protein results in decreased expression of PPARG mRNA]	18278065
C089730	rosiglitazone	rosiglitazone inhibits the reaction [AGT protein results in decreased expression of PPARG protein]	18278065
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	12055599
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Cyclosporine results in decreased expression of PPARG mRNA]	17461532
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Cyclosporine results in decreased expression of PPARG protein]	17461532
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG mRNA]	16617452
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Oxygen results in decreased expression of PPARG protein]	16617452
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Palmitates results in increased expression of PPARG mRNA]	16620699
C089730	rosiglitazone	rosiglitazone inhibits the reaction [PPARG protein alternative form results in decreased activity of SLC2A4 promoter]	12777391
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Streptozocin results in decreased expression of PPARG]	24136780
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG mRNA]	24612634
C089730	rosiglitazone	rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG protein]	24612634
C089730	rosiglitazone	rosiglitazone promotes the reaction [AGT protein results in increased expression of PPARG mRNA]	25874449
C089730	rosiglitazone	rosiglitazone promotes the reaction [Fructose results in increased expression of PPARG mRNA]	19196556
C089730	rosiglitazone	rosiglitazone promotes the reaction [PPARG protein results in increased expression of PPARB protein]	18543250
C089730	rosiglitazone	rosiglitazone results in decreased expression of PPARG mRNA	21515302
C089730	rosiglitazone	rosiglitazone results in increased activity of PPARG protein	19103650\|2284258
C089730	rosiglitazone	rosiglitazone results in increased expression of PPARG mRNA	17461532\|2051955
C089730	rosiglitazone	rosiglitazone results in increased expression of PPARG protein	16344371\|1746153
C089730	rosiglitazone	[T 0070907 binds to PPARG protein] which results in decreased susceptibility to rosiglitazone	18455351
C089730	rosiglitazone	T 0070907 inhibits the reaction [[rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of MBP mRNA]	18543250
C089730	rosiglitazone	T 0070907 inhibits the reaction [rosiglitazone results in increased expression of PPARG protein]	18455351
C089730	rosiglitazone	rosiglitazone affects the reaction [IL6 protein affects the expression of PPARG mRNA]	20921996
C089730	rosiglitazone	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]"	27602593
C089730	rosiglitazone	"2,4,5,2',4',5'-hexachlorobiphenyl inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]"	27602593
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
C089730	rosiglitazone	bisphenol A inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
C089730	rosiglitazone	Dichlorodiphenyl Dichloroethylene inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
C089730	rosiglitazone	Endosulfan inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
C089730	rosiglitazone	hexabromocyclododecane inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
C089730	rosiglitazone	oxychlordane inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
C089730	rosiglitazone	[Polychlorinated Biphenyls analog co-treated with Dichlorodiphenyl Dichloroethylene analog] inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	27602593
C089730	rosiglitazone	"[Polychlorinated Biphenyls co-treated with Halogenated Diphenyl Ethers co-treated with Hydrocarbons, Chlorinated] inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]"	27602593
C089730	rosiglitazone	rosiglitazone results in increased activity of PPARG protein	27602593
C089730	rosiglitazone	rosiglitazone results in increased activity of PPARG protein	27894914
C089730	rosiglitazone	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [LEP protein inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]]	21352814
C089730	rosiglitazone	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]"	10636887
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]	24025786
C089730	rosiglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [rosiglitazone promotes the reaction [PPARG protein results in increased activity of INSIG1 promoter]]	15073165
C089730	rosiglitazone	fludarabine inhibits the reaction [LEP protein inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]]	21352814
C089730	rosiglitazone	LEP protein inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]	21352814
C089730	rosiglitazone	PD 068235 inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	11416043
C089730	rosiglitazone	resveratrol inhibits the reaction [rosiglitazone binds to PPARG protein]	24796862
C089730	rosiglitazone	rosiglitazone binds to and affects the activity of PPARG protein	12897060
C089730	rosiglitazone	rosiglitazone binds to and results in increased activity of PPARG protein	10393202\|1052936
C089730	rosiglitazone	rosiglitazone binds to PPARG protein	10813377\|1963225
C089730	rosiglitazone	rosiglitazone binds to [PPARG protein binds to RXRA protein]	10882139
C089730	rosiglitazone	[rosiglitazone binds to PPARG protein] which affects the localization of EP300 protein	10871190
C089730	rosiglitazone	[rosiglitazone binds to PPARG protein] which binds to RXRA protein	15715931
C089730	rosiglitazone	rosiglitazone inhibits the reaction [AGT protein results in decreased expression of PPARG mRNA]	19451898
C089730	rosiglitazone	rosiglitazone inhibits the reaction [AGT protein results in decreased expression of PPARG protein]	19451898
C089730	rosiglitazone	rosiglitazone promotes the reaction [PPARG protein results in increased activity of INSIG1 promoter]	15073165
C089730	rosiglitazone	rosiglitazone results in increased activity of PPARG protein	10799317\|1141604
C089730	rosiglitazone	rosiglitazone results in increased activity of [RXRA protein binds to PPARG protein]	11752099
C089730	rosiglitazone	rosiglitazone results in increased expression of PPARG	17614770
C089730	rosiglitazone	TLR4 mRNA affects the reaction [rosiglitazone inhibits the reaction [AGT protein results in increased expression of PPARG protein]]	19451898
C041376	rosmarinic acid	2-chloro-5-nitrobenzanilide inhibits the reaction [rosmarinic acid affects the expression of PPARG mRNA]	28744220
C041376	rosmarinic acid	2-chloro-5-nitrobenzanilide inhibits the reaction [rosmarinic acid affects the expression of PPARG protein]	28744220
C041376	rosmarinic acid	rosmarinic acid affects the expression of PPARG mRNA	28744220
C041376	rosmarinic acid	rosmarinic acid affects the expression of PPARG protein	28744220
C041376	rosmarinic acid	T 0070907 inhibits the reaction [rosmarinic acid affects the expression of PPARG mRNA]	28744220
C041376	rosmarinic acid	T 0070907 inhibits the reaction [rosmarinic acid affects the expression of PPARG protein]	28744220
D012402	Rotenone	[rosiglitazone co-treated with Rotenone] results in increased expression of PPARG protein	24374061
D012402	Rotenone	Rotenone results in decreased expression of PPARG mRNA	19693701
D012402	Rotenone	Rotenone results in decreased expression of PPARG protein	19693701
C085746	rottlerin	rottlerin inhibits the reaction [[ABL1 protein results in increased phosphorylation of and results in decreased activity of PPARG protein] which results in increased expression of COL1A1 protein]	17030193
C064116	S-(1,1,2,2-tetrafluoroethyl)cysteine	"S-(1,1,2,2-tetrafluoroethyl)cysteine results in increased expression of PPARG mRNA"	16678137
D012450	Safflower Oil	Safflower Oil results in increased expression of PPARG mRNA	15203375
D012450	Safflower Oil	Vitamin A inhibits the reaction [Safflower Oil results in increased expression of PPARG mRNA]	15203375
D020156	Salicylic Acid	Salicylic Acid inhibits the reaction [Palmitic Acid results in decreased expression of PPARG mRNA]	25108154
D000068299	Salmeterol Xinafoate	Salmeterol Xinafoate promotes the reaction [15-deoxyprostaglandin J2 promotes the reaction [NR3C1 protein binds to PPARG protein]]	15531761
C018381	salvin	salvin results in increased activity of PPARG protein	20696231
C546519	San-Ao decoction	San-Ao decoction results in increased activity of PPARG protein	19924040
D012503	Saponins	Saponins results in increased activity of PPARG protein	21889336
C528847	sargahydroquinoic acid	sargahydroquinoic acid results in increased expression of PPARG mRNA	25019995
C093642	SB 203580	[SB 203580 results in decreased activity of MAPK14 protein] inhibits the reaction [[octanoic acid co-treated with Dexamethasone] results in increased expression of PPARG protein alternative form]	14984747
C093642	SB 203580	SB 203580 results in decreased expression of PPARG mRNA	23603106
C093642	SB 203580	SB 203580 results in decreased expression of PPARG protein	23603106
C093642	SB 203580	SB 203580 inhibits the reaction [Ethanol results in decreased expression of PPARG protein]	24412557
C093642	SB 203580	SB 203580 results in increased expression of PPARG mRNA	24412557
C093642	SB 203580	SB 203580 results in increased expression of PPARG protein	24412557
D064586	Selenic Acid	Selenic Acid results in increased expression of PPARG mRNA	16443359
D012643	Selenium	"PPARG protein promotes the reaction [Selenium inhibits the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased expression of PTGS2 protein]]"	17439952
D012643	Selenium	"Selenium promotes the reaction [lipopolysaccharide, Escherichia coli O111 B4 results in increased activity of PPARG protein]"	17439952
C042431	S-ethyl glutathione	S-ethyl glutathione inhibits the reaction [Buthionine Sulfoximine results in increased expression of PPARG mRNA]	21520053
C040115	shogaol	shogaol results in increased activity of PPARG protein	18577375
D000068677	Sildenafil Citrate	"8-(4-chlorophenylthio)guanosine 3',5'-cyclic monophosphorothioate inhibits the reaction [Sildenafil Citrate results in increased expression of PPARG protein]"	20471953
D000068677	Sildenafil Citrate	Sildenafil Citrate results in increased expression of PPARG mRNA	20471953
D000068677	Sildenafil Citrate	Sildenafil Citrate results in increased expression of PPARG protein	20471953
D012822	Silicon Dioxide	Silicon Dioxide analog results in increased expression of PPARG mRNA	25895662
D012834	Silver	Silver analog results in decreased expression of PPARG mRNA	22727896
D012835	Silver Nitrate	Silver Nitrate results in increased expression of PPARG mRNA	22727896
C440975	silybin	silybin results in decreased expression of PPARG mRNA	25559859
C440975	silybin	silybin results in increased expression of PPARG protein	27746612
C440975	silybin	silybin inhibits the reaction [[1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of PPARG protein]	25559859
D012838	Silymarin	Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	28428136
D012838	Silymarin	Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG protein]	28428136
D012838	Silymarin	Silymarin inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG mRNA]	28428136
D012838	Silymarin	Silymarin inhibits the reaction [Lipopolysaccharides results in decreased expression of PPARG protein]	28428136
D012838	Silymarin	Silymarin inhibits the reaction [Carbon Tetrachloride results in decreased expression of PPARG mRNA]	24582681
D012838	Silymarin	"Silymarin inhibits the reaction [Drugs, Chinese Herbal results in decreased expression of PPARG mRNA]"	24582681
D019821	Simvastatin	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 mRNA]	15781755
D019821	Simvastatin	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [Simvastatin results in decreased expression of CCR2 protein]	15781755
D019821	Simvastatin	"Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG mRNA]"	20835264
D019821	Simvastatin	"Simvastatin inhibits the reaction [[Dietary Fats co-treated with Cholesterol, Dietary] results in decreased expression of PPARG protein]"	20835264
D019821	Simvastatin	Simvastatin results in decreased expression of PPARG	19216230
D020123	Sirolimus	Sirolimus affects the expression of PPARG protein	17016853
D020123	Sirolimus	[Sirolimus co-treated with Cyclosporine] results in decreased expression of PPARG protein	17016853
D020123	Sirolimus	[Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein	17016853
D020123	Sirolimus	Sirolimus results in decreased expression of PPARG mRNA	15358118
D012906	Smoke	Smoke results in increased expression of PPARG mRNA	21095227
D012964	Sodium	PPARG protein affects the abundance of Sodium	16007095
C009277	sodium arsenate	sodium arsenate analog results in decreased expression of PPARG mRNA	23221991
C009277	sodium arsenate	sodium arsenate analog results in decreased expression of PPARG mRNA	23221991
C017947	sodium arsenite	sodium arsenite results in decreased expression of PPARG mRNA	20308225
C017947	sodium arsenite	sodium arsenite results in decreased expression of PPARG mRNA	23221991
C017947	sodium arsenite	gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG mRNA]	22285432
C017947	sodium arsenite	gingerol inhibits the reaction [sodium arsenite results in decreased expression of PPARG protein]	22285432
C017947	sodium arsenite	sodium arsenite inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]	23152186
C017947	sodium arsenite	sodium arsenite inhibits the reaction [Dietary Fats results in increased expression of PPARG protein]	28283972
C017947	sodium arsenite	sodium arsenite inhibits the reaction [[INS1 protein co-treated with Dexamethasone] results in increased expression of PPARG mRNA]	11812925
C017947	sodium arsenite	sodium arsenite results in decreased expression of PPARG mRNA	21396911\|2228543
C017947	sodium arsenite	sodium arsenite results in decreased expression of PPARG protein	22285432
C017947	sodium arsenite	sodium arsenite results in increased expression of PPARG mRNA	26151952
C017947	sodium arsenite	sodium arsenite results in increased expression of PPARG protein	25367288
C017947	sodium arsenite	CR8 compound inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]	24481447
C017947	sodium arsenite	[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein]	24481447
C017947	sodium arsenite	[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] promotes the reaction [PPARG protein binds to GFAP promoter]	24481447
C017947	sodium arsenite	[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein	24481447
C017947	sodium arsenite	[[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein	24481447
C017947	sodium arsenite	T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of PPARG protein]	24481447
C017947	sodium arsenite	T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]	24481447
D012967	Sodium Dodecyl Sulfate	2-chloro-5-nitrobenzanilide inhibits the reaction [Sodium Dodecyl Sulfate binds to and results in increased activity of PPARG protein]	24025786
D012967	Sodium Dodecyl Sulfate	Sodium Dodecyl Sulfate binds to and results in increased activity of PPARG protein	24025786
C538809	sodium pentaborate	CTNNB1 protein promotes the reaction [sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]]	28285642
C538809	sodium pentaborate	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG mRNA]	28285642
C538809	sodium pentaborate	sodium pentaborate inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS protein] results in increased expression of PPARG protein]	28285642
D012980	Sodium Salicylate	Sodium Salicylate results in increased expression of PPARG mRNA	18560754
D018038	Sodium Selenite	Sodium Selenite inhibits the reaction [2-cresol results in increased expression of PPARG mRNA]	21705299
D018038	Sodium Selenite	Sodium Selenite results in increased expression of PPARG protein	24140496
D053260	Soot	PPARG protein affects the susceptibility to Soot	24464499
D053260	Soot	[Soot co-treated with Benzo(a)pyrene] results in decreased activity of PPARG protein	24464499
D053260	Soot	Soot results in decreased activity of PPARG protein	24464499
C018665	sorbitan monooleate	sorbitan monooleate binds to and results in increased activity of PPARG protein	27131391
C444426	splitomicin	splitomicin promotes the reaction [resveratrol results in decreased expression of PPARG mRNA]	23525482
C444426	splitomicin	splitomicin promotes the reaction [resveratrol results in decreased expression of PPARG protein]	23525482
C087130	SR 11237	PPARG protein promotes the reaction [ciglitazone promotes the reaction [SR 11237 results in increased expression of RARB protein]]	12839938
C031183	stearic acid	stearic acid inhibits the reaction [Hydrogen Peroxide results in decreased expression of PPARG protein]	17302992
C017725	stearoyl-coenzyme A	stearoyl-coenzyme A binds to and results in increased activity of PPARG protein	11139385
C012042	steviol	steviol affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA]	25554529
C012043	stevioside	stevioside affects the reaction [[LEP protein co-treated with LDLR protein] affects the expression of PPARG mRNA]	25554529
D013311	Streptozocin	[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA	27769711
D013311	Streptozocin	esculetin inhibits the reaction [[Dietary Fats co-treated with Streptozocin] results in increased expression of PPARG mRNA]	27769711
D013311	Streptozocin	Streptozocin results in decreased expression of PPARG protein	21381899
D013311	Streptozocin	Streptozocin results in increased expression of PPARG mRNA	23319174
D013311	Streptozocin	telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]	21381899
D013311	Streptozocin	2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]	24954035
D013311	Streptozocin	Bezafibrate inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]	12967931
D013311	Streptozocin	esculetin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]	21450970
D013311	Streptozocin	esculetin inhibits the reaction [Streptozocin results in increased expression of PPARG protein]	21450970
D013311	Streptozocin	Ficusin inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]	27350165
D013311	Streptozocin	Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]	29223569
D013311	Streptozocin	Glyburide inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]	29223569
D013311	Streptozocin	Hesperidin inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]]	24954035
D013311	Streptozocin	Hesperidin inhibits the reaction [[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein]	24954035
D013311	Streptozocin	INS protein promotes the reaction [Streptozocin results in increased expression of PPARG mRNA]	20219977
D013311	Streptozocin	mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]	29223569
D013311	Streptozocin	mangiferin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]	29223569
D013311	Streptozocin	naringenin inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]	29223569
D013311	Streptozocin	naringenin inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]	29223569
D013311	Streptozocin	Olive Oil inhibits the reaction [Streptozocin results in decreased expression of PPARG mRNA]	25246140
D013311	Streptozocin	pioglitazone inhibits the reaction [[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA]	27350165
D013311	Streptozocin	rosiglitazone inhibits the reaction [Streptozocin results in decreased expression of PPARG]	24136780
D013311	Streptozocin	[Streptozocin co-treated with Dietary Fats] results in decreased expression of PPARG mRNA	27350165
D013311	Streptozocin	[Streptozocin co-treated with Isoproterenol] affects the expression of PPARG protein	24954035
D013311	Streptozocin	Streptozocin results in decreased expression of PPARG	24136780
D013311	Streptozocin	Streptozocin results in decreased expression of PPARG mRNA	12967931\|2524614
D013311	Streptozocin	Streptozocin results in decreased expression of PPARG protein	16980342\|2145097
D013311	Streptozocin	Streptozocin results in increased expression of PPARG mRNA	20219977
D013311	Streptozocin	Streptozocin results in increased expression of PPARG protein	21450970
D004113	Succimer	[Succimer co-treated with Magnetite Nanoparticles] results in decreased expression of PPARG mRNA	26378955
D013395	Sucrose	Atrazine promotes the reaction [[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA]	24440342
D013395	Sucrose	[lard co-treated with Cholesterol co-treated with Sucrose] results in increased expression of PPARG mRNA	24440342
D012460	Sulfasalazine	Sulfasalazine results in increased expression of PPARG mRNA	19365232
C016766	sulforafan	sulforafan results in increased expression of PPARG mRNA	26833863
D013458	Sulfur Dioxide	glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein]	26209559
D013458	Sulfur Dioxide	JZL 184 inhibits the reaction [Sulfur Dioxide results in decreased expression of PPARG protein]	26209559
D013458	Sulfur Dioxide	PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased expression of PTGS2 protein]]	26209559
D013458	Sulfur Dioxide	PPARG protein affects the reaction [glyceryl 2-arachidonate inhibits the reaction [Sulfur Dioxide results in increased phosphorylation of RELA protein]]	26209559
D013458	Sulfur Dioxide	Sulfur Dioxide results in decreased expression of PPARG protein	26209559
C025462	sulindac sulfide	PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP1 protein]	18665581
C025462	sulindac sulfide	PPARG protein affects the reaction [sulindac sulfide analog results in increased expression of FABP4 protein]	18665581
C025462	sulindac sulfide	PPARG protein promotes the reaction [sulindac sulfide results in increased expression of CDKN1A mRNA]	16091736
C025462	sulindac sulfide	sulindac sulfide analog binds to and results in increased activity of PPARG protein	17602619
C025462	sulindac sulfide	sulindac sulfide analog binds to PPARG protein	18665581
C025462	sulindac sulfide	sulindac sulfide analog inhibits the reaction [troglitazone binds to PPARG protein]	18665581
C025462	sulindac sulfide	sulindac sulfide binds to and results in increased activity of PPARG protein	16091736
C025462	sulindac sulfide	sulindac sulfide results in increased activity of PPARG protein	10866999
C025462	sulindac sulfide	[sulindac sulfide results in increased activity of PPARG protein] which results in increased expression of PTGS2 protein	10866999
C025462	sulindac sulfide	sulindac sulfide results in increased expression of PPARG mRNA	11948457
C025463	sulindac sulfone	PPARG protein promotes the reaction [sulindac sulfone results in increased expression of SAT1 mRNA]	14506281
C025463	sulindac sulfone	[sulindac sulfone results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to SAT1 enhancer]	14506281
C025463	sulindac sulfone	sulindac sulfone results in increased expression of PPARG mRNA	11948457
C458508	T 0070907	T 0070907 inhibits the reaction [glyceryl 2-arachidonate metabolite results in increased expression of PPARG mRNA]	21511917
C458508	T 0070907	T 0070907 inhibits the reaction [rosiglitazone results in increased expression of PPARG mRNA]	21354099
C458508	T 0070907	T 0070907 promotes the reaction [Arsenic results in decreased expression of PPARG protein]	23108036
C458508	T 0070907	T 0070907 results in decreased activity of PPARG protein	23108036
C458508	T 0070907	T 0070907 binds to and results in decreased activity of PPARG protein	24155963
C458508	T 0070907	T 0070907 inhibits the reaction [[[INS protein co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone] co-treated with bisphenol A] results in increased activity of PPARG protein]	26944108
C458508	T 0070907	T 0070907 inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]	24155963
C458508	T 0070907	T 0070907 inhibits the reaction [tributyltin binds to and results in increased activity of PPARG protein]	24155963
C458508	T 0070907	[T 0070907 results in decreased activity of PPARG protein] which results in decreased expression of ERO1L mRNA	17452443
C458508	T 0070907	T 0070907 binds to and results in decreased activity of PPARG protein	18543250
C458508	T 0070907	[T 0070907 binds to PPARG protein] which results in decreased susceptibility to rosiglitazone	18455351
C458508	T 0070907	T 0070907 inhibits the reaction [pioglitazone affects the expression of PPARG mRNA]	28744220
C458508	T 0070907	T 0070907 inhibits the reaction [pioglitazone affects the expression of PPARG protein]	28744220
C458508	T 0070907	T 0070907 inhibits the reaction [[rosiglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of MBP mRNA]	18543250
C458508	T 0070907	T 0070907 inhibits the reaction [rosiglitazone results in increased expression of PPARG protein]	18455351
C458508	T 0070907	T 0070907 inhibits the reaction [rosmarinic acid affects the expression of PPARG mRNA]	28744220
C458508	T 0070907	T 0070907 inhibits the reaction [rosmarinic acid affects the expression of PPARG protein]	28744220
C458508	T 0070907	T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in decreased expression of PPARG protein]	24481447
C458508	T 0070907	T 0070907 inhibits the reaction [[sodium arsenite co-treated with lead acetate co-treated with Cadmium Chloride] results in increased phosphorylation of PPARG protein]	24481447
C458508	T 0070907	T 0070907 binds to and results in decreased activity of PPARG protein	16091293\|1932178
C458508	T 0070907	T 0070907 binds to and results in increased activity of PPARG protein	21067863
D013605	T-2 Toxin	T-2 Toxin results in increased expression of PPARG mRNA	26141394
D016559	Tacrolimus	[Sirolimus co-treated with Tacrolimus] results in increased expression of PPARG protein	17016853
C013698	tallow	tallow affects the expression of PPARG mRNA	19680557
D013629	Tamoxifen	Tamoxifen inhibits the reaction [PPARG protein binds to CD36 promoter]	27358406
D013629	Tamoxifen	Tamoxifen inhibits the reaction [PPARG protein results in increased expression of CD36 mRNA]	27358406
D013629	Tamoxifen	Tamoxifen results in decreased expression of and results in increased phosphorylation of PPARG protein	27358406
D013629	Tamoxifen	PPARG mRNA promotes the reaction [Tamoxifen inhibits the reaction [Buthionine Sulfoximine results in increased expression of CD36 protein]]	27358406
D013629	Tamoxifen	PPARG mRNA promotes the reaction [Tamoxifen results in decreased expression of CD36 mRNA]	27358406
D013629	Tamoxifen	PPARG mRNA promotes the reaction [Tamoxifen results in decreased expression of CD36 protein]	27358406
D013629	Tamoxifen	Tamoxifen results in decreased expression of PPARG protein	27358406
D013629	Tamoxifen	Tamoxifen results in increased expression of PPARG mRNA	25123088
C021751	tanshinone	tanshinone results in decreased expression of PPARG mRNA	20854809
C084178	telmisartan	PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of NFKBIA mRNA]]	22124178
C084178	telmisartan	PPARG mutant form inhibits the reaction [telmisartan inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]	22124178
C084178	telmisartan	PPARG mutant form inhibits the reaction [telmisartan results in increased expression of ABCG1 mRNA]	22124178
C084178	telmisartan	PPARG mutant form inhibits the reaction [telmisartan results in increased expression of CD36 mRNA]	22124178
C084178	telmisartan	PPARG protein promotes the reaction [telmisartan inhibits the reaction [CXCL12 protein affects the localization of ICAM3 protein]]	18158351
C084178	telmisartan	telmisartan results in increased activity of PPARG protein	22124178
C084178	telmisartan	telmisartan inhibits the reaction [Streptozocin results in decreased expression of PPARG protein]	21381899
C084178	telmisartan	telmisartan results in increased expression of PPARG protein	20176998
C084178	telmisartan	telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]	24831514
C084178	telmisartan	telmisartan promotes the reaction [Daunorubicin results in increased expression of PPARG protein]	20888384
C084178	telmisartan	telmisartan binds to and affects the activity of PPARG protein	20888384
C084178	telmisartan	telmisartan results in increased activity of PPARG protein	22253423
C084178	telmisartan	telmisartan results in increased expression of PPARG protein	20307515
D000068698	Tenofovir	Tenofovir affects the expression of PPARG mRNA	20032539
C046393	tert-butylphenyl diphenyl phosphate	tert-butylphenyl diphenyl phosphate results in increased activity of PPARG protein	26172262
C501413	tesaglitazar	tesaglitazar binds to and results in increased activity of PPARG protein	17610302
C501413	tesaglitazar	tesaglitazar results in increased activity of PPARG protein	12401884
C501413	tesaglitazar	tesaglitazar results in increased activity of PPARG protein	12401884
C501413	tesaglitazar	tesaglitazar affects the expression of PPARG mRNA	21270424
C501413	tesaglitazar	tesaglitazar affects the activity of PPARG protein	16168052
C501413	tesaglitazar	tesaglitazar binds to and results in increased activity of PPARG protein	12401884\|1746818
D013739	Testosterone	Testosterone results in decreased expression of PPARG mRNA	21632903
D013739	Testosterone	Testosterone results in decreased expression of PPARG mRNA	12960001\|2084415
D013739	Testosterone	Testosterone results in decreased expression of PPARG protein	12960001
D013739	Testosterone	Testosterone affects the expression of PPARG mRNA	20843997
C020806	tetrabromobisphenol A	tetrabromobisphenol A binds to and results in increased activity of PPARG protein	21561829
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in increased activity of PPARG protein	24591153
C020806	tetrabromobisphenol A	tetrabromobisphenol A binds to and results in increased activity of PPARG protein	21561829\|2162294
C020806	tetrabromobisphenol A	tetrabromobisphenol A binds to PPARG protein	25314719
C020806	tetrabromobisphenol A	tetrabromobisphenol A metabolite binds to and results in increased activity of PPARG protein	21622942
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in increased activity of PPARG protein	24591153\|2828212
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in increased activity of PPARG protein	25777084\|2586318
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in increased expression of PPARG mRNA	25863188
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in decreased expression of PPARG mRNA	26988606
C020806	tetrabromobisphenol A	tetrabromobisphenol A results in increased activity of PPARG protein	27602593
C020806	tetrabromobisphenol A	tetrabromobisphenol A binds to and results in increased activity of PPARG protein	21561829
C020806	tetrabromobisphenol A	tetrabromobisphenol A binds to PPARG protein	23959441
C102881	tetrabutyltin	tetrabutyltin binds to and results in increased activity of PPARG protein	19497422
C102881	tetrabutyltin	tetrabutyltin inhibits the reaction [rosiglitazone binds to PPARG protein]	19497422
C102881	tetrabutyltin	tetrabutyltin inhibits the reaction [triphenyltin chloride binds to PPARG protein]	19497422
C041181	tetrachlorodian	tetrachlorodian binds to and results in increased activity of PPARG protein	21561829
C041181	tetrachlorodian	tetrachlorodian results in increased activity of PPARG protein	24591153
C041181	tetrachlorodian	tetrachlorodian analog results in increased activity of PPARG protein	28282128
C041181	tetrachlorodian	tetrachlorodian binds to and results in increased activity of PPARG protein	21561829
C041181	tetrachlorodian	tetrachlorodian binds to PPARG protein	25314719
C041181	tetrachlorodian	tetrachlorodian metabolite binds to and results in increased activity of PPARG protein	21622942
C041181	tetrachlorodian	tetrachlorodian results in increased activity of PPARG protein	24591153\|2617226
C041181	tetrachlorodian	tetrachlorodian binds to PPARG protein	23959441
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA	18336851
D013749	Tetrachlorodibenzodioxin	[Estradiol co-treated with Tetrachlorodibenzodioxin] results in increased expression of PPARG mRNA	19619570
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA	19619570\|2010694
D013749	Tetrachlorodibenzodioxin	2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]	12758056\|1505041
D013749	Tetrachlorodibenzodioxin	3'-methoxy-4'-nitroflavone inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]	15050417
D013749	Tetrachlorodibenzodioxin	AG 1879 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
D013749	Tetrachlorodibenzodioxin	Arachidonic Acid promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA]	19063610
D013749	Tetrachlorodibenzodioxin	arachidonyltrifluoromethane inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA]	19063610
D013749	Tetrachlorodibenzodioxin	Dietary Fats promotes the reaction [Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA]	27713108
D013749	Tetrachlorodibenzodioxin	EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]	16971554
D013749	Tetrachlorodibenzodioxin	MAP2K1 protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]	12758056
D013749	Tetrachlorodibenzodioxin	MAPK1 protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]	12758056
D013749	Tetrachlorodibenzodioxin	MAPK3 protein promotes the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]	12758056
D013749	Tetrachlorodibenzodioxin	methyl-beta-cyclodextrin inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
D013749	Tetrachlorodibenzodioxin	[NFE2L2 gene mutant form results in increased susceptibility to Tetrachlorodibenzodioxin] which results in decreased expression of PPARG mRNA	21846477
D013749	Tetrachlorodibenzodioxin	SRC protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]]	14505802
D013749	Tetrachlorodibenzodioxin	[Tetrachlorodibenzodioxin co-treated with EGF protein] inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]	16054899
D013749	Tetrachlorodibenzodioxin	[Tetrachlorodibenzodioxin co-treated with EGF protein] results in decreased expression of PPARG mRNA	16054899
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin inhibits the reaction [[Ascorbic Acid co-treated with beta-glycerophosphoric acid] results in increased expression of PPARG mRNA]	14505802
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]	16971554
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with rosiglitazone co-treated with 1-Methyl-3-isobutylxanthine co-treated with INS1 protein] results in increased expression of PPARG mRNA]	16054899
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin promotes the reaction [Dietary Fats results in increased expression of PPARG mRNA]	27713108
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of PPARG mRNA	12758056\|1505041
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in decreased expression of PPARG protein	12758056\|1505041
D013749	Tetrachlorodibenzodioxin	Tetrachlorodibenzodioxin results in increased expression of PPARG mRNA	24058054\|2771310
D013749	Tetrachlorodibenzodioxin	U 0126 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
D013749	Tetrachlorodibenzodioxin	U 0126 inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]	12758056
D013755	Tetradecanoylphorbol Acetate	[2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased activity of MAP2K1 protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]	16945329
D013755	Tetradecanoylphorbol Acetate	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of troglitazone]	16945329
D013755	Tetradecanoylphorbol Acetate	Acetylcysteine inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]	16945329
D013755	Tetradecanoylphorbol Acetate	bisindolylmaleimide I inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]	16945329
D013755	Tetradecanoylphorbol Acetate	MAP2K1 protein affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]	16945329
D013755	Tetradecanoylphorbol Acetate	Reactive Oxygen Species affects the reaction [Tetradecanoylphorbol Acetate results in increased expression of PPARG protein]	16945329
D013755	Tetradecanoylphorbol Acetate	[Tetradecanoylphorbol Acetate co-treated with Calcium Ionophores] affects the expression of PPARG mRNA	21511917
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased activity of PPARG protein	15707588
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased expression of PPARG mRNA	12044893\|1694532
D013755	Tetradecanoylphorbol Acetate	Tetradecanoylphorbol Acetate results in increased expression of PPARG protein	16945329
D013755	Tetradecanoylphorbol Acetate	[Tetradecanoylphorbol Acetate results in increased expression of PPARG] which affects the susceptibility to troglitazone	16945329
C410666	tetradecylselenoacetic acid	tetradecylselenoacetic acid results in increased activity of PPARG protein	17185614
C017953	tetramethylpyrazine	tetramethylpyrazine results in increased expression of PPARG mRNA	28034800
C017953	tetramethylpyrazine	tetramethylpyrazine inhibits the reaction [Oxazolone results in increased expression of PPARG protein]	22200888
C017953	tetramethylpyrazine	tetramethylpyrazine results in increased expression of PPARG protein	23022513
D013806	Theophylline	Theophylline results in increased expression of PPARG mRNA	16569937
D013806	Theophylline	Theophylline results in increased expression of PPARG protein	16569937
D045162	Thiazolidinediones	PPARG protein promotes the reaction [Thiazolidinediones results in increased abundance of Lipids]	20079722
D045162	Thiazolidinediones	Thiazolidinediones results in increased expression of PPARG mRNA	21870829
D045162	Thiazolidinediones	Thiazolidinediones binds to and results in increased activity of PPARG protein	19248225
D045162	Thiazolidinediones	[Thiazolidinediones binds to and results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides	19248225
D045162	Thiazolidinediones	Thiazolidinediones binds to and results in increased activity of PPARG protein	15824748
D045162	Thiazolidinediones	Thiazolidinediones binds to PPARG protein	12163127\|1749971
D053778	Thiazolidines	Thiazolidines binds to and results in increased activity of PPARG protein	20540935
D013853	Thioacetamide	Thioacetamide results in increased expression of PPARG mRNA	23411599
D008063	Thioctic Acid	[Thioctic Acid co-treated with Dietary Fats] results in increased expression of PPARG mRNA	22464149
D013864	Thioglycolates	Thioglycolates results in increased expression of PPARG protein	24163073
D013974	Thyroxine	Thyroxine inhibits the reaction [Triclosan results in decreased expression of PPARG protein]	28973666
D013974	Thyroxine	Thyroxine results in increased expression of PPARG mRNA	17403546
C003466	thymoquinone	PRKAA1 protein promotes the reaction [thymoquinone results in increased expression of PPARG protein]	27688165
C003466	thymoquinone	thymoquinone inhibits the reaction [TGFB1 protein results in decreased expression of PPARG protein]	27688165
C003466	thymoquinone	thymoquinone results in increased expression of PPARG protein	27688165
C009495	titanium dioxide	titanium dioxide results in decreased expression of PPARG mRNA	23557971
C009495	titanium dioxide	titanium dioxide results in decreased expression of PPARG protein	28646487
C423915	TO-901317	TO-901317 affects the expression of PPARG mRNA	28903485
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in decreased expression of PPARG protein	24188201
D014028	Tobacco Smoke Pollution	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG mRNA]]"	24612634
D014028	Tobacco Smoke Pollution	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG protein]]"	24612634
D014028	Tobacco Smoke Pollution	rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG mRNA]	24612634
D014028	Tobacco Smoke Pollution	rosiglitazone inhibits the reaction [Tobacco Smoke Pollution results in decreased expression of PPARG protein]	24612634
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in decreased expression of PPARG mRNA	24188201\|2461263
D014028	Tobacco Smoke Pollution	Tobacco Smoke Pollution results in decreased expression of PPARG protein	24188201\|2461263
D014051	Toluene 2,4-Diisocyanate	"pioglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein]"	17015710
D014051	Toluene 2,4-Diisocyanate	"PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL11 protein]"	17015710
D014051	Toluene 2,4-Diisocyanate	"PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of CCL5 protein]"	17015710
D014051	Toluene 2,4-Diisocyanate	"PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of ICAM1 protein]"	17015710
D014051	Toluene 2,4-Diisocyanate	"PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL13 protein]"	17015710
D014051	Toluene 2,4-Diisocyanate	"PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL4 protein]"	17015710
D014051	Toluene 2,4-Diisocyanate	"PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of IL5 protein]"	17015710
D014051	Toluene 2,4-Diisocyanate	"PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of TGFB1 protein]"	17015710
D014051	Toluene 2,4-Diisocyanate	"PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased expression of VCAM1 protein]"	17015710
D014051	Toluene 2,4-Diisocyanate	"PPARG protein affects the reaction [Toluene 2,4-Diisocyanate results in increased localization of RELA protein]"	17015710
D014051	Toluene 2,4-Diisocyanate	"rosiglitazone promotes the reaction [Toluene 2,4-Diisocyanate results in increased localization of PPARG protein]"	17015710
D014051	Toluene 2,4-Diisocyanate	"Toluene 2,4-Diisocyanate results in increased localization of PPARG protein"	17015710
D019772	Topotecan	[oxaliplatin co-treated with Topotecan] results in decreased expression of PPARG mRNA	25729387
D019772	Topotecan	Topotecan affects the expression of PPARG mRNA	25729387
C483909	torcetrapib	2-acetylphenothiazine inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA]	25617244
C483909	torcetrapib	GKT137831 inhibits the reaction [torcetrapib results in increased expression of PPARG mRNA]	25617244
C483909	torcetrapib	torcetrapib results in increased expression of PPARG mRNA	25617244
C496197	trans-10,cis-12-conjugated linoleic acid	"trans-10,cis-12-conjugated linoleic acid results in increased expression of PPARG mRNA"	17951470
C496197	trans-10,cis-12-conjugated linoleic acid	"trans-10,cis-12-conjugated linoleic acid results in decreased expression of PPARG mRNA"	15888570
C496197	trans-10,cis-12-conjugated linoleic acid	"trans-10,cis-12-conjugated linoleic acid results in increased expression of PPARG mRNA"	17217567
C495469	trans-3-(4'-hydroxyphenyl)-2-propenoic acid	trans-3-(4'-hydroxyphenyl)-2-propenoic acid results in decreased expression of PPARG protein	23810795
C495469	trans-3-(4'-hydroxyphenyl)-2-propenoic acid	trans-3-(4'-hydroxyphenyl)-2-propenoic acid results in increased expression of PPARG mRNA	21870829
D014212	Tretinoin	[PPARG protein results in increased expression of ALDH1A2 protein] which results in increased chemical synthesis of Tretinoin	16982809
D014212	Tretinoin	[PPARG protein results in increased expression of RDH10 protein] which results in increased chemical synthesis of Tretinoin	16982809
D014212	Tretinoin	[rosiglitazone results in increased activity of PPARG protein] which results in increased abundance of Tretinoin	16982809
D014212	Tretinoin	Tretinoin results in increased expression of PPARG mRNA	21934132\|2372400
D014212	Tretinoin	Tretinoin results in decreased expression of PPARG mRNA	11237167
D014212	Tretinoin	Tretinoin results in increased expression of PPARG mRNA	17198874
D014212	Tretinoin	Tretinoin results in increased expression of PPARG mRNA	14568882
D014212	Tretinoin	Tretinoin results in increased expression of PPARG protein	14568882
C533760	tribromodiphenyl ether 28	tribromodiphenyl ether 28 results in increased activity of PPARG protein	27602593
C009524	tributyl phosphate	tributyl phosphate binds to PPARG protein	25314719
C009524	tributyl phosphate	tributyl phosphate results in increased activity of PPARG protein	26172262\|2828212
C011559	tributyltin	tributyltin binds to and results in increased activity of PPARG protein	19497422\|2415596
C011559	tributyltin	tributyltin binds to PPARG protein	25314719
C011559	tributyltin	tributyltin inhibits the reaction [rosiglitazone binds to PPARG protein]	19497422
C011559	tributyltin	tributyltin inhibits the reaction [triphenyltin chloride binds to PPARG protein]	19497422
C011559	tributyltin	tributyltin results in increased activity of PPARG protein	21622945\|2617226
C011559	tributyltin	tributyltin results in increased expression of PPARG mRNA	26961604
C011559	tributyltin	PPARG protein promotes the reaction [tributyltin binds to and results in increased activity of PPARG protein]	24155963
C011559	tributyltin	T 0070907 inhibits the reaction [tributyltin binds to and results in increased activity of PPARG protein]	24155963
C011559	tributyltin	tributyltin binds to and results in increased activity of PPARG protein	24155963
C011559	tributyltin	tributyltin promotes the reaction [[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG mRNA alternative form]	22197818
C011559	tributyltin	tributyltin results in increased activity of PPARG protein	25777084
C011559	tributyltin	tributyltin results in increased expression of PPARG mRNA	23322813\|2451344
C011559	tributyltin	tributyltin results in increased expression of PPARG protein	21622945
C011559	tributyltin	tributyltin results in increased expression of PPARG protein	25819109
C011559	tributyltin	Colforsin promotes the reaction [tributyltin results in decreased expression of PPARG mRNA]	20211155
C011559	tributyltin	tributyltin results in decreased expression of PPARG mRNA	20211155
C011559	tributyltin	tributyltin results in increased expression of PPARG mRNA	20211155
C011559	tributyltin	tributyltin results in increased activity of PPARG protein	24513447
D014241	Trichloroethylene	PPARA protein inhibits the reaction [Trichloroethylene results in increased expression of PPARG mRNA]	20709644
D014241	Trichloroethylene	Trichloroethylene results in increased expression of PPARG mRNA	20709644
D014260	Triclosan	Triclosan binds to PPARG protein	25314719
D014260	Triclosan	[rosiglitazone results in increased activity of PPARG protein] inhibits the reaction [Triclosan results in decreased phosphorylation of AKT1 protein]	28973666
D014260	Triclosan	Thyroxine inhibits the reaction [Triclosan results in decreased expression of PPARG protein]	28973666
D014260	Triclosan	Triclosan results in decreased expression of PPARG mRNA	15707987
D014260	Triclosan	Triclosan results in decreased expression of PPARG protein	28973666
C053549	triflumizol	triflumizol results in increased activity of PPARG protein	20143881
C053549	triflumizol	triflumizol results in increased activity of PPARG protein	23086663
C053549	triflumizol	triflumizol results in increased expression of PPARG mRNA	23086663
D014280	Triglycerides	[pioglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [Dietary Fats results in increased abundance of Triglycerides]	19403437
D014280	Triglycerides	[pioglitazone results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides	19439812
D014280	Triglycerides	[Thiazolidinediones binds to and results in increased activity of PPARG protein] which results in decreased abundance of Triglycerides	19248225
D014280	Triglycerides	[[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides	19248225
D014302	Trinitrobenzenesulfonic Acid	Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA	21829567
D014302	Trinitrobenzenesulfonic Acid	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]	16782535
D014302	Trinitrobenzenesulfonic Acid	Curcumin inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]	16782535
D014302	Trinitrobenzenesulfonic Acid	Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]	16782535
D014302	Trinitrobenzenesulfonic Acid	Dexamethasone inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein]	16782535
D014302	Trinitrobenzenesulfonic Acid	telmisartan inhibits the reaction [Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA]	24831514
D014302	Trinitrobenzenesulfonic Acid	Trinitrobenzenesulfonic Acid results in decreased expression of PPARG mRNA	16782535\|2483151
D014302	Trinitrobenzenesulfonic Acid	Trinitrobenzenesulfonic Acid results in decreased expression of PPARG protein	16782535\|1961764
C000613766	triphenylarsine	triphenylarsine inhibits the reaction [rosiglitazone binds to PPARG protein]	27725436
C076672	triphenyl bismuth	triphenyl bismuth inhibits the reaction [rosiglitazone binds to PPARG protein]	27725436
C005445	triphenyl phosphate	triphenyl phosphate results in increased expression of PPARG mRNA	23306105
C005445	triphenyl phosphate	PPARG protein affects the reaction [triphenyl phosphate results in increased expression of HSD3B1 mRNA]	28282128
C005445	triphenyl phosphate	triphenyl phosphate binds to PPARG protein	25062436\|2531471
C005445	triphenyl phosphate	triphenyl phosphate metabolite binds to PPARG protein	25314719
C005445	triphenyl phosphate	triphenyl phosphate results in increased activity of PPARG protein	26172262\|2828212
C005445	triphenyl phosphate	triphenyl phosphate results in increased expression of PPARG mRNA	25062436\|2893409
C005445	triphenyl phosphate	triphenyl phosphate results in increased expression of PPARG mRNA	28163246
C005445	triphenyl phosphate	"[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of PPARG mRNA"	29112739
C013318	triphenyl phosphite	triphenyl phosphite affects the activity of PPARG protein	26172262
C030665	triphenyltin	triphenyltin binds to and results in increased activity of PPARG protein	24786373
C030665	triphenyltin	triphenyltin binds to PPARG protein	25314719\|2772543
C030665	triphenyltin	triphenyltin results in increased activity of PPARG protein	25777084
C030665	triphenyltin	triphenyltin results in decreased expression of PPARG mRNA	24177218
C030665	triphenyltin	triphenyltin results in decreased expression of PPARG mRNA	27894914
C012594	triphenyltin chloride	diphenyltin chloride inhibits the reaction [triphenyltin chloride binds to PPARG protein]	19497422
C012594	triphenyltin chloride	tetrabutyltin inhibits the reaction [triphenyltin chloride binds to PPARG protein]	19497422
C012594	triphenyltin chloride	tributyltin inhibits the reaction [triphenyltin chloride binds to PPARG protein]	19497422
C012594	triphenyltin chloride	triphenyltin chloride binds to and results in increased activity of PPARG protein	19497422
C012594	triphenyltin chloride	triphenyltin chloride inhibits the reaction [rosiglitazone binds to PPARG protein]	19497422
C012594	triphenyltin chloride	triphenyltin chloride results in increased activity of PPARG protein	26172262
C050414	tripterine	tripterine affects the expression of PPARG mRNA	27085773
C050414	tripterine	tripterine affects the expression of PPARG protein	27085773
C016805	tris(1,3-dichloro-2-propyl)phosphate	"tris(1,3-dichloro-2-propyl)phosphate results in increased expression of PPARG mRNA"	26179874
C016805	tris(1,3-dichloro-2-propyl)phosphate	"[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of PPARG mRNA"	29112739
C013320	tris(2-butoxyethyl) phosphate	tris(2-butoxyethyl) phosphate binds to PPARG protein	25314719
C013320	tris(2-butoxyethyl) phosphate	tris(2-butoxyethyl) phosphate results in decreased expression of PPARG mRNA	27484134
C013320	tris(2-butoxyethyl) phosphate	tris(2-butoxyethyl) phosphate results in decreased expression of PPARG protein	27484134
C031324	tris(chloroethyl)phosphate	tris(chloroethyl)phosphate results in increased expression of PPARG mRNA	27776230
C031324	tris(chloroethyl)phosphate	tris(chloroethyl)phosphate results in decreased expression of PPARG mRNA	27484134
C031324	tris(chloroethyl)phosphate	tris(chloroethyl)phosphate results in decreased expression of PPARG protein	27484134
D014317	Tritolyl Phosphates	"[tris(1,3-dichloro-2-propyl)phosphate co-treated with triphenyl phosphate co-treated with Tritolyl Phosphates] results in increased expression of PPARG mRNA"	29112739
C057693	troglitazone	troglitazone promotes the reaction [PPARG protein binds to ASS1 promoter]	18375203
C057693	troglitazone	troglitazone promotes the reaction [[PPARG protein binds to ASS1 promoter] which results in increased expression of ASS1 mRNA]	18375203
C057693	troglitazone	[1-Methyl-3-isobutylxanthine co-treated with troglitazone co-treated with INS protein] results in increased expression of PPARG mRNA	27003841
C057693	troglitazone	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [PPARG protein results in increased susceptibility to troglitazone]"	12824901
C057693	troglitazone	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [troglitazone affects the localization of CYCS protein]	22108328
C057693	troglitazone	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [troglitazone results in increased abundance of Reactive Oxygen Species]	22108328
C057693	troglitazone	[2-chloro-5-nitrobenzanilide binds to and results in decreased activity of PPARG protein] inhibits the reaction [troglitazone results in increased expression of PRODH]	22108328
C057693	troglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [troglitazone results in increased activity of PPARG protein]	15345676\|2396492
C057693	troglitazone	[2-chloro-5-nitrobenzanilide results in decreased activity of PPARG protein] inhibits the reaction [Tetradecanoylphorbol Acetate results in increased activity of troglitazone]	16945329
C057693	troglitazone	PPARG gene SNP affects the susceptibility to troglitazone	16249460
C057693	troglitazone	PPARG mutant form inhibits the reaction [troglitazone results in increased expression of VEGFA protein]	15705899
C057693	troglitazone	PPARG protein affects the reaction [troglitazone results in decreased expression of SPP1 mRNA]	11426586
C057693	troglitazone	PPARG protein affects the reaction [troglitazone results in increased expression of ICAM1 mRNA]	11401521
C057693	troglitazone	PPARG protein promotes the reaction [troglitazone results in decreased expression of FN1 protein]	15908479
C057693	troglitazone	PPARG protein promotes the reaction [troglitazone results in increased activity of DIO2 protein]	19036883
C057693	troglitazone	PPARG protein results in increased susceptibility to troglitazone	12824901
C057693	troglitazone	Pravastatin inhibits the reaction [[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol]	12044893
C057693	troglitazone	sulindac sulfide analog inhibits the reaction [troglitazone binds to PPARG protein]	18665581
C057693	troglitazone	[Tetradecanoylphorbol Acetate results in increased expression of PPARG] which affects the susceptibility to troglitazone	16945329
C057693	troglitazone	troglitazone analog binds to PPARG protein	18665581
C057693	troglitazone	troglitazone binds to and results in increased activity of PPARG protein	10871190\|1103410
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased abundance of Cholesterol	16946405
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased degradation of CDKN1B protein	14618613
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 mRNA	16946405
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein	16946405
C057693	troglitazone	[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased abundance of Cholesterol	16946405
C057693	troglitazone	[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of HMGCR mRNA	16946405
C057693	troglitazone	[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased expression of SREBF2 protein] which results in decreased expression of LDLR mRNA	16946405
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in increased abundance of Cholesterol	12044893
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of and results in increased ubiquitination of CDKN1B protein	14618613
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of CDKN1B protein	11034103
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of HMGCR mRNA	12044893
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of HMGCS1 mRNA	12044893
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in increased susceptibility to arsenic trioxide	22684020
C057693	troglitazone	troglitazone binds to PPARG protein	11779144\|1538321
C057693	troglitazone	[troglitazone binds to PPARG protein] which affects the localization of NCOA1 protein	10871190
C057693	troglitazone	troglitazone inhibits the reaction [Arsenic results in decreased expression of PPARG mRNA]	23108036
C057693	troglitazone	troglitazone inhibits the reaction [Arsenic results in decreased expression of PPARG protein]	23108036
C057693	troglitazone	troglitazone inhibits the reaction [rosiglitazone binds to and results in increased activity of PPARG protein]	10871190
C057693	troglitazone	troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to AMOTL2 promoter]]	20847119
C057693	troglitazone	troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CCL2 promoter]]	20847119
C057693	troglitazone	troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CDKN1C promoter]]	20847119
C057693	troglitazone	troglitazone inhibits the reaction [tert-Butylhydroperoxide promotes the reaction [PPARG protein binds to CXCR4 promoter]]	20847119
C057693	troglitazone	troglitazone inhibits the reaction [TNF protein results in decreased expression of PPARG mRNA]	16483873
C057693	troglitazone	troglitazone promotes the reaction [NCOA1 protein binds to and results in increased activity of PPARG protein]	27551952
C057693	troglitazone	troglitazone promotes the reaction [PPARG protein binds to PRODH promoter]	16303758
C057693	troglitazone	troglitazone promotes the reaction [PPARG protein results in increased activity of [PPARG protein binds to RXRA protein]]	15581905
C057693	troglitazone	troglitazone promotes the reaction [PPARG protein results in increased expression of PRODH mRNA]	16303758
C057693	troglitazone	troglitazone results in decreased activity of PPARG protein alternative form	12475986
C057693	troglitazone	troglitazone results in increased activity of PPARG protein	15345676\|1614907
C057693	troglitazone	troglitazone results in increased activity of [PPARG protein binds to RXRA protein]	20008677
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 mRNA]	21617575
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of HMGB1 protein]	21617575
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] which results in decreased expression of HMGB1 mRNA	21617575
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] which results in decreased expression of HMGB1 protein	21617575
C057693	troglitazone	troglitazone results in increased expression of PPARG mRNA	10097144\|1117246
C057693	troglitazone	troglitazone results in increased expression of PPARG mRNA alternative form	11162573\|1191692
C057693	troglitazone	troglitazone results in increased expression of PPARG protein	11172467\|1463480
C057693	troglitazone	troglitazone results in increased phosphorylation of PPARG protein alternative form	12475986
C057693	troglitazone	ZNF366 protein promotes the reaction [troglitazone results in increased activity of [PPARG protein binds to RXRA protein]]	20008677
C057693	troglitazone	[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein	26117538
C057693	troglitazone	JMJD6 mutant form inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	26117538
C057693	troglitazone	(+)-JQ1 compound inhibits the reaction [[INS1 protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with troglitazone] results in increased expression of PPARG protein]	26117538
C057693	troglitazone	PPARG protein affects the reaction [troglitazone results in increased activity of CYP1A1 protein]	18308446
C057693	troglitazone	PPARG protein affects the reaction [troglitazone results in increased expression of CYP1A1 mRNA]	18308446
C057693	troglitazone	PPARG protein promotes the reaction [troglitazone results in increased expression of PPARGC1A mRNA]	16513826
C057693	troglitazone	PPARG protein results in increased susceptibility to troglitazone	15581905
C057693	troglitazone	troglitazone binds to and results in decreased activity of PPARG protein	16368784
C057693	troglitazone	troglitazone binds to and results in increased activity of PPARG protein	10871190\|1957761
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [PPARG protein binds to CYP1A1 promoter]	18308446
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] promotes the reaction [[PPARG protein binds to CYP1A1 promoter] which results in increased expression of CYP1A1 mRNA]	18308446
C057693	troglitazone	[troglitazone co-treated with Diethylstilbestrol] results in increased expression of PPARG protein	22710028
C057693	troglitazone	troglitazone promotes the reaction [PPARG protein results in increased expression of FABP4 mRNA]	10871190
C057693	troglitazone	troglitazone promotes the reaction [PPARG protein results in increased expression of SORBS1 mRNA]	10871190
C057693	troglitazone	troglitazone results in decreased expression of PPARG mRNA	12732648\|1681352
C057693	troglitazone	troglitazone results in decreased methylation of PPARG promoter	24559133
C057693	troglitazone	troglitazone results in increased activity of PPARG protein	11683414\|1191185
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] which results in increased expression of CD36 mRNA	11089532
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] which results in increased expression of ERO1L mRNA	17452443
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] which results in increased expression of FABP4 mRNA	11089532
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] which results in increased expression of UCP2 mRNA	11089532
C057693	troglitazone	troglitazone results in increased expression of PPARG mRNA	11113387\|1175209
C057693	troglitazone	troglitazone results in increased expression of PPARG protein	11752099\|1968244
C057693	troglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]]	21153920
C057693	troglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]]	21153920
C057693	troglitazone	2-chloro-5-nitrobenzanilide inhibits the reaction [[troglitazone results in increased activity of PPARG protein] which results in increased expression of SFTPA1 mRNA]	21153920
C057693	troglitazone	CR8 compound inhibits the reaction [troglitazone results in increased phosphorylation of PPARG protein]	24481447
C057693	troglitazone	troglitazone affects the activity of PPARG protein	25596134
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG mRNA] which results in decreased expression of SERPINE1 mRNA	11318962
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG mRNA] which results in decreased expression of SERPINE1 protein	11318962
C057693	troglitazone	troglitazone binds to and results in increased activity of PPARG protein	15150131\|1870410
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein	19248225
C057693	troglitazone	[[[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased localization of and results in decreased activity of SREBF1 protein] which results in decreased expression of FASN mRNA] which results in decreased abundance of Triglycerides	19248225
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of INSIG1 protein	19248225
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in increased expression of INSIG2 protein	19248225
C057693	troglitazone	troglitazone promotes the reaction [CDK5 protein results in increased phosphorylation of PPARG protein]	24481447
C057693	troglitazone	troglitazone promotes the reaction [PPARG protein binds to GFAP promoter]	24481447
C057693	troglitazone	troglitazone results in increased activity of PPARG protein alternative form	15211114
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased expression of TNF mRNA]	21153920
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein]	21153920
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] which results in decreased susceptibility to Lipopolysaccharides	21153920
C057693	troglitazone	[troglitazone results in increased activity of PPARG protein] which results in increased expression of SFTPA1 mRNA	21153920
C057693	troglitazone	troglitazone results in increased expression of PPARG mRNA	10662598\|2151530
C057693	troglitazone	troglitazone results in increased expression of PPARG protein	10662598\|1175209
C057693	troglitazone	troglitazone results in increased phosphorylation of and results in increased activity of PPARG protein	24481447
C057693	troglitazone	[troglitazone results in increased phosphorylation of and results in increased activity of PPARG protein] which results in decreased expression of GFAP protein	24481447
C057693	troglitazone	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [troglitazone results in increased activity of PPARG protein]"	14506076
C057693	troglitazone	troglitazone inhibits the reaction [pioglitazone results in increased activity of PPARG protein]	17065204
C057693	troglitazone	troglitazone results in increased activity of PPARG protein	14506076
C057693	troglitazone	PPARG protein affects the reaction [troglitazone inhibits the reaction [[PDGFB protein binds to PDGFB protein] which results in increased expression of FOS mRNA]]	10678274
C057693	troglitazone	PPARG protein affects the reaction [troglitazone inhibits the reaction [TNF protein results in increased expression of FOS mRNA]]	11401521
C057693	troglitazone	PPARG protein affects the reaction [troglitazone inhibits the reaction [TNF protein results in increased expression of FOS protein]]	11401521
C057693	troglitazone	PPARG protein affects the reaction [troglitazone results in decreased activity of TGFB1 protein]	19120328
C057693	troglitazone	PPARG protein affects the reaction [troglitazone results in decreased susceptibility to TNF protein]	11401521
C057693	troglitazone	troglitazone binds to and affects the activity of PPARG protein	11401521
C057693	troglitazone	troglitazone binds to and results in increased activity of PPARG mRNA	11318962
C057693	troglitazone	troglitazone binds to and results in increased activity of PPARG protein	10385688\|1117246
C057693	troglitazone	[troglitazone binds to and results in increased activity of PPARG protein] which results in decreased secretion of LEP protein	16037295
C057693	troglitazone	troglitazone binds to PPARG protein	10753628\|1081337
C057693	troglitazone	[troglitazone binds to PPARG protein] which affects the localization of EP300 protein	10871190
C057693	troglitazone	[troglitazone binds to PPARG protein] which binds to RXRA protein	15715931
C057693	troglitazone	[troglitazone co-treated with TNF protein] results in decreased expression of PPARG mRNA	12732648
C057693	troglitazone	troglitazone promotes the reaction [BMP2 protein affects the expression of PPARG mRNA]	19122273
C057693	troglitazone	troglitazone promotes the reaction [PPARG protein results in decreased activity of RELA protein]	12732648
C057693	troglitazone	troglitazone results in increased activity of PPARG protein	10678274\|1090998
C057693	troglitazone	troglitazone results in increased activity of [RXRA protein binds to PPARG protein]	11752099
D014414	Tungsten	Tungsten promotes the reaction [rosiglitazone results in increased expression of PPARG mRNA]	26865663
D014414	Tungsten	Tungsten results in increased expression of PPARG mRNA	26865663
C113580	U 0126	U 0126 inhibits the reaction [Acetaldehyde inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]]	17030193
C113580	U 0126	U 0126 inhibits the reaction [Acetaldehyde results in increased phosphorylation of and results in decreased activity of PPARG protein]	17030193
C113580	U 0126	U 0126 inhibits the reaction [deoxynivalenol results in increased expression of PPARG mRNA]	18485432
C113580	U 0126	U 0126 promotes the reaction [PPARG protein results in increased expression of PCSK9 protein]	22593575
C113580	U 0126	U 0126 inhibits the reaction [EGF protein promotes the reaction [Tetrachlorodibenzodioxin inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]]	16971554
C113580	U 0126	U 0126 inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of PPARG protein]	12758056
D014580	Ursodeoxycholic Acid	Ursodeoxycholic Acid results in decreased expression of PPARG mRNA	24312631
C005466	ursolic acid	"2,2-bis(4-glycidyloxyphenyl)propane inhibits the reaction [ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]]"	27274199
C005466	ursolic acid	ursolic acid inhibits the reaction [[Oxygen deficiency co-treated with Blood Glucose deficiency] results in decreased expression of PPARG protein]	27274199
C525131	UVI 3003	UVI 3003 results in decreased expression of PPARG mRNA	27894914
C525131	UVI 3003	UVI 3003 results in increased activity of PPARG protein	27894914
D014635	Valproic Acid	"[NOG protein co-treated with Valproic Acid co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of PPARG mRNA"	27188386
D014635	Valproic Acid	Valproic Acid affects the expression of PPARG mRNA	25979313
D014635	Valproic Acid	Valproic Acid binds to and results in increased activity of PPARG protein	24489787
D014635	Valproic Acid	Valproic Acid results in decreased methylation of PPARG gene	29154799
D014635	Valproic Acid	Valproic Acid results in increased expression of PPARG mRNA	24383497\|2800136
D000068756	Valsartan	Valsartan results in decreased expression of PPARG mRNA	22768174
D014638	Vanadates	EGF protein promotes the reaction [Vanadates inhibits the reaction [[Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine] results in increased expression of PPARG protein]]	16971554
D001335	Vehicle Emissions	Vehicle Emissions results in increased methylation of PPARG gene	25560391
D001335	Vehicle Emissions	2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in decreased expression of PPARG protein]	24192212
D001335	Vehicle Emissions	hydroxysafflor yellow A inhibits the reaction [2-chloro-5-nitrobenzanilide promotes the reaction [Vehicle Emissions results in decreased expression of PPARG protein]]	24192212
D001335	Vehicle Emissions	hydroxysafflor yellow A inhibits the reaction [Vehicle Emissions results in decreased expression of PPARG protein]	24192212
D001335	Vehicle Emissions	Vehicle Emissions results in decreased expression of PPARG protein	24192212
C029297	vinylidene chloride	vinylidene chloride results in increased expression of PPARG mRNA	26682919
D014801	Vitamin A	Vitamin A inhibits the reaction [Safflower Oil results in increased expression of PPARG mRNA]	15203375
D014801	Vitamin A	Vitamin A results in increased expression of PPARG mRNA	16180333
D009536	Niacinamide	Niacinamide results in increased expression of PPARG protein	22539994
D009536	Niacinamide	resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein]	22539994
D009536	Niacinamide	Niacinamide affects the reaction [PPARG protein binds to NCOR1 protein]	22539994
D009536	Niacinamide	Niacinamide results in increased expression of PPARG protein	22539994
D009536	Niacinamide	resveratrol inhibits the reaction [Niacinamide results in increased expression of PPARG protein]	22539994
D009536	Niacinamide	Niacinamide results in increased expression of PPARG mRNA	17851734
D009536	Niacinamide	[resveratrol promotes the reaction [SIRT1 protein binds to RUNX2 protein]] inhibits the reaction [Niacinamide results in increased expression of PPARG]	22539994
D009536	Niacinamide	[resveratrol results in decreased acetylation of RUNX2 protein] inhibits the reaction [Niacinamide results in increased expression of PPARG]	22539994
D014807	Vitamin D	Vitamin D affects the expression of PPARG mRNA	20368581
D014810	Vitamin E	Vitamin E inhibits the reaction [Linoleic Acid results in increased activity of PPARG protein]	15051824
D062065	Waste Water	Waste Water results in increased expression of PPARG mRNA	26944108
C009687	wortmannin	wortmannin inhibits the reaction [bisphenol A results in decreased expression of PPARG mRNA]	23399309
C108830	Y 27632	Y 27632 results in increased expression of PPARG mRNA	20578043
C029659	zearalenol	zearalenol results in decreased activity of PPARG protein	27481073
D015215	Zidovudine	Zidovudine results in decreased expression of PPARG mRNA	17926646
D015215	Zidovudine	Zidovudine results in decreased expression of PPARG protein	15722030
D015032	Zinc	Zinc results in decreased expression of PPARG mRNA	26602879
D015032	Zinc	[PCI 5002 co-treated with Zinc] results in increased expression of PPARG mRNA	18593933
D015032	Zinc	[LDLR gene mutant form results in increased susceptibility to Zinc deficiency] which results in increased expression of PPARG mRNA	16140885
D015032	Zinc	PPARG protein affects the reaction [Zinc results in increased abundance of Reactive Oxygen Species]	16737744
D015032	Zinc	Zinc deficiency results in decreased expression of PPARG mRNA	20128680
D015032	Zinc	"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of and results in increased activity of PPARG protein]"	14519784
D015032	Zinc	"N,N,N',N'-tetrakis(2-pyridylmethyl)ethylenediamine inhibits the reaction [Zinc results in increased expression of PPARG mRNA]"	14519784
D015032	Zinc	Zinc results in increased expression of and results in increased activity of PPARG protein	14519784
D015032	Zinc	Zinc results in increased expression of PPARG mRNA	14519784
C017803	zinc protoporphyrin	zinc protoporphyrin inhibits the reaction [cilostazol results in increased activity of PPARG protein]	21660147
C017803	zinc protoporphyrin	zinc protoporphyrin inhibits the reaction [rosiglitazone results in increased activity of PPARG protein]	21660147
C088658	zoledronic acid	zoledronic acid affects the activity of PPARG protein	25596134
D015054	Zymosan	Zymosan results in decreased expression of PPARG mRNA	16847310

GO/Pathway

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000976	transcription regulatory region sequence-specific DNA binding	-	IBA	21873635
GO:0000977	RNA polymerase II regulatory region sequence-specific DNA binding	-	IBA	21873635
GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	-	ISA	-
GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	-	ISM	19274049
GO:0000981	RNA polymerase II transcription factor activity, sequence-specific DNA binding	-	NAS	19274049
GO:0001076	transcription factor activity, RNA polymerase II transcription factor binding	-	IBA	21873635
GO:0001078	transcriptional repressor activity, RNA polymerase II proximal promoter sequence-specific DNA binding	-	IBA	21873635
GO:0001103	RNA polymerase II repressing transcription factor binding	-	IBA	21873635
GO:0001227	transcriptional repressor activity, RNA polymerase II transcription regulatory region sequence-specific DNA binding	-	IBA	21873635
GO:0003677	DNA binding	-	IDA	16239304
GO:0003677	DNA binding	-	ISS	-
GO:0003682	chromatin binding	-	ISS	-
GO:0003690	double-stranded DNA binding	-	IMP	19043829
GO:0003700	DNA-binding transcription factor activity	CONTRIBUTES_TO	IBA	21873635
GO:0003700	DNA-binding transcription factor activity	-	IDA	9568715
GO:0003700	DNA-binding transcription factor activity	-	ISS	-
GO:0003707	steroid hormone receptor activity	-	IEA	-
GO:0004879	nuclear receptor activity	-	IBA	21873635
GO:0004879	nuclear receptor activity	-	IDA	10622252
GO:0004955	prostaglandin receptor activity	-	TAS	9568715
GO:0005504	fatty acid binding	-	IBA	21873635
GO:0005515	protein binding	-	IPI	10428834 12040021 12522104 14701856 16239304 17500595 19846556 20195357 22351778
GO:0008022	protein C-terminus binding	-	IDA	19043829
GO:0008134	transcription factor binding	-	IBA	21873635
GO:0008134	transcription factor binding	-	IPI	26504087
GO:0008144	drug binding	-	IBA	21873635
GO:0008144	drug binding	-	IDA	9113987 10622252 19043829
GO:0008270	zinc ion binding	-	IDA	19043829
GO:0008289	lipid binding	-	IBA	21873635
GO:0019899	enzyme binding	-	IPI	12039952
GO:0019903	protein phosphatase binding	-	IEA	-
GO:0030331	estrogen receptor binding	-	IEA	-
GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	-	IBA	21873635
GO:0030374	ligand-dependent nuclear receptor transcription coactivator activity	-	IDA	16239304
GO:0033613	activating transcription factor binding	-	IDA	10622252
GO:0042277	peptide binding	-	IDA	19043829
GO:0042802	identical protein binding	-	IPI	25609649
GO:0043565	sequence-specific DNA binding	contributes_to	IDA	9568716
GO:0043621	protein self-association	-	IDA	19043829
GO:0044212	transcription regulatory region DNA binding	-	IDA	18293083
GO:0044212	transcription regulatory region DNA binding	-	ISS	-
GO:0046965	retinoid X receptor binding	-	IDA	9568715
GO:0046965	retinoid X receptor binding	-	IPI	19043829
GO:0046982	protein heterodimerization activity	-	IDA	19043829
GO:0050544	arachidonic acid binding	-	ISS	9568715
GO:0050692	DBD domain binding	-	IDA	19043829
GO:0050693	LBD domain binding	-	IDA	19043829
GO:0051393	alpha-actinin binding	-	IPI	22351778
GO:0070888	E-box binding	-	ISS	-
GO:0098531	transcription factor activity, direct ligand regulated sequence-specific DNA binding	-	IBA	21873635

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0000122	negative regulation of transcription by RNA polymerase II	-	IBA	21873635
GO:0000122	negative regulation of transcription by RNA polymerase II	-	IDA	12700342
GO:0000122	negative regulation of transcription by RNA polymerase II	-	ISS	-
GO:0001890	placenta development	-	ISS	-
GO:0002674	negative regulation of acute inflammatory response	-	IEA	-
GO:0006367	transcription initiation from RNA polymerase II promoter	-	TAS	-
GO:0006629	lipid metabolic process	-	TAS	9568716
GO:0006631	fatty acid metabolic process	-	IBA	21873635
GO:0006919	activation of cysteine-type endopeptidase activity involved in apoptotic process	-	IDA	18293083
GO:0007165	signal transduction	-	IDA	9568716
GO:0007186	G-protein coupled receptor signaling pathway	-	IEA	-
GO:0007275	multicellular organism development	-	IBA	21873635
GO:0007507	heart development	-	IEA	-
GO:0007584	response to nutrient	-	TAS	10973253
GO:0008217	regulation of blood pressure	-	IMP	10622252
GO:0009409	response to cold	-	IEA	-
GO:0009612	response to mechanical stimulus	-	IEA	-
GO:0009755	hormone-mediated signaling pathway	-	IBA	21873635
GO:0010742	macrophage derived foam cell differentiation	-	IDA	26504087
GO:0010745	negative regulation of macrophage derived foam cell differentiation	-	IC	12700342
GO:0010745	negative regulation of macrophage derived foam cell differentiation	-	IDA	19114110
GO:0010871	negative regulation of receptor biosynthetic process	-	IDA	12700342
GO:0010887	negative regulation of cholesterol storage	-	IBA	21873635
GO:0010887	negative regulation of cholesterol storage	-	IDA	19114110
GO:0010891	negative regulation of sequestering of triglyceride	-	IDA	12700342
GO:0015909	long-chain fatty acid transport	-	ISS	-
GO:0016525	negative regulation of angiogenesis	-	IDA	28566713
GO:0019216	regulation of lipid metabolic process	-	IBA	21873635
GO:0019395	fatty acid oxidation	-	IEA	-
GO:0030154	cell differentiation	-	IBA	21873635
GO:0030224	monocyte differentiation	-	IDA	9568716
GO:0030308	negative regulation of cell growth	-	IEA	-
GO:0030855	epithelial cell differentiation	-	ISS	-
GO:0031000	response to caffeine	-	IEA	-
GO:0031100	animal organ regeneration	-	IEA	-
GO:0031667	response to nutrient levels	-	IBA	21873635
GO:0032526	response to retinoic acid	-	IBA	21873635
GO:0032526	response to retinoic acid	-	IDA	16239304
GO:0032869	cellular response to insulin stimulus	-	IBA	21873635
GO:0032869	cellular response to insulin stimulus	-	IMP	10622252
GO:0032966	negative regulation of collagen biosynthetic process	-	IEA	-
GO:0033189	response to vitamin A	-	IEA	-
GO:0033993	response to lipid	-	IBA	21873635
GO:0033993	response to lipid	-	ISS	9568715
GO:0035357	peroxisome proliferator activated receptor signaling pathway	-	IMP	20622039
GO:0035902	response to immobilization stress	-	IEA	-
GO:0042593	glucose homeostasis	-	IMP	10622252
GO:0042594	response to starvation	-	IEA	-
GO:0042752	regulation of circadian rhythm	-	ISS	-
GO:0042953	lipoprotein transport	-	IDA	9568716
GO:0043388	positive regulation of DNA binding	-	IMP	19043829
GO:0043401	steroid hormone mediated signaling pathway	-	IEA	-
GO:0043537	negative regulation of blood vessel endothelial cell migration	-	IDA	28566713
GO:0043627	response to estrogen	-	IEA	-
GO:0045087	innate immune response	-	TAS	17145956
GO:0045165	cell fate commitment	-	ISS	-
GO:0045600	positive regulation of fat cell differentiation	-	ISS	-
GO:0045713	low-density lipoprotein particle receptor biosynthetic process	-	IDA	9568716
GO:0045892	negative regulation of transcription, DNA-templated	-	IBA	21873635
GO:0045892	negative regulation of transcription, DNA-templated	-	ISS	-
GO:0045893	positive regulation of transcription, DNA-templated	-	IMP	19043829
GO:0045893	positive regulation of transcription, DNA-templated	-	ISS	-
GO:0045923	positive regulation of fatty acid metabolic process	-	IBA	21873635
GO:0045944	positive regulation of transcription by RNA polymerase II	-	IBA	21873635
GO:0045944	positive regulation of transcription by RNA polymerase II	-	IDA	9568715 12700342 16239304 17611579
GO:0045944	positive regulation of transcription by RNA polymerase II	-	IMP	20622039
GO:0046321	positive regulation of fatty acid oxidation	-	IEA	-
GO:0048469	cell maturation	-	IDA	9568716
GO:0048511	rhythmic process	-	IEA	-
GO:0048662	negative regulation of smooth muscle cell proliferation	-	IDA	20622039
GO:0048714	positive regulation of oligodendrocyte differentiation	-	IEA	-
GO:0050728	negative regulation of inflammatory response	-	IBA	21873635
GO:0050872	white fat cell differentiation	-	ISS	-
GO:0050872	white fat cell differentiation	-	TAS	12588810
GO:0051091	positive regulation of DNA-binding transcription factor activity	-	IDA	18293083
GO:0051974	negative regulation of telomerase activity	-	IEA	-
GO:0055088	lipid homeostasis	-	TAS	9113987
GO:0060100	positive regulation of phagocytosis, engulfment	-	IEA	-
GO:0060336	negative regulation of interferon-gamma-mediated signaling pathway	-	IMP	21268089
GO:0060694	regulation of cholesterol transporter activity	-	IC	17611579
GO:0060850	regulation of transcription involved in cell fate commitment	-	ISS	-
GO:0060965	negative regulation of gene silencing by miRNA	-	IMP	28522568
GO:0061614	pri-miRNA transcription by RNA polymerase II	-	IDA	28566713
GO:0071300	cellular response to retinoic acid	-	IEA	-
GO:0071306	cellular response to vitamin E	-	IEA	-
GO:0071380	cellular response to prostaglandin E stimulus	-	IEA	-
GO:0071396	cellular response to lipid	-	IBA	21873635
GO:0071404	cellular response to low-density lipoprotein particle stimulus	-	IDA	9568716
GO:0071455	cellular response to hyperoxia	-	IEA	-
GO:1901558	response to metformin	-	IEA	-
GO:1904706	negative regulation of vascular smooth muscle cell proliferation	-	IDA	28522568
GO:1904706	negative regulation of vascular smooth muscle cell proliferation	-	IMP	24960162
GO:1905461	positive regulation of vascular associated smooth muscle cell apoptotic process	-	IMP	28522568
GO:1905563	negative regulation of vascular endothelial cell proliferation	-	IMP	24244514 24960162
GO:2000230	negative regulation of pancreatic stellate cell proliferation	-	IEA	-

GO ID	GO Term	Qualifier	Evidence	PubMed
GO:0005634	nucleus	-	IBA	21873635
GO:0005634	nucleus	-	IDA	9568716
GO:0005654	nucleoplasm	-	TAS	-
GO:0005829	cytosol	-	ISS	-
GO:0032991	protein-containing complex	-	IDA	19043829
GO:0043231	intracellular membrane-bounded organelle	-	IDA	-
GO:0048471	perinuclear region of cytoplasm	-	IEA	-
GO:0090575	RNA polymerase II transcription factor complex	-	IBA	21873635
GO:0090575	RNA polymerase II transcription factor complex	-	IDA	9568716

KEGG ID	KEGG Term
hsa03320	PPAR signaling pathway
hsa04380	Osteoclast differentiation
hsa05016	Huntington's disease
hsa05200	Pathways in cancer
hsa05216	Thyroid cancer

Reactome ID	Reactome Term	Evidence
R-HSA-1257604	PIP3 activates AKT signaling	TAS
R-HSA-1257604	PIP3 activates AKT signaling	IEA
R-HSA-1266738	Developmental Biology	TAS
R-HSA-1266738	Developmental Biology	IEA
R-HSA-1430728	Metabolism	TAS
R-HSA-162582	Signal Transduction	TAS
R-HSA-162582	Signal Transduction	IEA
R-HSA-1989781	PPARA activates gene expression	TAS
R-HSA-212436	Generic Transcription Pathway	TAS
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	TAS
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	IEA
R-HSA-383280	Nuclear Receptor transcription pathway	TAS
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	TAS
R-HSA-556833	Metabolism of lipids	TAS
R-HSA-6807070	PTEN Regulation	TAS
R-HSA-6807070	PTEN Regulation	IEA
R-HSA-73857	RNA Polymerase II Transcription	TAS
R-HSA-74160	Gene expression (Transcription)	TAS
R-HSA-8943724	Regulation of PTEN gene transcription	TAS
R-HSA-8943724	Regulation of PTEN gene transcription	IEA
R-HSA-9006925	Intracellular signaling by second messengers	TAS
R-HSA-9006925	Intracellular signaling by second messengers	IEA

Interactions (STRING v10.5, Interaction Score >= 0.400)

Publications (Co-occurrence of gene symbol strings and ANCO-Dependence terms)

PMID	Title (Year)	Author	Journal
19745552	Pro12Ala polymorphism of the peroxisome proliferatoractivated receptor-gamma gene is associated with metabolic syndrome and surrogate measures of insulin resistance in healthy men: interaction with smoking status. (2009 Nov)	Tellechea ML	Circ J
21044285	Analyses of association between PPAR gamma and EPHX1 polymorphisms and susceptibility to COPD in a Hungarian cohort, a case-control study. (2010 Nov 2)	Penyige A	BMC Med Genet
28386678	Identification of novel potential genetic predictors of urothelial bladder carcinoma susceptibility in Pakistani population. (2017 Oct)	Ali SHB	Fam Cancer
23587006	Validation of reported genetic risk factors for periodontitis in a large-scale replication study. (2013 Jun)	Schaefer AS	J Clin Periodontol
16110031	Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. (2005 Aug 20)	Leibovici D	J Clin Oncol
15486307	Cardiovascular risk in type 2 diabetes is associated with variation at the PPARG locus: a Go-DARTS study. (2004 Dec)	Doney AS	Arterioscler Thromb Vasc Biol
24045924	Genetic variation in the inflammation and innate immunity pathways and colorectal cancer risk. (2013 Nov)	Wang H	Cancer Epidemiol Biomarkers Prev
25516156	Peroxisome proliferator-activated receptors alpha and gamma are linked with alcohol consumption in mice and withdrawal and dependence in humans. (2015 Jan)	Blednov YA	Alcohol Clin Exp Res
24570271	The association between genetic variants of RUNX2, ADIPOQ and vertebral fracture in Korean postmenopausal women. (2015 Mar)	Kim KC	J Bone Miner Metab
19837787	Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients. (2010 Jan)	Liu L	Diabetes Care
21939732	PPARG gene Pro12Ala variant contributes to the development of non-alcoholic fatty liver in middle-aged and older Chinese population. (2012 Jan 2)	Yang Z	Mol Cell Endocrinol
28418876	PPARGC1A rs3736265 G>A polymorphism is associated with decreased risk of type 2 diabetes mellitus and fasting plasma glucose level. (2017 Jun 6)	Zhu L	Oncotarget
19020324	Clinical risk factors, DNA variants, and the development of type 2 diabetes. (2008 Nov 20)	Lyssenko V	N Engl J Med
21252350	Variants of the human PPARG locus and the susceptibility to chronic periodontitis. (2011 Dec)	Folwaczny M	Innate Immun
17903300	Genome-wide association to body mass index and waist circumference: the Framingham Heart Study 100K project. (2007 Sep 19)	Fox CS	BMC Med Genet
29254243	PPARG c.1347C>T polymorphism is associated with cancer susceptibility: from a case-control study to a meta-analysis. (2017 Nov 24)	Ding H	Oncotarget
12663371	Alanine for proline substitution in the peroxisome proliferator-activated receptor gamma-2 (PPARG2) gene and the risk of incident myocardial infarction. (2003 May 1)	Ridker PM	Arterioscler Thromb Vasc Biol
17999084	Relationship between two sequence variations in the gene for peroxisome proliferator-activated receptor-gamma and plasma homocysteine concentration. Health in men study. (2008 Feb)	Golledge J	Hum Genet
23372645	Graphical modeling of gene expression in monocytes suggests molecular mechanisms explaining increased atherosclerosis in smokers. (2013)	Verdugo RA	PLoS One
25102261	Maternal folate, alcohol and energy metabolism-related gene polymorphisms and the risk of recurrent pregnancy loss. (2012 Oct)	Sata F	J Dev Orig Health Dis